Trinity Capital Inc. - Quarter Report: 2021 September (Form 10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


⌧	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 2021


◻	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 000-56139

TRINITY CAPITAL INC.

(Exact name of registrant as specified in its charter)


Maryland	35-2670395
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)


1 N. 1^st Street 3^rd Floor Phoenix, Arizona	85004
(Address of principal executive offices)	(Zip Code)

(480) 374-5350

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of Each Class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	TRIN	Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ⌧ No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ◻ No ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:


Large accelerated filer	◻	Accelerated filer	◻
Non-accelerated filer	⌧	Smaller reporting company	◻
		Emerging growth company	⌧

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Indicate by check mark whether the registrant is a shell Company (as defined in Rule 12b-2 of the Act). Yes ◻ No ⌧

As of November 3, 2021, the registrant had 27,202,146 shares of common stock ($0.001 par value per share) outstanding.

Table of Contents

TRINITY CAPITAL INC.

FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2021
TABLE OF CONTENTS


		PAGE NO.
PART I	FINANCIAL INFORMATION	3
Item 1.	Consolidated Financial Statements	3
	Consolidated Statements of Assets and Liabilities as of September 30, 2021 (unaudited) and December 31, 2020	3
	Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2021 and 2020 (unaudited)	4
	Consolidated Statements of Changes in Net Assets for the Three and Nine Months Ended September 30, 2021 and 2020 (unaudited)	5
	Consolidated Statement of Cash Flows for the Nine Months Ended September 30, 2021 and 2020 (unaudited)	7
	Consolidated Schedule of Investments as of September 30, 2021 (unaudited)	9
	Consolidated Schedule of Investments as of December 31, 2020	25
	Notes to Consolidated Financial Statements (unaudited)	40
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	75
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	94
Item 4.	Controls and Procedures	96
PART II	OTHER INFORMATION	97
Item 1.	Legal Proceedings	97
Item 1A.	Risk Factors	97
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	99
Item 3.	Defaults Upon Senior Securities	99
Item 4.	Mine Safety Disclosures	99
Item 5.	Other Information	99
Item 6.	Exhibits	100
SIGNATURES		102

Table of Contents

PART I: FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

TRINITY CAPITAL INC.

Consolidated Statements of Assets and Liabilities

(In thousands, except share and per share data)


	September 30,		December 31,
	2021		2020
	(Unaudited)
ASSETS
Investments at fair value:
Control investments (cost of $37,934 and $57,072, respectively)	$	30,672	$	48,730
Affiliate investments (cost of $41,475 and $20,653, respectively)		34,309		27,650
Non-control / Non-affiliate investments (cost of $559,305 and $420,611, respectively)		612,265		417,271
Total investments (cost of $638,714 and $498,336, respectively)		677,246		493,651
Cash and cash equivalents		25,313		44,656
Restricted cash		15,000		16,445
Interest receivable		4,481		3,468
Prepaid expenses		1,025		744
Other assets		4,342		744
Total assets	$	727,407	$	559,708

LIABILITIES
2026 Notes, net of $2,564, and $0, respectively, of unamortized deferred financing costs	$	122,436	$	—
2025 Notes, net of $3,902, and $4,697, respectively, of unamortized deferred financing costs		121,098		120,303
Convertible Notes, net of $2,650, and $3,448, respectively, of unamortized deferred financing costs and discount		47,350		46,552
Credit Facility, net of $526 and $2,107, respectively, of unamortized deferred financing costs		9,474		132,893
Distribution payable		8,959		4,947
Security deposits		7,705		7,874
Accounts payable, accrued expenses and other liabilities		11,379		8,391
Total liabilities		328,401		320,960

Commitments and contingencies (Note 6)

NET ASSETS
Common stock, $0.001 par value per share (200,000,000 authorized, 27,148,096 and 18,321,274 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively)		27		18
Paid-in capital in excess of par		370,442		263,366
Distributable earnings/(accumulated loss)		28,537		(24,636)
Total net assets		399,006		238,748
Total liabilities and net assets	$	727,407	$	559,708
NET ASSET VALUE PER SHARE	$	14.70	$	13.03

See accompanying notes to consolidated financial statements.

Table of Contents

TRINITY CAPITAL INC.

Consolidated Statements of Operations

(In thousands, except share and per share data)

(Unaudited)


	Three Months Ended				Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
INVESTMENT INCOME:
Interest income:
Control investments	$	1,288	$	1,045	$	3,860	$	2,617
Affiliate investments		273		144		1,155		876
Non-Control / Non-Affiliate investments		19,098		11,372		50,103		33,322
Total interest income		20,659		12,561		55,118		36,815
Fee income:
Non-Control / Non-Affiliate investments		1,131		965		3,468		2,808
Total fee income		1,131		965		3,468		2,808
Total investment income		21,790		13,526		58,586		39,623

EXPENSES:
Interest expense and other debt financing costs		5,112		3,893		14,153		12,433
Compensation and benefits		3,677		2,904		11,043		5,983
Professional fees		762		733		1,979		1,913
General and administrative		1,116		381		2,955		1,209
Total expenses		10,667		7,911		30,130		21,538

NET INVESTMENT INCOME		11,123		5,615		28,456		18,085

NET REALIZED GAIN/(LOSS) FROM INVESTMENTS:
Control investments		(2,725)		—		(2,725)		—
Affiliate investments		—		—		1,491		—
Non-Control / Non-Affiliate investments		3,391		(1,490)		6,490		(4,374)
Net realized gain/(loss) from investments		666		(1,490)		5,256		(4,374)

NET CHANGE IN UNREALIZED APPRECIATION/(DEPRECIATION) FROM INVESTMENTS:
Control investments		13,172		818		1,088		(7,350)
Affiliate investments		(5,960)		2,605		(14,165)		471
Non-Control / Non-Affiliate investments		8,180		4,786		56,575		(7,081)
Net change in unrealized appreciation/(depreciation) from investments		15,392		8,209		43,498		(13,960)

NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS BEFORE FORMATION COSTS		27,181		12,334		77,210		(249)
Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds		—		—		—		(15,586)
NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS	$	27,181	$	12,334	$	77,210	$	(15,835)

NET INVESTMENT INCOME PER SHARE - BASIC	$	0.42	$	0.31	$	1.11	$	1.00
NET INVESTMENT INCOME PER SHARE - DILUTED	$	0.40		0.31	$	1.08	$	1.00

NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - BASIC	$	1.02	$	0.68	$	3.02	$	(0.88)
NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - DILUTED	$	0.94	$	0.68	$	2.77	$	(0.88)

WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC		26,641,084		18,166,491		25,569,565		18,033,173
WEIGHTED AVERAGE SHARES OUTSTANDING - DILUTED		29,974,419		18,166,491		28,902,900		18,033,173

See accompanying notes to consolidated financial statements.

Table of Contents

TRINITY CAPITAL INC.

Consolidated Statements of Changes in Net Assets

(In thousands, except share and per share data)

(Unaudited)

Three Months Ended September 30, 2021:


						Distributable
						Earnings /
	Common Stock			Paid In Capital		(Accumulated		Total
	Shares	Par Value		in Excess of Par		Loss)		Net Assets
Balance as of June 30, 2021	26,491,274	$	26	$	369,379	$	10,315	$	379,720
Issuance of common stock pursuant to distribution reinvestment plan	63,390		—		915		—		915
Stock based compensation	—		—		149		—		149
Issuance of restricted stock	593,432		1		(1)		—		—
Distributions to stockholders	—		—		—		(8,959)		(8,959)
Net increase/(decrease) in net assets resulting from operations:
Net investment income	—		—		—		11,123		11,123
Net realized gain/(loss) from investments	—		—		—		666		666
Net unrealized appreciation/(depreciation) from investments	—		—		—		15,392		15,392
Balance as of September 30, 2021	27,148,096	$	27	$	370,442	$	28,537	$	399,006

Three Months Ended September 30, 2020:


						Distributable
				Paid In Capital		Earnings /
	Common Stock			in Excess of		(Accumulated		Total
	Shares	Par Value		Par Value		Loss)		Net Assets
Balance as of June 30, 2020	18,137,600	$	18	$	261,292	$	(32,664)	$	228,646
Issuance of common stock pursuant to distribution reinvestment plan	98,443		—		1,242		—		1,242
Distributions to stockholders	—		—		—		(4,897)		(4,897)
Net increase/(decrease) in net assets resulting from operations:
Net investment income	—		—		—		5,615		5,615
Net realized gain/(loss) from investments	—		—		—		(1,490)		(1,490)
Net unrealized appreciation/(depreciation) from investments	—		—		—		8,209		8,209
Balance as of September 30, 2020	18,236,043	$	18	$	262,534	$	(25,227)	$	237,325

Table of Contents

Nine Months Ended September 30, 2021:


						Distributable
				Paid In Capital		Earnings /
	Common Stock			in Excess of		(Accumulated		Total
	Shares	Par Value		Par Value		Loss)		Net Assets
Balance as of December 31, 2020	18,321,274	$	18	$	263,366	$	(24,636)	$	238,748
Impact of adoption of ASU 2020-06	—		—		(462)		—		(462)
Issuance of common stock in initial public offering, net of issuance costs	8,006,291		8		104,200		—		104,208
Issuance of common stock pursuant to distribution reinvestment plan	227,099		—		3,190		—		3,190
Stock based compensation	—		—		149		—		149
Issuance of restricted stock	593,432		1		(1)		—		—
Distributions to stockholders	—		—		—		(24,037)		(24,037)
Net increase/(decrease) in net assets resulting from operations:
Net investment income	—		—		—		28,456		28,456
Net realized gain/(loss) from investments	—		—		—		5,256		5,256
Net unrealized appreciation/(depreciation) from investments	—		—		—		43,498		43,498
Balance as of September 30, 2021	27,148,096	$	27	$	370,442	$	28,537	$	399,006

Nine Months Ended September 30, 2020:


						Distributable
				Paid In Capital		Earnings /
	Common Stock			in Excess of		(Accumulated		Total
	Shares	Par Value		Par Value		Loss)		Net Assets
Balance as of December 31, 2019	10	$	—	$	—	$	(524)	$	(524)
Issuance of shares related to Formation Transaction ⁽¹⁾	9,716,517		10		145,738		—		145,748
Issuance of common stock, net of issuance costs	8,333,333		8		114,463		—		114,471
Issuance of common stock pursuant to distribution reinvestment plan	186,183		—		2,333		—		2,333
Distributions to stockholders	—		—		—		(8,868)		(8,868)
Net increase/(decrease) in net assets resulting from operations:
Net investment income	—		—		—		18,085		18,085
Net realized gain/(loss) from investments	—		—		—		(4,374)		(4,374)
Net unrealized appreciation/(depreciation) from investments	—		—		—		(13,960)		(13,960)
Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds	—		—		—		(15,586)		(15,586)
Balance as of September 30, 2020	18,236,043	$	18	$	262,534	$	(25,227)	$	237,325

(1)	See “Note 1 - Organization and Basis of Presentation”

See accompanying notes to consolidated financial statements.

Table of Contents

TRINITY CAPITAL INC.

Consolidated Statement of Cash Flows

(In thousands)

(Unaudited)


	Nine Months Ended
	September 30, 2021		September 30, 2020
Cash flows provided by/(used in) operating activities:
Net increase/(decrease) in net assets resulting from operations	$	77,210	$	(15,835)
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash provided by/(used in) operating activities:
Purchase of investments, net of deferred fees		(358,450)		(137,505)
Proceeds from sales and paydowns of investments		240,132		118,644
Net change in unrealized appreciation/(depreciation) from investments, net of third party participation		(43,215)		13,960
Net realized gain/(loss) from investments		(5,256)		4,374
Accretion of original issue discounts and end of term payments on investments		(16,807)		(7,810)
Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds		—		15,586
Amortization of deferred financing costs		2,850		2,182
Share-based compensation		149
Change in operating assets and liabilities
(Increase)/Decrease in interest receivable		(1,013)		(2,045)
(Increase)/Decrease in prepaid expenses		(281)		(511)
(Increase)/Decrease in other assets		(2,441)		(217)
Increase/(Decrease) in security deposits		(169)		2,811
Increase/(Decrease) in accounts payable, accrued expenses and other liabilities		2,991		3,522
Increase/(Decrease) in due to related party		—		(1,058)
Net cash provided by/(used in) operating activities		(104,300)		(3,902)

Cash flows provided by/(used in) investing activities:
Formation Transactions of Legacy Funds, net of cash acquired ⁽¹⁾		—		(89,515)
Acquisition of Trinity Capital Holdings		—		(2,211)
Acquisition of fixed assets		(1,157)		(61)
Net cash provided by/(used in) investing activities		(1,157)		(91,787)

Cash flows provided by/(used in) financing activities
Issuance of common stock		112,088		125,000
Common stock issuance costs		(7,880)		(10,529)
Cash distributions paid		(16,835)		(6,535)
Proceeds from issuance of 2025 Notes		—		125,000
Financing costs paid related to 2025 Notes		(85)		(5,610)
Proceeds from issuance of 2026 Notes		125,000		—
Financing costs paid related to 2026 Notes		(2,619)		—
Proceeds under Credit Facility		71,000		(85,000)
Repayments under Credit Facility		(196,000)		10,000
Financing costs paid related to credit facility		—		(3,983)
Net cash provided by/(used in) financing activities		84,669		148,343

Net increase/(decrease) in cash, cash equivalents and restricted cash		(20,788)		52,654
Cash, cash equivalents and restricted cash at beginning of period		61,101		—
Cash, cash equivalents and restricted cash at end of period	$	40,313	$	52,654


	For the Nine Months Ended
	September 30, 2021		September 30, 2020
Supplemental and non-cash investing and financing activities:
Cash paid for interest	$	9,618	$	9,592
Shares issued to Trinity Capital Holdings ⁽¹⁾	$	—	$	8,000
Assumption of severance liability ⁽¹⁾	$	—	$	3,508
Shares issued to the Legacy Investors as part of the Formation Transactions ⁽¹⁾	$	—	$	137,748
Accrued but unpaid distributions	$	8,959	$	—
Value of shares issued in connection with the distribution reinvestment plan	$	3,190	$	2,333
Non-cash settlement of investments	$	5,065	$	731

Table of Contents

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the Consolidated Statements of Assets and Liabilities that sum to the total of the same such amounts on the Consolidated Statement of Cash Flows:


	September 30,		September 30,
	2021		2020
Cash and cash equivalents	$	25,313	$	36,323
Restricted cash		15,000		16,331
Total cash, cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows	$	40,313	$	52,654

(1)

See “Note 1 - Organization and Basis of Presentation”

See accompanying notes to consolidated financial statements.

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

September 30, 2021

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities

Administrative and Support and Waste Management and Remediation ⁽⁷⁾
SeaOn Environmental, LLC	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 9.0%; EOT 12.0%	$	1,378	$	1,726	$	1,715

Gabi Personal Insurance Agency, Inc.	Secured Loan⁽¹⁴⁾	August 6, 2021	September 1, 2025	Variable interest rate Prime + 3.3% or Floor rate 11.8%; EOT 5.5% ⁽⁸⁾	$	5,000	$	4,924	$	5,275


Sub-total: Administrative and Support and Waste Management and Remediation (0.5%)*					$	6,378	$	6,650	$	6,990

Agriculture, Forestry, Fishing and Hunting ⁽⁷⁾
Bowery Farming, Inc.	Secured Loan⁽¹⁴⁾	September 10, 2021	January 1, 2026	Variable interest rate LIBOR + 11.0% or Floor rate 10.1% ⁽⁸⁾	$	10,000	$	9,197	$	9,197

Robotany, Inc.	Equipment Financing	January 16, 2020	January 1, 2024	Fixed interest rate 7.6%; EOT 22.0%	$	1,322	$	1,545	$	1,593

Sub-total: Agriculture, Forestry, Fishing and Hunting (4.8%)*					$	11,322	$	10,742	$	10,790

Construction ⁽⁷⁾
Dandelion Energy, Inc.	Equipment Financing	March 17, 2020	April 1, 2024	Fixed interest rate 9.0%; EOT 12.5%	$	365	$	394	$	395
	Equipment Financing	October 27, 2020	November 1, 2024	Fixed interest rate 9.2%; EOT 12.5%		453		481		480
	Equipment Financing ⁽¹⁹⁾	November 19, 2020	December 1, 2024	Fixed interest rate 9.1%; EOT 12.5%		447		479		478
	Equipment Financing	December 29, 2020	January 1, 2025	Fixed interest rate 9.2%; EOT 12.5%		659		692		690
	Equipment Financing⁽¹⁹⁾	March 25, 2021	April 1, 2025	Fixed interest rate 9.1%; EOT 12.5%		994		1,037		1,037
Total Dandelion Energy, Inc.						2,918		3,083		3,080

Project Frog, Inc. ⁽²¹⁾	Secured Loan	April 30, 2020	December 1, 2023	Fixed interest rate 12.0%	$	4,128	$	4,063	$	3,757

Sub-total: Construction (1.9%)*					$	7,046	$	7,146	$	6,837

Educational Services ⁽⁷⁾
Medical Sales Training Holding Company	Secured Loan	March 18, 2021	April 1, 2025	Variable interest rate Prime + 3.3% or Floor rate 12.0%; EOT 5.0% ⁽⁸⁾	$	6,000	$	5,993	$	6,026
	Secured Loan	July 21, 2021	August 1, 2025	Variable interest rate Prime + 3.3% or Floor rate 12.0%; EOT 5.0% ⁽⁸⁾		2,000		1,983		1,983
Total Medical Sales Training Holding Company						8,000		7,976		8,009

Yellowbrick Learning, Inc.	Secured Loan	February 1, 2021	September 1, 2025	Variable interest rate Prime + 3.3% or Floor rate 11.5%; EOT 5.0% ⁽⁸⁾	$	7,500	$	7,546	$	7,546
	Secured Loan	August 10, 2021	March 1, 2026	Variable interest rate Prime + 3.3% or Floor rate 11.5%; EOT 5.0% ⁽⁸⁾		2,500		2,493		2,493
Total Yellowbrick Learning, Inc.						10,000		10,039		10,039

Sub-total: Educational Services (3.6%)*					$	18,000	$	18,015	$	18,048

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

September 30, 2021

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾

Debt Securities, Continued

Finance and Insurance ⁽⁷⁾
DailyPay, Inc.	Secured Loan	September 30, 2020	November 1, 2024	Variable interest rate Prime + 5.0% or Floor rate 12.0%; EOT 6.0% ⁽⁸⁾	$	20,000	$	20,195	$	20,682
	Secured Loan	December 30, 2020	January 1, 2025	Variable interest rate Prime + 5.0% or Floor rate 12.0%; EOT 6.0% ⁽⁸⁾		5,000		5,041		5,149
Total DailyPay, Inc.						25,000		25,236		25,831

Petal Card, Inc.	Secured Loan	January 16, 2020	October 1, 2024	Variable interest rate Prime + 3.5% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾	$	10,000	$	10,112	$	10,040
	Secured Loan ^(12)(14)	January 28, 2021	January 1, 2024	Variable interest rate Prime + 4.3% or Floor rate 11.5% ⁽⁸⁾		8,235		9,214		9,603
	Secured Loan	August 6, 2021	October 1, 2024	Variable interest rate Prime + 11.0% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾		7,000		6,798		6,800
						25,235		26,124		26,443

Sub-total: Finance and Insurance (10.7%)*					$	50,235	$	51,360	$	52,274

Health Care and Social Assistance ⁽⁷⁾
FemTec Health, Inc.	Secured Loan	July 23, 2021	February 1, 2026	Fixed interest rate 11.0%; EOT 7.5%	$	10,000	$	10,517	$	10,127
	Secured Loan	July 23, 2021	September 1, 2022	Fixed interest rate 11.0%; EOT 0.0%		2,151		2,151		2,171
	Secured Loan	September 29, 2021	April 1, 2026	Fixed interest rate 11.0%; EOT 7.5%		3,000		3,000		3,000
Total FemTec Health, Inc. ⁽²¹⁾						15,151		15,668		15,298

Lark Technologies, Inc.	Secured Loan	September 30, 2020	April 1, 2025	Variable interest rate Prime + 3.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾	$	5,000	$	4,905	$	4,959
	Secured Loan	June 30, 2021	January 1, 2026	Variable interest rate Prime + 3.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾		5,000		4,780		4,819
Total Lark Technologies, Inc.						10,000		9,685		9,778

WorkWell Prevention & Care Inc.	Secured Loan	January 16, 2020	March 1, 2024	Fixed interest rate 8.0%; EOT 10.0%	$	3,370	$	3,646	$	3,614
	Secured Loan	January 16, 2020	March 1, 2024	Fixed interest rate 8.0%		700		722		693
Total WorkWell Prevention & Care Inc. ⁽²¹⁾						4,070		4,368		4,307

Sub-total: Health Care and Social Assistance (3.7%)*					$	29,221	$	29,721	$	29,383

Information ⁽⁷⁾

Firefly Systems, Inc.	Equipment Financing	January 29, 2020	February 1, 2023	Fixed interest rate 9.0%; EOT 10.0%	$	2,609	$	2,986	$	2,953
	Equipment Financing	August 28, 2020	September 1, 2023	Fixed interest rate 8.9%; EOT 10.0%		2,382		2,609		2,594
	Equipment Financing	September 18, 2020	October 1, 2023	Fixed interest rate 8.8%; EOT 10.0%		290		315		314
Total Firefly Systems, Inc.						5,281		5,910		5,861

Gobiquity, Inc.	Equipment Financing	January 16, 2020	April 1, 2022	Fixed interest rate 7.5%; EOT 20.0%	$	122	$	250	$	244

Group Nine Media, Inc.	Secured Loan⁽¹⁴⁾	September 17, 2021	October 1, 2026	Variable interest rate Prime + 3.3% or Floor rate 10.5%; EOT 3.5% ⁽⁸⁾	$	20,000	$	19,907	$	19,907

Rigetti & Co, Inc.	Secured Loan	March 10, 2021	April 1, 2025	Variable interest rate Prime + 3.5% or Floor rate 11.0%; EOT 2.8% ⁽⁸⁾	$	12,000	$	11,837	$	11,934
	Secured Loan	May 18, 2021	June 1, 2025	Variable interest rate Prime + 3.5% or Floor rate 11.0%; EOT 2.8% ⁽⁸⁾		8,000		7,858		7,925
Total Rigetti & Co, Inc.						20,000		19,695		19,859

Smule, Inc.	Secured Loan⁽¹⁵⁾	July 1, 2020	January 1, 2022	Fixed interest rate 0.0%	$	40	$	40	$	40

Stratifyd, Inc.	Secured Loan⁽¹⁴⁾	September 3, 2021	December 1, 2025	Variable interest rate Prime + 3.3% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾	$	6,000	$	5,921	$	5,921

Whip Networks, Inc.	Secured Loan⁽¹⁴⁾	June 14, 2021	July 1, 2025	Variable interest rate Prime + 3.3% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾	$	5,000	$	4,973	$	5,014
	Secured Loan⁽¹⁴⁾	September 10, 2021	July 1, 2025	Variable interest rate Prime + 3.3% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾		1,000		991		991
Total Whip Networks, Inc.						6,000		5,964		6,005

Sub-total: Information (8.3%)*					$	57,443	$	57,687	$	57,837

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

September 30, 2021

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Manufacturing ⁽⁷⁾
Circle Media Labs, Inc.	Secured Loan⁽¹⁴⁾	May 5, 2021	June 1, 2025	Variable interest rate Prime + 5.3% or Floor rate 12.0%; EOT 5.0% ⁽⁸⁾	$	5,000	$	4,977	$	2,700

Daring Foods, Inc.	Equipment Financing⁽¹⁴⁾	April 8, 2021	May 1, 2024	Fixed interest rate 9.6%; EOT 7.5%	$	438	$	443	$	445
	Equipment Financing⁽¹⁴⁾	July 7, 2021	July 1, 2024	Fixed interest rate 9.5%; EOT 7.5%		2,079		2,072		2,072
	Equipment Financing⁽¹⁴⁾	August 17, 2021	September 1, 2024	Fixed interest rate 9.7%; EOT 7.5%		1,018		1,009		1,009
	Equipment Financing⁽¹⁴⁾	August 31, 2021	September 1, 2024	Fixed interest rate 10.0%; EOT 7.5%		591		584		584
Total Daring Foods, Inc.						4,126		4,108		4,110


Footprint International Holding, Inc.	Equipment Financing	February 14, 2020	March 1, 2024	Fixed interest rate 10.3%; EOT 8.0%	$	11,691	$	12,544	$	12,597
	Secured Loan	June 22, 2020	November 1, 2024	Fixed interest rate 12.0%; EOT 9.0%		6,837		7,110		7,097
Total Footprint International Holding, Inc.						18,528		19,654		19,694

Happiest Baby, Inc.	Equipment Financing	January 16, 2020	September 1, 2022	Fixed interest rate 8.4%; EOT 9.5%	$	524	$	669	$	654
	Equipment Financing	January 16, 2020	November 1, 2022	Fixed interest rate 8.6%; EOT 9.5%		456		563		561
	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 8.6%; EOT 9.5%		463		550		552
	Equipment Financing	February 7, 2020	June 1, 2023	Fixed interest rate 8.2%; EOT 9.5%		640		723		722
	Equipment Financing	September 16, 2020	January 1, 2024	Fixed interest rate 8.4%; EOT 9.5%		965		1,032		1,034
	Equipment Financing	January 22, 2021	May 1, 2025	Fixed interest rate 8.4%; EOT 9.5%		816		851		853
Total Happiest Baby, Inc.						3,864		4,388		4,376

Health-Ade, LLC	Equipment Financing	January 16, 2020	February 1, 2022	Fixed interest rate 9.4%; EOT 15.0%	$	434	$	1,027	$	1,012
	Equipment Financing	January 16, 2020	April 1, 2022	Fixed interest rate 8.6%; EOT 15.0%		324		616		607
	Equipment Financing	January 16, 2020	July 1, 2022	Fixed interest rate 9.1%; EOT 15.0%		1,011		1,603		1,583
Total Health-Ade, LLC						1,769		3,246		3,202

Hi-Power, LLC	Equipment Financing⁽¹⁴⁾	September 30, 2021	April 1, 2025	Fixed interest rate 12.4%; EOT 1.0%	$	7,000	$	6,983	$	6,983

Mainspring Energy, Inc.	Secured Loan	January 16, 2020	August 1, 2023	Fixed interest rate 11.0%; EOT 3.8%	$	6,423	$	6,682	$	6,702
	Secured Loan	November 20, 2020	December 1, 2024	Fixed interest rate 11.0%; EOT 3.8%		5,500		5,392		5,511
Total Mainspring Energy, Inc.						11,923		12,074		12,213

Miyoko's Kitchen	Equipment Financing	February 19, 2020	September 1, 2022	Fixed interest rate 8.8%; EOT 9.0%	$	329	$	392	$	392
	Equipment Financing	August 27, 2020	March 1, 2023	Fixed interest rate 8.9%; EOT 9.0%		586		646		646
	Equipment Financing	February 5, 2021	September 1, 2023	Fixed interest rate 8.5%; EOT 9.0%		512		538		538
	Equipment Financing	June 25, 2021	December 1, 2023	Fixed interest rate 8.9%; EOT 9.0%		541		551		552
Total Miyoko's Kitchen						1,968		2,127		2,128

Molekule, Inc.	Equipment Financing	June 19, 2020	January 1, 2024	Fixed interest rate 8.8%; EOT 10.0%	$	1,955	$	2,101	$	2,089
	Equipment Financing	September 29, 2020	April 1, 2024	Fixed interest rate 9.0%; EOT 10.0%		430		458		455
	Equipment Financing	December 18, 2020	July 1, 2024	Fixed interest rate 8.8%; EOT 10.0%		709		743		737
	Equipment Financing	August 25, 2021	March 1, 2025	Fixed interest rate 8.9%; EOT 10.0%		527		530		530
Total Molekule, Inc.						3,621		3,832		3,811

Nexii Building Solutions, Inc.	Secured Loan⁽¹⁰⁾⁽¹⁴⁾	August 27, 2021	September 1, 2025	Variable interest rate Prime + 3.3% or Floor rate 10.3%; EOT 2.5% ⁽⁸⁾	$	10,000	$	9,515	$	9,515

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

September 30, 2021

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Manufacturing, Continued ⁽⁷⁾
Quip NYC, Inc.	Secured Loan	March 9, 2021	April 1, 2026	Variable interest rate Prime + 3.3% or Floor rate 11.3%; EOT 3.0% ⁽⁸⁾	$	17,500	$	17,256	$	17,402

Store Intelligence, Inc. ⁽²¹⁾	Secured Loan ⁽¹⁸⁾	May 2, 2020	August 1, 2024	Fixed interest rate 12.0%; EOT 7.7%	$	11,761	$	12,153	$	6,919

Tarana Wireless, Inc.	Secured Loan⁽¹⁴⁾	June 30, 2021	July 1, 2025	Variable interest rate Prime + 3.5% or Floor rate 11.5%; EOT 4.5% ⁽⁸⁾	$	18,500	$	17,540	$	17,373

The Fynder Group, Inc.	Equipment Financing	October 14, 2020	May 1, 2024	Fixed interest rate 9.1%; EOT 10.0%	$	536	$	555	$	556

Vertical Communications, Inc.	Secured Loan	August 23, 2021	March 1, 2026	Fixed interest rate 11.0%; EOT 23.8%	$	13,300	$	14,796	$	13,493

VitaCup, Inc.	Secured Loan⁽¹⁴⁾	June 23, 2021	July 1, 2025	Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 2.5% ⁽⁸⁾	$	5,500	$	5,454	$	5,505

Sub-total: Manufacturing (31.7%)*					$	134,896	$	138,658	$	129,980

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

September 30, 2021

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Pharmaceutical ⁽⁷⁾
Zosano Pharma Corporation	Equipment Financing	January 16, 2020	April 1, 2022	Fixed interest rate 9.4%; EOT 12.0%	$	934	$	1,519	$	1,449
	Equipment Financing	January 16, 2020	July 1, 2022	Fixed interest rate 9.7%; EOT 12.0%		778		1,094		1,045
	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 9.9%; EOT 12.0%		1,042		1,273		1,233
	Equipment Financing	January 16, 2020	April 1, 2023	Fixed interest rate 9.9%; EOT 12.0%		1,235		1,446		1,416
	Equipment Financing	January 16, 2020	May 1, 2023	Fixed interest rate 10.5%; EOT 12.0%		943		1,093		1,065
Total Zosano Pharma Corporation						4,932		6,425		6,208

Sub-total: Pharmaceutical (1.9%)*					$	4,932	$	6,425	$	6,208

Professional, Scientific, and Technical Services ⁽⁷⁾
BackBlaze, Inc.	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 7.2%; EOT 11.5%	$	582	$	753	$	749
	Equipment Financing	January 16, 2020	April 1, 2023	Fixed interest rate 7.4%; EOT 11.5%		80		99		98
	Equipment Financing	January 16, 2020	June 1, 2023	Fixed interest rate 7.4%; EOT 11.5%		641		772		769
	Equipment Financing	January 16, 2020	August 1, 2023	Fixed interest rate 7.5%; EOT 11.5%		131		155		154
	Equipment Financing	January 16, 2020	September 1, 2023	Fixed interest rate 7.7%; EOT 11.5%		136		160		159
	Equipment Financing	January 16, 2020	October 1, 2023	Fixed interest rate 7.5%; EOT 11.5%		139		161		160
	Equipment Financing	January 16, 2020	November 1, 2023	Fixed interest rate 7.2%; EOT 11.5%		469		540		537
	Equipment Financing	January 16, 2020	December 1, 2023	Fixed interest rate 7.5%; EOT 11.5%		628		716		712
	Equipment Financing	January 16, 2020	January 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		552		625		621
	Equipment Financing	January 20, 2020	February 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		569		638		635
	Equipment Financing	February 1, 2020	March 1, 2024	Fixed interest rate 7.2%; EOT 11.5%		498		557		554
	Equipment Financing	March 26, 2020	April 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		152		168		170
	Equipment Financing	April 17, 2020	May 1, 2024	Fixed interest rate 7.3%; EOT 11.5%		991		1,093		1,092
	Equipment Financing	July 27, 2020	August 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		1,085		1,172		1,168
	Equipment Financing	September 4, 2020	October 1, 2024	Fixed interest rate 7.2%; EOT 11.5%		196		209		209
	Equipment Financing	March 29, 2021	April 1, 2025	Fixed interest rate 7.5%; EOT 11.5%		2,466		2,548		2,551
Total BackBlaze, Inc.						9,315		10,366		10,338

Commonwealth Fusion Systems LLC	Equipment Financing⁽¹⁴⁾	September 10, 2021	October 1, 2024	Fixed interest rate 9.5%; EOT 8.5%	$	2,345	$	2,341	$	2,341

Core Scientific, Inc.	Equipment Financing⁽¹⁴⁾	August 31, 2021	October 1, 2024	Fixed interest rate 10.3%; EOT 5.0%	$	1,000	$	1,002	$	1,002

Edeniq, Inc.	Secured Loan	January 16, 2020	September 1, 2021	Fixed interest rate 18.0%	$	1,726	$	36	$	2,211
	Secured Loan	January 16, 2020	September 1, 2021	Fixed interest rate 18.0%		1,290		27		1,668
Total Edeniq, Inc. ⁽²¹⁾						3,016		63		3,879

Emerald Cloud Lab, Inc.	Equipment Financing⁽¹⁴⁾	July 13, 2021	August 1, 2024	Fixed interest rate 9.7%; EOT 7.0%	$	10,059	$	10,158	$	10,158

Emergy, Inc.	Equipment Financing⁽¹⁴⁾	January 8, 2021	May 1, 2024	Fixed interest rate 9.1%; EOT 8.5%	$	475	$	491	$	492

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

September 30, 2021

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Professional, Scientific, and Technical Services, Continued
Greenlight Biosciences Inc.	Equipment Financing	March 29, 2021	April 1, 2024	Fixed interest rate 9.7%; EOT 8.0%	$	2,828	$	2,867	$	2,883
	Equipment Financing	June 17, 2021	July 1, 2024	Fixed interest rate 9.5%; EOT 8.0%		4,042		4,041		4,084
	Equipment Financing	August 31, 2021	September 1, 2024	Fixed interest rate 9.7%; EOT 8.0%		2,165		2,138		2,138
	Equipment Financing	August 31, 2021	September 1, 2024	Fixed interest rate 9.7%; EOT 8.0%		1,254		1238		1,238
Total Greenlight Biosciences Inc.						10,289		10,284		10,343

Incontext Solutions, Inc.	Secured Loan	January 16, 2020	October 1, 2024	Fixed interest rate 11.8%; EOT 16.4%	$	6,149	$	6,744	$	5,430

PebblePost, Inc.	Secured Loan⁽¹⁴⁾	May 7, 2021	June 1, 2025	Variable interest rate Prime + 3.3% or Floor rate 11.5%; EOT 3.8% ⁽⁸⁾	$	12,500	$	12,394	$	12,504

Pendulum Therapeutics, Inc.	Equipment Financing	January 16, 2020	May 1, 2023	Fixed interest rate 7.7%; EOT 5.0%	$	243	$	251	$	252
	Equipment Financing	January 17, 2020	August 1, 2023	Fixed interest rate 7.8%; EOT 5.0%		1,521		1,621		1,632
	Equipment Financing	March 6, 2020	October 1, 2023	Fixed interest rate 7.7%; EOT 5.0%		460		480		484
	Equipment Financing	July 15, 2020	February 1, 2024	Fixed interest rate 9.8%; EOT 6.0%		700		726		733
Total Pendulum Therapeutics, Inc.						2,924		3,078		3,101

Reciprocity, Inc.	Secured Loan	September 25, 2020	October 1, 2024	Variable interest rate Prime + 3.3% or Floor rate 11.3%; EOT 2.0% ⁽⁸⁾	$	10,000	$	9,951	$	9,938
	Secured Loan	April 29, 2021	May 1, 2025	Variable interest rate Prime + 3.3% or Floor rate 11.3%; EOT 2.0% ⁽⁸⁾		5,000		4,970		4,922
Total Reciprocity, Inc.						15,000		14,921		14,860

Sun Basket, Inc.	Secured Loan	December 31, 2020	December 1, 2024	Variable interest rate Prime + 3.3% or Floor rate 11.8%; EOT 5.0% ⁽⁸⁾	$	18,375	$	18,276	$	18,388

Utility Associates, Inc.	Secured Loan⁽¹⁸⁾	January 16, 2020	September 30, 2023	PIK Fixed interest rate 11.0% ⁽²⁰⁾	$	750	$	830	$	697

ZenDrive, Inc.	Secured Loan⁽¹⁴⁾	July 16, 2021	August 1, 2026	Variable interest rate Prime + 3.3% or Floor rate 10.3%; EOT 3.0% ⁽⁸⁾	$	15,000	$	14,856	$	14,856

Sub-total: Professional, Scientific, and Technical Services (20.6%)*					$	107,197	$	105,804	$	108,389

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

September 30, 2021

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Real Estate ⁽⁷⁾
Knockaway, Inc.	Secured Loan	January 16, 2020	December 1, 2023	Fixed interest rate 11.0%; EOT 3.0%	$	7,799	$	7,985	$	7,995
	Secured Loan	January 16, 2020	February 1, 2024	Fixed interest rate 11.0%; EOT 3.0%		2,076		2,117		2,129
	Secured Loan	January 16, 2020	March 1, 2024	Fixed interest rate 11.0%; EOT 3.0%		2,138		2,177		2,190
Total Knockaway, Inc.						12,013		12,279		12,314

Orchard Technologies, Inc.	Secured Loan	March 11, 2021	April 1, 2026	Variable interest rate Prime + 3.5% or Floor rate 11.0%; EOT 4.0% ⁽⁸⁾	$	5,000	$	5,012	$	5,052
	Secured Loan	July 23, 2021	April 1, 2026	Variable interest rate Prime + 3.5% or Floor rate 11.0%; EOT 4.0% ⁽⁸⁾		12,500		12,472		12,580
Total Orchard Technologies, Inc.						17,500		17,484		17,632

Wanderjaunt, Inc.	Equipment Financing	January 16, 2020	June 1, 2023	Fixed interest rate 10.2%; EOT 12.0%	$	277	$	309	$	304
	Equipment Financing	January 16, 2020	August 1, 2023	Fixed interest rate 10.2%; EOT 12.0%		905		1,036		1,030
Total Wanderjaunt, Inc.						1,182		1,345		1,334

Sub-total: Real Estate (5.2%)*					$	30,695	$	31,108	$	31,280

Rental and Leasing Services⁽⁷⁾
EquipmentShare, Inc.	Equipment Financing	June 24, 2020	July 1, 2023	Fixed interest rate 11.0%; EOT 5.0%	$	3,764	$	3,968	$	4,110
	Equipment Financing	August 7, 2020	September 1, 2023	Fixed interest rate 10.2%; EOT 5.0%		1,423		1,487		1,496
	Equipment Financing	October 2, 2020	November 1, 2023	Fixed interest rate 10.4%; EOT 5.0%		619		642		649
	Equipment Financing	October 9, 2020	November 1, 2023	Fixed interest rate 10.5%; EOT 5.0%		1,954		2,027		2,047
Total EquipmentShare, Inc.						7,760		8,124		8,302

Maxwell Financial Labs, Inc.	Secured Loan	September 30, 2021	April 1, 2026	Variable interest rate Prime + 4.0% or Floor rate 10.0%; EOT 5.0% ⁽⁸⁾	$	18,000	$	17,735	$	17,735

Sub-total: Rental and Leasing Services (8.1%)*					$	25,760	$	25,859	$	26,037

Retail Trade ⁽⁷⁾
Gobble, Inc.	Secured Loan	January 16, 2020	July 1, 2023	Fixed interest rate 11.3%; EOT 6.0%	$	2,543	$	2,712	$	2,717
	Secured Loan	January 16, 2020	July 1, 2023	Fixed interest rate 11.5%; EOT 6.0%		1,279		1,364		1,366
Total Gobble Inc.						3,822		4,076		4,083

Portofino Labs, Inc.	Secured Loan⁽¹⁴⁾	December 31, 2020	July 1, 2025	Variable interest rate Prime + 3.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾	$	2,000	$	2,006	$	2,017
	Secured Loan⁽¹⁴⁾	March 12, 2021	October 1, 2025	Variable interest rate Prime + 3.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾		3,000		2,881		2,900
	Secured Loan⁽¹⁴⁾	April 1, 2021	November 1, 2025	Variable interest rate Prime + 3.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾		2,000		1,840		1,856
Total Portofino Labs, Inc.						7,000		6,727		6,773

Super73, Inc.	Secured Loan	December 31, 2020	January 1, 2025	Variable interest rate Prime + 4.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾	$	5,500	$	5,499	$	5,464

UnTuckIt, Inc.	Secured Loan	January 16, 2020	June 1, 2025	Fixed interest rate 12.0%; EOT 3.8%	$	15,000	$	15,797	$	15,139

Sub-total: Retail Trade (18.7%)*					$	31,322	$	32,099	$	31,459

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

September 30, 2021

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Space Research and Technology ⁽⁷⁾

Axiom Space, Inc.	Secured Loan⁽¹⁴⁾	May 28, 2021	June 1, 2026	Variable interest rate Prime + 3.3% or Floor rate 9.3%; EOT 2.5% ⁽⁸⁾	$	30,000	$	29,744	$	29,959

Sub-total: Space Research and Technology (7.8%)*					$	30,000	$	29,744	$	29,959

Utilities ⁽⁷⁾
Invenia, Inc.	Secured Loan⁽¹⁰⁾	January 16, 2020	January 1, 2023	Fixed interest rate 11.5%; EOT 5.0%	$	4,383	$	4,841	$	4,789
	Secured Loan⁽¹⁰⁾	January 16, 2020	May 1, 2023	Fixed interest rate 11.5%; EOT 5.0%		2,390		2,595		2,583
	Secured Loan⁽¹⁰⁾	January 16, 2020	January 1, 2024	Fixed interest rate 11.5%; EOT 5.0%		2,419		2,515		2,556
	Secured Loan⁽¹⁰⁾	January 17, 2020	February 1, 2024	Fixed interest rate 11.5%; EOT 5.0%		3,326		3,473		3,507
	Secured Loan⁽¹⁰⁾	June 8, 2020	July 1, 2024	Fixed interest rate 11.5%; EOT 5.0%		3,812		3,909		3,998
	Secured Loan⁽¹⁰⁾	October 29, 2020	November 1, 2024	Fixed interest rate 11.5%; EOT 5.0%		5,000		5,087		5,203
Total Invenia, Inc. ⁽¹⁰⁾						21,330		22,420		22,636

Sub-total: Utilities (6.4%)*					$	21,330	$	22,420	$	22,636

Wholesale Trade ⁽⁷⁾
BaubleBar, Inc.	Secured Loan	January 16, 2020	March 1, 2023	Fixed interest rate 11.5%; EOT 7.3%	$	3,997	$	4,886	$	4,634

Grandpad, Inc.	Equipment Financing⁽¹⁴⁾	November 16, 2020	June 1, 2023	Fixed interest rate 10.6%; EOT 5.0%	$	2,078	$	2,157	$	2,167
	Equipment Financing⁽¹⁴⁾	December 23, 2020	July 1, 2023	Fixed interest rate 10.8%; EOT 5.0%		2,655		2,743		2,755
Total Grandpad, Inc.						4,733		4,900		4,922

Sub-total: Wholesale Trade (2.8%)*					$	8,730	$	9,786	$	9,556

Total: Debt Securities (136.5%)* ⁽¹³⁾					$	574,507	$	583,224	$	577,663

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

September 30, 2021

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾
Warrant Investments

Administrative and Support and Waste Management and Remediation ⁽⁷⁾

Gabi Personal Insurance Agency, Inc.	Warrant⁽¹⁴⁾	August 6, 2031	August 6, 2031	Common Stock	123,058	$	0.81	$	58	$	900

Sub-Total: Administrative and Support and Waste Management and Remediation (0.7%)*								$	58	$	900

Agriculture, Forestry, Fishing and Hunting ⁽⁷⁾
Bowery Farming, Inc.	Warrant	January 16, 2020	June 10, 2029	Common Stock	68,863	$	5.08	$	410	$	1,747
	Warrant	December 22, 2020	December 22, 2030	Common Stock	29,925	$	6.24		160		738
	Warrant	September 10, 2021	September 10, 2028	Common Stock	21,577	$	0.01		617		616
Total Bowery Farming, Inc.									1,187		3,101


Robotany, Inc.	Warrant	January 16, 2020	July 19, 2029	Common Stock	262,870	$	0.26	$	128	$	275

Sub-Total: Agriculture, Forestry, Fishing and Hunting (0.7%)*								$	1,315	$	3,376

Construction ⁽⁷⁾
Project Frog, Inc. ⁽²¹⁾	Warrant	January 16, 2020	July 26, 2026	Preferred Series AA	211,633	$	0.19	$	9	$	1
	Warrant	January 16, 2020	July 26, 2026	Common Stock	180,356	$	0.19		9		—
	Warrant	August 3, 2021	December 31, 2031	Preferred Series CC	250,000	$	0.01		20		78
Total Project Frog, Inc.									38		79

Sub-Total: Construction (0.0%)*								$	38	$	79

Educational Services ⁽⁷⁾
Medical Sales Training Holding Company	Warrant⁽¹⁴⁾	March 18, 2021	March 18, 2031	Common Stock	3,232	$	7.74	$	21	$	17

Yellowbrick Learning, Inc.	Warrant	January 16, 2020	September 28, 2028	Common Stock	222,222	$	0.90	$	120	$	676

Sub-Total: Educational Services (0.1%)*								$	141	$	693

Finance and Insurance ⁽⁷⁾
DailyPay, Inc.	Warrant	September 30, 2020	September 30, 2030	Common Stock	89,264	$	3.00	$	151	$	857

Petal Card, Inc.	Warrant	January 16, 2020	November 27, 2029	Preferred Series B	250,268	$	1.32	$	147	$	447
	Warrant⁽¹⁴⁾	January 11, 2021	January 11, 2031	Common Stock	135,835	$	0.01		312		363
	Warrant	August 6, 2021	August 6, 2031	Common Stock	111,555	$	1.60		198		181
Total Petal Card, Inc.									657		991

Realty Mogul	Warrant	January 16, 2020	December 18, 2027	Preferred Series B	234,421	$	3.88	$	285	$	19

Sub-Total: Finance and Insurance (0.5%)*								$	1,093	$	1,867

Health Care and Social Assistance ⁽⁷⁾
Lark Technologies, Inc.	Warrant	September 30, 2020	September 30, 2030	Common Stock	76,231	$	1.76	$	177	$	708
	Warrant	June 30, 2021	June 30, 2031	Common Stock	79,325	$	1.76		258		737
Total Lark Technologies, Inc.									435		1,445

Sub-Total: Health Care and Social Assistance (0.1%)*								$	435	$	1,445

Information ⁽⁷⁾
Everalbum, Inc.	Warrant	January 16, 2020	July 29, 2026	Preferred Series A	851,063	$	0.10	$	24	$	4

Figg, Inc.	Warrant⁽¹¹⁾	January 16, 2020	March 31, 2028	Common Stock	935,198	$	0.07	$	—	$	—

Firefly Systems, Inc.	Warrant	January 31, 2020	January 29, 2030	Common Stock	133,147	$	1.14	$	282	$	241

Gtxcel, Inc.	Warrant	January 16, 2020	September 24, 2025	Preferred Series C	1,000,000	$	0.21	$	83	$	25
	Warrant	January 16, 2020	September 24, 2025	Preferred Series D	1,000,000	$	0.21		83		25
Total Gtxcel, Inc.									166		50

Lucidworks, Inc.	Warrant	January 16, 2020	June 27, 2026	Preferred Series D	619,435	$	0.77	$	806	$	1,632

Oto Analytics, Inc.	Warrant	January 16, 2020	August 31, 2028	Preferred Series B	1,018,718	$	0.79	$	295	$	119

RapidMiner, Inc.	Warrant	January 16, 2020	March 25, 2029	Preferred Series C-1	11,624	$	60.22	$	528	$	32

Rigetti & Co, Inc.	Warrant	May 18, 2021	May 18, 2031	Common Stock	995,099	$	0.21	$	506	$	2,265

Stratifyd, Inc.	Warrant	September 3, 2021	September 3, 2031	Preferred Series B-2	106,719	$	2.53	$	84	$	84

Sub-Total: Information (0.7%)*								$	2,691	$	4,427

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

September 30, 2021

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾
Warrant Investments, Continued

Manufacturing ⁽⁷⁾
Circle Media Labs, Inc.	Warrant⁽¹⁴⁾	May 5, 2021	May 5, 2031	Common Stock	101,667	$	0.31	$	29	$	—

Daring Foods, Inc.	Warrant⁽¹⁴⁾	April 8, 2021	April 8, 2031	Common Stock	68,100	$	0.27	$	106	$	448

Footprint International Holding, Inc.	Warrant	February 14, 2020	February 14, 2030	Common Stock	26,852	$	0.31	$	5	$	521
	Warrant	June 22, 2020	June 22, 2030	Common Stock	10,836	$	0.31		4		210
Total Footprint International Holding, Inc.									9		731

Happiest Baby, Inc.	Warrant	January 16, 2020	May 16, 2029	Common Stock	182,554	$	0.33	$	193	$	233

Lensvector, Inc.	Warrant	January 16, 2020	December 30, 2021	Preferred Series C	85,065	$	1.18	$	32	$	—

Mainspring Energy, Inc.	Warrant	January 16, 2020	July 9, 2029	Common Stock	140,186	$	1.15	$	283	$	541
	Warrant	November 20, 2020	November 20, 2030	Common Stock	81,294	$	1.15		226		314
Total Mainspring Energy, Inc.									509		855

Molekule, Inc.	Warrant	June 19, 2020	June 19, 2030	Preferred Series C-1	32,051	$	3.12	$	16	$	26

Nexii Building Solutions, Inc.	Warrant⁽¹⁰⁾⁽¹⁴⁾	August 27, 2021	August 27, 2026	Common Stock	63,071	$	15.86	$	410	$	416

Quip NYC, Inc.	Warrant	March 9, 2021	March 9, 2031	Preferred Series A-1	10,833	$	48.46	$	204	$	314

SBG Labs, Inc.	Warrant	January 16, 2020	June 29, 2023	Preferred Series A-1	42,857	$	0.70	$	13	$	—
	Warrant	January 16, 2020	September 18, 2024	Preferred Series A-1	25,714	$	0.70		8		—
	Warrant	January 16, 2020	January 14, 2024	Preferred Series A-1	21,492	$	0.70		7		—
	Warrant	January 16, 2020	March 24, 2025	Preferred Series A-1	12,155	$	0.70		4		—
	Warrant	January 16, 2020	October 10, 2023	Preferred Series A-1	11,150	$	0.70		4		—
	Warrant	January 16, 2020	May 6, 2024	Preferred Series A-1	11,145	$	0.70		4		—
	Warrant	January 16, 2020	June 9, 2024	Preferred Series A-1	7,085	$	0.70		2		—
	Warrant	January 16, 2020	May 20, 2024	Preferred Series A-1	342,857	$	0.70		110		—
	Warrant	January 16, 2020	March 26, 2025	Preferred Series A-1	200,000	$	0.70		65		—
Total SBG Labs, Inc.									217		—

Tarana Wireless, Inc.	Warrant⁽¹⁴⁾	June 30, 2021	June 30, 2031	Common Stock	5,027,629	$	0.19	$	967	$	816

The Fynder Group, Inc.	Warrant	October 14, 2020	October 14, 2030	Common Stock	36,445	$	0.49	$	68	$	357

Vertical Communications, Inc. ⁽²¹⁾	Warrant⁽¹¹⁾	January 16, 2020	July 11, 2026	Preferred Series A	828,479	$	1.00	$	—	$	—

VitaCup, Inc.	Warrant⁽¹⁴⁾	June 23, 2021	June 23, 2031	Preferred Series C	68,996	$	2.79	$	9	$	5

Sub-Total: Manufacturing (1.0%)*								$	2,769	$	4,201

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

September 30, 2021

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾
Warrant Investments, Continued

Pharmaceutical ⁽⁷⁾
Zosano Pharma Corporation	Warrant ⁽⁹⁾	January 16, 2020	September 25, 2025	Common Stock	75,000	$	3.59	$	69	$	23

Sub-Total: Pharmaceutical (0.0%)*								$	69	$	23

Professional, Scientific, and Technical Services ⁽⁷⁾
Augmedix, Inc.	Warrant ⁽⁹⁾	January 16, 2020	September 3, 2029	Common Stock	580,383	$	1.21	$	449	$	945

Continuity, Inc.	Warrant	January 16, 2020	March 29, 2026	Preferred Series C	1,588,806	$	0.25	$	21	$	8

Crowdtap, Inc.	Warrant	January 16, 2020	December 16, 2025	Preferred Series B	442,233	$	1.09	$	42	$	240
	Warrant	January 16, 2020	November 30, 2027	Preferred Series B	100,000	$	1.09		9		54
Total Crowdtap, Inc.									51		294

Dynamics, Inc.	Warrant	January 16, 2020	March 10, 2024	Common Stock	17,000	$	10.59	$	86	$	—

E La Carte, Inc.	Warrant	January 16, 2020	July 28, 2027	Common Stock	497,183	$	0.30	$	185	$	124
	Warrant	January 16, 2020	July 28, 2027	Preferred Series A	104,284	$	7.49		14		39
	Warrant	January 16, 2020	July 28, 2027	Preferred Series AA-1	106,841	$	7.49		14		1
Total E La Carte, Inc.									213		164

Edeniq, Inc.	Warrant⁽¹¹⁾	January 16, 2020	December 23, 2026	Preferred Series B	2,685,501	$	0.22	$	—	$	—
	Warrant⁽¹¹⁾	December 23, 2016	December 23, 2026	Preferred Series B	2,184,672	$	0.01		—		—
	Warrant⁽¹¹⁾	January 16, 2020	March 12, 2028	Preferred Series C	5,106,972	$	0.44		—		—
	Warrant⁽¹¹⁾	January 16, 2020	October 15, 2028	Preferred Series C	3,850,294	$	0.01		—		—
Total Edeniq, Inc. ⁽²¹⁾									—		—

Greenlight Biosciences Inc.	Warrant⁽¹⁴⁾	March 29, 2021	March 29, 2031	Common Stock	219,839	$	0.82	$	139	$	842

Hologram, Inc.	Warrant	January 31, 2020	January 27, 2030	Common Stock	193,054	$	0.26	$	49	$	914

Hospitalists Now, Inc.	Warrant	January 16, 2020	March 30, 2026	Preferred Series D-2	135,807	$	5.89	$	71	$	1,606
	Warrant	January 16, 2020	December 6, 2026	Preferred Series D-2	750,000	$	5.89		391		291
Total Hospitalists Now, Inc.									462		1,897

Incontext Solutions, Inc.	Warrant	January 16, 2020	September 28, 2028	Preferred Series AA-1	332,858	$	1.47	$	34	$	2

PebblePost, Inc.	Warrant⁽¹⁴⁾	May 7, 2021	May 7, 2031	Common Stock	657,343	$	0.75	$	68	$	86

Pendulum Therapeutics, Inc.	Warrant	January 16, 2020	October 9, 2029	Preferred Series B	55,263	$	1.90	$	44	$	47
	Warrant	June 1, 2020	July 15, 2030	Preferred Series B	36,842	$	1.90		36		31
Total Pendulum Therapeutics, Inc.									80		78

Reciprocity, Inc.	Warrant	September 25, 2020	September 25, 2030	Common Stock	114,678	$	4.17	$	99	$	113
	Warrant	April 29, 2021	April 29, 2031	Common Stock	57,195	$	4.17		54		57
Total Reciprocity, Inc.									153		170

Resilinc, Inc.	Warrant	January 16, 2020	December 15, 2025	Preferred Series A	589,275	$	0.51	$	40	$	—

Sun Basket, Inc.	Warrant	January 16, 2020	October 5, 2027	Preferred Series C-2	249,306	$	6.02	$	111	$	53
	Warrant	December 31, 2020	December 29, 2032	Common Stock	118,678	$	0.89		545		420
									656		473

Utility Associates, Inc.	Warrant	January 16, 2020	June 30, 2025	Preferred Series A	92,511	$	4.54	$	55	$	—
	Warrant	January 16, 2020	May 1, 2026	Preferred Series A	60,000	$	4.54		36		—
	Warrant	January 16, 2020	May 22, 2027	Preferred Series A	200,000	$	4.54		120		—
Total Utility Associates, Inc.									211		—

ZenDrive, Inc.	Warrant⁽¹⁴⁾	July 16, 2021	July 16, 2031	Common Stock	30,466	$	2.46	$	29	$	107

Sub-Total: Professional, Scientific, and Technical Services (2.8%)*								$	2,741	$	5,980

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

September 30, 2021

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾
Warrant Investments, Continued

Real Estate ⁽⁷⁾
Egomotion Corporation	Warrant⁽¹¹⁾	January 16, 2020	December 10, 2028	Preferred Series A	60,786	$	1.32	$	—	$	30
	Warrant	January 16, 2020	June 29, 2028	Preferred Series A	121,571	$	1.32		219		61
Total Egomotion Corporation									219		91

Knockaway, Inc.	Warrant	January 16, 2020	May 24, 2029	Preferred Series B	87,955	$	8.53	$	209	$	140

Sub-Total: Real Estate (0.1%)*								$	428	$	231

Rental and Leasing Services ⁽⁷⁾

Maxwell Financial Labs, Inc.	Warrant	October 7, 2020	October 7, 2030	Common Stock	106,735	$	0.29	$	21	$	246
	Warrant	December 22, 2020	December 22, 2030	Common Stock	110,860	$	0.29		34		236
	Warrant	September 30, 2021	September 30, 2031	Common Stock	79,135	$	1.04		147		148
Total Maxwell Financial Labs, Inc.									202		630

Sub-Total: Rental and Leasing Services (0.1%)*								$	202	$	630

Retail Trade ⁽⁷⁾
Boosted eCommerce, Inc.	Warrant	December 18, 2020	December 14, 2030	Preferred Series A-1	759,263	$	0.84	$	259	$	177

Gobble, Inc.	Warrant	January 16, 2020	May 9, 2028	Common Stock	74,635	$	1.20	$	73	$	95
	Warrant	January 16, 2020	December 27, 2029	Common Stock	10,000	$	1.22		617		714
Total Gobble, Inc.									690		809

Madison Reed, Inc.	Warrant	January 16, 2020	March 23, 2027	Preferred Series C	194,553	$	2.57	$	185	$	361
	Warrant	January 16, 2020	July 18, 2028	Common Stock	43,158	$	0.99		71		119
	Warrant	January 16, 2020	May 19, 2029	Common Stock	36,585	$	1.23		56		95
Total Madison Reed, Inc.									312		575

Portofino Labs, Inc.	Warrant⁽¹⁴⁾	December 31, 2020	December 31, 2030	Common Stock	39,659	$	1.53	$	160	$	243
	Warrant⁽¹⁴⁾	April 1, 2021	April 1, 2031	Common Stock	39,912	$	1.46		99		99
Total Portofino Labs, Inc.									259		342

Super73, Inc.	Warrant⁽¹⁴⁾	December 31, 2020	December 31, 2030	Common Stock	177,305	$	3.16	$	105	$	69

Trendly, Inc.	Warrant	January 16, 2020	August 10, 2026	Preferred Series A	245,506	$	1.14	$	222	$	127

Sub-Total: Retail Trade (0.6%)*								$	1,847	$	2,099

Space Research and Technology ⁽⁷⁾
Axiom Space, Inc.	Warrant⁽¹⁴⁾	May 28, 2021	May 28, 2031	Common Stock	1,773	$	169.24	$	121	$	127
	Warrant⁽¹⁴⁾	May 28, 2021	May 28, 2031	Common Stock	882	$	340.11		39		40
Total Axiom Space, Inc.									160		167

Sub-Total: Space Research and Technology (0.0%)*								$	160	$	167

Wholesale Trade ⁽⁷⁾
BaubleBar, Inc.	Warrant	January 16, 2020	March 29, 2027	Preferred Series C	531,806	$	1.96	$	638	$	755
	Warrant	January 16, 2020	April 20, 2028	Preferred Series C	60,000	$	1.96		72		85
Total BaubleBar, Inc.									710		840

GrubMarket, Inc.	Warrant	June 15, 2020	June 15, 2030	Common Stock	405,000	$	1.10	$	116	$	559

Sub-Total: Wholesale Trade (0.2%)*								$	826	$	1,399

Total: Warrant Investments (7.0%)*⁽¹³⁾								$	14,813	$	27,517

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

September 30, 2021

(In thousands, except share and per share data)

(Unaudited)


Portfolio Company ⁽¹⁾	Type of Investment ⁽²⁾	Investment Date ⁽³⁾	Shares / Principal		Series	Cost		Fair Value ⁽⁶⁾
Equity Investments
Construction ⁽⁷⁾
Project Frog, Inc.	Equity	January 16, 2020		4,383,173	Preferred Series AA-1⁽¹⁷⁾	$	352	$	53
	Equity	January 16, 2020		3,401,427	Preferred Series BB⁽¹⁷⁾		1,333		10
	Equity	August 3, 2021		6,634,061	Common Stock		1,684		188
	Equity	August 3, 2021		3,379,887	Preferred Series CC⁽¹⁷⁾		1,253		1,011
Total Project Frog, Inc. ⁽²¹⁾							4,622		1,262

Sub-Total: Construction (0.3%)*						$	4,622	$	1,262

Health Care and Social Assistance ⁽⁷⁾
FemTec, Inc. ⁽²¹⁾	Equity	July 22, 2021		1,098,093	Common Stock	$	13,046	$	12,092

Lark Technologies, Inc.	Equity⁽¹⁴⁾	August 19, 2021		32,416	Preferred Series D⁽¹⁷⁾	$	500	$	500

WorkWell Prevention & Care Inc.	Equity	January 16, 2020		7,000,000	Common Stock	$	51	$	—
	Equity	January 16, 2020		3,450	Preferred Series P⁽¹⁷⁾		3,450		—
	Equity	January 16, 2020	$		Convertible Note⁽¹⁶⁾		2,519		1,402
Total WorkWell Prevention & Care Inc. ⁽²¹⁾							6,020		1,402

Sub-Total: Health Care and Social Assistance (0.6%)*						$	19,566	$	13,994

Manufacturing ⁽⁷⁾
indie Semiconductor, Inc.	Equity ⁽⁹⁾	June 2, 2021		196,346	Common Stock	$	31	$	2,281

Lucid Motors, Inc.	Equity ⁽⁹⁾	July 26, 2021		1,867,973	Common Stock	$	8,560	$	39,961

Quip NYC, Inc.	Equity⁽¹⁴⁾	August 17, 2021		3,321	Preferred Series B-1⁽¹⁷⁾	$	500	$	500

Store Intelligence, Inc. ⁽²¹⁾	Equity	May 2, 2020		1,430,000	Preferred Series A⁽¹⁷⁾	$	608	$	—

Vertical Communications, Inc.	Equity⁽¹¹⁾	January 16, 2020		3,892,485	Preferred Series 1⁽¹⁷⁾	$	—	$	—
	Equity	January 16, 2020	$	5,500	Convertible Note⁽¹⁶⁾		3,966		2,492
Total Vertical Communications, Inc. ⁽²¹⁾							3,966		2,492

Sub-Total: Manufacturing (11.3%)*						$	13,665	$	45,234

Professional, Scientific, and Technical Services ⁽⁷⁾
Dynamics, Inc.	Equity	January 16, 2020		17,726	Preferred Series A⁽¹⁷⁾	$	390	$	—

Matterport, Inc.	Equity ⁽⁹⁾	July 23, 2021		571,941	Common Stock	$	434	$	9,569

Edeniq, Inc.	Equity⁽¹¹⁾	January 16, 2020		2,527,449	Preferred Series B⁽¹⁷⁾	$	—	$	—
	Equity⁽¹¹⁾	January 16, 2020		2,441,082	Preferred Series C⁽¹⁷⁾		—		—
	Equity⁽¹¹⁾	January 16, 2020	$	1,303	Convertible Note⁽¹⁶⁾		—		—
Total Edeniq, Inc. ⁽²¹⁾							—		—

Emergy, Inc.	Equity	June 28, 2021		75,958	Preferred Series B⁽¹⁷⁾	$	500	$	500

Sub-Total: Professional, Scientific, and Technical Services (0.1%)*						$	1,324	$	10,069

Real Estate ⁽⁷⁾
Orchard Technologies, Inc.	Equity⁽¹⁴⁾	August 6, 2021		74,406	Preferred Series D⁽¹⁷⁾	$	500	$	500

Sub-Total: Real Estate (0.0%)*						$	500	$	500

Rental and Leasing Services ⁽⁷⁾
Maxwell Financial Labs, Inc	Equity⁽¹⁴⁾	January 22, 2021		135,641	Preferred Series B⁽¹⁷⁾	$	500	$	507

Sub-Total: Rental and Leasing Services (0.1%)*						$	500	$	507

Space Research and Technology ⁽⁷⁾

Axiom Space, Inc.	Equity⁽¹⁴⁾	August 11, 2021	$	500	Convertible Note⁽¹⁶⁾	$	500	$	500

Sub-Total: Rental and Leasing Services (0.0%)*						$	500	$	500

Total: Equity Investments (13.8%)*⁽¹³⁾						$	40,677	$	72,066

Total Investment in Securities (157.4%)*						$	638,714	$	677,246

Cash, Cash Equivalents, and Restricted Cash
Goldman Sachs Financial Square Government Institutional Fund						$	39,724	$	39,724
Other cash accounts							589		589
Cash, Cash Equivalents, and Restricted Cash (9.1%)*							40,313		40,313

Total Portfolio Investments and Cash and Cash Equivalents (166.5% of net assets)						$	679,027	$	717,559

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

September 30, 2021

(In thousands, except share and per share data)

(Unaudited)

(1)

All portfolio companies are located in North America. As of September 30, 2021, the Company had two foreign domiciled portfolio companies, which are based in Canada and, in total, represent 4.5% of total net asset value based on fair value. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale and may be deemed to be “restricted securities” under the Securities Act.

(2)

All debt investments are income producing unless otherwise noted. All equity and warrant investments are non-income producing unless otherwise noted. Equipment financed under our equipment financing investments relates to operational equipment essential to revenue production for the portfolio company in the industry noted.

(3)	Investment date represents the date of initial investment date, either purchases or funding, not adjusted for modifications. For assets purchased from the Legacy Funds as part of the Formation Transactions, investment date is January 16, 2020, the date of the Formation Transactions.

(4)

Interest rate is the fixed or variable rate of the debt investments and does not include any original issue discount, end-of-term (“EOT”) payment, or any additional fees related to such investments, such as deferred interest, commitment fees, prepayment fees or exit fees. EOT payments are contractual payments due in cash at the maturity date of the loan, including upon prepayment, and are a fixed rate determined at the inception of the loan. At the end of the term of certain equipment financings, the borrower has the option to purchase the underlying assets at fair market value in certain cases subject to a cap, or return the equipment and pay a restocking fee. The fair values of the financed assets have been estimated as a percentage of original cost for purpose of the EOT payment value. The EOT payment is amortized and recognized as non-cash income over the loan or equipment financing prior to its payment and is included as a component of the cost basis of the Company’s current debt securities

(5)	Principal is net of repayments, if any, as per the terms of the debt instrument’s contract.

(6)	Except as noted, all investments were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s board of directors.

(7)	The Company uses the North American Industry Classification System (“NAICS”) code for classifying the industry grouping of its portfolio companies.

(8)	The interest rate on variable interest rate investments represents a benchmark rate plus spread. The benchmark interest rate is subject to an interest rate floor. The benchmark rate Prime was 3.25% and 1-month USD LIBOR was 0.08% as of September 30, 2021

(9)	Asset is valued using Level 2 inputs.

(10)

Indicates a “non-qualifying asset” under section 55(a) by the Investment Company Act of 1940, as amended. The Company’s percentage of non-qualifying assets at fair value represents 4.5% of the Company’s total assets as of September 30, 2021. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets. Asset is not a U.S. entity. Invenia, Inc. and Nexii, Inc. are Canadian corporations.

(11)	Investment has zero cost basis as it was purchased at a fair market value of zero as part of the Formation Transactions.

Table of Contents

(12)	Investment is a secured loan warehouse facility collateralized by interest in specific assets that meet the eligibility requirements under the facility during the warehouse period. Repayment of the facility will occur over the amortizing period unless otherwise prepaid.

(13)	All of the Company’s debt, warrant and equity securities are pledged as collateral supporting the amounts outstanding under the credit facility with Credit Suisse AG (see “Note 5 – Borrowings”), except as noted.

(14)	Investment is not pledged as collateral supporting amounts outstanding under the credit facility with Credit Suisse AG.

(15)	Investment is considered non-income producing.

(16)	Convertible notes represent investments through which the Company will participate in future equity rounds at preferential rates. There are no principal or interest payments made against the note unless conversion does not take place.

(17)	Preferred stock represent investments through which the Company will have preference in liquidation rights and do not contain any cumulative preferred dividends.

(18)	Investment is on non-accrual status as of September 30, 2021, and is therefore considered non-income producing.

(19)	Investment has an unfunded commitment as of September 30, 2021 (see “Note 6 – Commitments and Contingencies”). The fair value of the investment includes the impact of the fair value of any unfunded commitments.

(20)

Interest on this loan includes a payment-in-kind (“PIK”) provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected.

Table of Contents

(21)

This investment is deemed to be a “Control Investment” or an “Affiliate Investment.” The Company classifies its investment portfolio in accordance with the requirements of the 1940 Act. Control Investments are defined by the Investment Company Act of 1940, as amended, as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. Affiliate Investments are defined by the Investment Company Act of 1940, as amended, as investments in companies in which the Company owns between 5% and 25% (inclusive) of the voting securities and does not have rights to maintain greater than 50% of the board representation. As defined in the Investment Company Act, the Company is deemed to be an “Affiliated Person” of this portfolio company. Fair value as of September 30, 2021, along with transactions during the nine months ended September 30, 2021 in these control or affiliated investments are as follows:


									Net change in
									Unrealized
	Fair Value at		Gross		Gross		Realized		(Depreciation)/		Fair Value at		Interest
	December 31, 2020		Additions ⁽¹⁾		Reductions ⁽²⁾		Gain/(Loss)		Appreciation		September 30, 2021		Income
For the Nine Months Ended September 30, 2021
Control Investments
Birchbox, Inc.	$	19,369	$	5,569	$	(23,548)	$	(2,725)	$	1,335	$	—	$	576
Edeniq, Inc.		1,507		504		(2,305)		—		4,174		3,880		1,030
Project Frog, Inc.		4,516		1,302		(20)		—		(701)		5,097		409
Vertical Communications, Inc.		16,953		1,376		(325)		—		(2,019)		15,985		1,575
WorkWell Prevention and Care Inc.		6,385		1,026		—		—		(1,701)		5,710		270
Total Control Investments	$	48,730	$	9,777	$	(26,198)	$	(2,725)	$	1,088	$	30,672	$	3,860

Affiliate Investments
FemTec Health, Inc.	$	—	$	28,714	$	—	$	—	$	(1,324)	$	27,390	$	273
Ology Bioservices, Inc.		15,072		—		(9,304)		1,491		(7,259)		—		—
Store Intelligence, Inc.		12,578		163		(240)		—		(5,582)		6,919		882
Total Affiliate Investments	$	27,650	$	28,877	$	(9,544)	$	1,491	$	(14,165)	$	34,309	$	1,155

Total Control and Affiliate Investments	$	76,380	$	38,654	$	(35,742)	$	(1,234)	$	(13,077)	$	64,981	$	5,015

(1)

Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK interest, the accretion of discounts, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.

(2)

Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽¹⁷⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities

Administrative and Support and Waste Management and Remediation ⁽²⁾
SeaOn Environmental, LLC	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 9.0%; EOT 12.0%	$	2,134	$	2,370	$	2,328

Sub-total: Administrative and Support and Waste Management and Remediation (1.0%)*					$	2,134	$	2,370	$	2,328

Agriculture, Forestry, Fishing and Hunting ⁽²⁾
Bowery Farming, Inc.	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 8.5%; EOT 8.5%	$	2,481	$	2,742	$	2,574
	Equipment Financing	January 16, 2020	February 1, 2023	Fixed interest rate 8.7%; EOT 8.5%		2,453		2,650		2,684
	Equipment Financing	January 16, 2020	May 1, 2023	Fixed interest rate 8.7%; EOT 8.5%		3,054		3,259		3,303
	Equipment Financing	December 22, 2020	January 1, 2024	Fixed interest rate 7.5%; EOT 8.5%		10,000		9,912		9,912
Total Bowery Farming, Inc.						17,988		18,563		18,473

Robotany, Inc.	Equipment Financing	January 16, 2020	January 1, 2024	Fixed interest rate 7.6%; EOT 22.0%	$	1,667	$	1,720	$	1,709

Sub-total: Agriculture, Forestry, Fishing and Hunting (8.5%)*					$	19,655	$	20,283	$	20,182

Construction ⁽²⁾
Dandelion Energy, Inc.	Equipment Financing	March 17, 2020	April 1, 2024	Fixed interest rate 9.0%; EOT 12.5%	$	460	$	467	$	471
	Equipment Financing	October 27, 2020	November 1, 2024	Fixed interest rate 9.2%; EOT 12.5%		545		551		551
	Equipment Financing ⁽¹²⁾	November 19, 2020	December 1, 2024	Fixed interest rate 9.1%; EOT 12.5%		558		563		563
	Equipment Financing	December 29, 2020	January 1, 2025	Fixed interest rate 9.2%; EOT 12.5%		791		791		791
Total Dandelion Energy, Inc.						2,354		2,372		2,376

Project Frog, Inc. ⁽²⁰⁾	Secured Loan	April 30, 2020	May 1, 2023	Fixed interest rate 12.0%	$	4,128	$	4,045	$	4,029

Sub-total: Construction (2.7%)*					$	6,482	$	6,417	$	6,405

Educational Services ⁽²⁾
Examity, Inc.	Secured Loan	January 16, 2020	February 1, 2022	Fixed interest rate 11.5%; EOT 8.0%	$	3,280	$	4,028	$	3,994
	Secured Loan	January 16, 2020	February 1, 2022	Fixed interest rate 11.5%; EOT 4.0%		3,516		1,775		1,775
	Secured Loan	January 16, 2020	January 1, 2023	Fixed interest rate 12.25%; EOT 4.0%		1,658		1,005		1,004
Total Examity, Inc.						8,454		6,808		6,773

Qubed, Inc. dba Yellowbrick	Secured Loan	January 16, 2020	October 1, 2023	Variable interest rate PRIME + 8.3% or Floor rate 11.5%; EOT 5.0% ⁽⁹⁾	$	1,906	$	1,950	$	1,957
	Secured Loan	January 16, 2020	October 1, 2023	Fixed interest rate 11.5%; EOT 4.0%		476		481		493
Total Qubed, Inc. dba Yellowbrick						2,382		2,431		2,450

Sub-total: Educational Services (3.9%)*					$	10,836	$	9,239	$	9,223

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽¹⁷⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾

Debt Securities, Continued

Finance and Insurance ⁽²⁾
DailyPay, Inc.	Secured Loan	September 30, 2020	November 1, 2024	Variable interest rate PRIME + 7.0% or Floor rate 12.0%; EOT 6.0% ⁽⁹⁾	$	20,000	$	19,800	$	20,062
	Secured Loan	December 30, 2020	January 1, 2025	Variable interest rate PRIME + 7.0% or Floor rate 12.0%; EOT 6.0% ⁽⁹⁾		5,000		4,939		4,939
Total DailyPay, Inc.						25,000		24,739		25,001

Petal Card, Inc.	Secured Loan	January 16, 2020	December 1, 2023	Fixed interest rate 11.0%; EOT 3.0%	$	10,000	$	9,998	$	10,116

Sub-total: Finance and Insurance (14.7%)*					$	35,000	$	34,737	$	35,117

Health Care and Social Assistance ⁽²⁾
Lark Technologies, Inc.	Secured Loan	September 30, 2020	April 1, 2025	Variable interest rate PRIME + 8.3% or Floor rate 11.5%; EOT 4.0% ⁽⁹⁾	$	5,000	$	4,809	$	4,874

WorkWell Prevention & Care Inc.	Secured Loan	January 16, 2020	March 1, 2024	Fixed interest rate 8.0%; EOT 10.0%	$	3,370	$	3,608	$	3,493
	Secured Loan	January 16, 2020	March 1, 2024	Fixed interest rate 8.0%; EOT 10.0%		700		734		693
Total WorkWell Prevention & Care Inc. ⁽²⁰⁾						4,070		4,342		4,186

Sub-total: Health Care and Social Assistance (3.8%)*					$	9,070	$	9,151	$	9,060

Information ⁽²⁾
Firefly Systems, Inc.	Equipment Financing	January 29, 2020	February 1, 2023	Fixed interest rate 9.0%; EOT 10.0%	$	3,946	$	4,080	$	4,052
	Equipment Financing	August 28, 2020	September 1, 2023	Fixed interest rate 9.0%; EOT 10.0%		3,208		3,308		3,307
	Equipment Financing	September 18, 2020	October 1, 2023	Fixed interest rate 9.0%; EOT 10.0%		386		396		396
Total Firefly Systems, Inc.						7,540		7,784		7,755

Gobiquity, Inc.	Equipment Financing	January 16, 2020	April 1, 2022	Fixed interest rate 7.5%; EOT 20.0%	$	296	$	394	$	395

Hytrust, Inc.	Secured Loan	January 16, 2020	February 1, 2021	Fixed interest rate 11.1%; EOT 10.5%	$	194	$	717	$	621

Oto Analytics, Inc.	Secured Loan	January 16, 2020	March 1, 2023	Fixed interest rate 11.5%; EOT 6.0%	$	7,294	$	7,755	$	7,735

RapidMiner, Inc.	Secured Loan	January 16, 2020	April 1, 2024	Fixed interest rate 12.0%; EOT 7.5%	$	10,000	$	10,099	$	10,113

Smule, Inc.	Secured Loan	July 1, 2020	January 1, 2022	Fixed interest rate 0.0% ⁽¹⁵⁾	$	145	$	145	$	145

STS Media, Inc. ⁽¹¹⁾	Secured Loan	January 16, 2020	May 1, 2022	Fixed interest rate 11.9%; EOT 4.0%	$	7,811	$	737	$	100

Unitas Global, Inc.	Equipment Financing	January 16, 2020	July 1, 2021	Fixed interest rate 9.0%; EOT 12.0%	$	580	$	938	$	921
	Equipment Financing	January 16, 2020	April 1, 2021	Fixed interest rate 7.8%; EOT 6.0%		53		76		74
Total Unitas Global, Inc.						633		1,014		995

Sub-total: Information (11.7%)*					$	33,913	$	28,645	$	27,859

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date⁽¹⁷⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Manufacturing ⁽²⁾
AyDeeKay LLC	Secured Loan	January 16, 2020	August 1, 2024	Variable interest rate PRIME + 7.5% or Floor rate 10.8%; EOT 3.0% ⁽⁹⁾	$	12,000	$	11,893	$	11,779

BHCosmetics, LLC	Equipment Financing	January 16, 2020	March 1, 2021	Fixed interest rate 8.9%; EOT 5.0%	$	106	$	165	$	165
	Equipment Financing	January 16, 2020	April 1, 2021	Fixed interest rate 8.7%; EOT 5.0%		159		217		218
Total BHCosmetics, LLC						265		382		383

Footprint International Holding, Inc.	Equipment Financing	February 14, 2020	March 1, 2024	Fixed interest rate 10.3%; EOT 8.0%	$	14,771	$	15,244	$	15,352
	Secured Loan	June 22, 2020	July 1, 2024	Fixed interest rate 12.0%; EOT 9.0%		7,000		7,095		7,177
Total Footprint International Holding, Inc.						21,771		22,339		22,529

Happiest Baby, Inc.	Equipment Financing	January 16, 2020	September 1, 2022	Fixed interest rate 8.4%; EOT 9.5%	$	924	$	1,031	$	998
	Equipment Financing	January 16, 2020	November 1, 2022	Fixed interest rate 8.6%; EOT 9.5%		748		822		830
	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 8.6%; EOT 9.5%		719		775		786
	Equipment Financing	February 7, 2020	June 1, 2023	Fixed interest rate 8.2%; EOT 9.5%		901		953		955
	Equipment Financing	September 16, 2020	January 1, 2024	Fixed interest rate 7.8%; EOT 9.5%		1,248		1,270		1,278
Total Happiest Baby, Inc.						4,540		4,851		4,847

Health-Ade, LLC	Equipment Financing	January 16, 2020	February 1, 2022	Fixed interest rate 9.4%; EOT 15.0%	$	1,361	$	1,887	$	1,877
	Equipment Financing	January 16, 2020	April 1, 2022	Fixed interest rate 8.6%; EOT 15.0%		784		1,031		1,030
	Equipment Financing	January 16, 2020	July 1, 2022	Fixed interest rate 9.1%; EOT 15.0%		1,956		2,436		2,441
Total Health-Ade, LLC						4,101		5,354		5,348

Mainspring Energy, Inc.	Secured Loan	January 16, 2020	August 1, 2023	Fixed interest rate 11.0%; EOT 3.8%	$	8,592	$	8,759	$	8,801
	Secured Loan	November 20, 2020	December 1, 2024	Fixed interest rate 11.0%; EOT 3.8%		5,500		5,267		5,267
Total Mainspring Energy, Inc.						14,092		14,026		14,068

Miyoko's Kitchen	Equipment Financing	February 19, 2020	September 1, 2022	Fixed interest rate 8.8%; EOT 9.0%	$	580	$	617	$	618
	Equipment Financing	August 27, 2020	March 1, 2023	Fixed interest rate 8.9%; EOT 9.0%		867		889		896
Total Miyoko's Kitchen						1,447		1,506		1,514

Molekule, Inc.	Equipment Financing	June 19, 2020	January 1, 2024	Fixed interest rate 8.8%; EOT 10.0%	$	2,526	$	2,571	$	2,588
	Equipment Financing	September 29, 2020	April 1, 2024	Fixed interest rate 9.0%; EOT 10.0%		542		550		554
	Equipment Financing	December 18, 2020	July 1, 2024	Fixed interest rate 8.8%; EOT 10.0%		879		879		881
Total Molekule, Inc.						3,947		4,000		4,023

Second Nature Brands, Inc.	Equipment Financing	September 29, 2020	April 1, 2024	Fixed interest rate 9.7%; EOT 11.50%	$	2,196	$	2,157	$	2,144

Store Intelligence, Inc. ⁽²⁰⁾	Secured Loan	May 2, 2020	June 1, 2024	Fixed interest rate 12.0%; EOT 7.8%	$	12,001	$	12,232	$	11,884

The Fynder Group, Inc.	Equipment Financing	October 14, 2020	May 1, 2024	Fixed interest rate 9.1%; EOT 10.0%	$	612	$	604	$	604

Vertical Communications, Inc.	Secured Loan	May 1, 2020	November 1, 2024	Fixed interest rate 9.5%; EOT 26.4%	$	12,000	$	12,937	$	12,787
	Secured Loan	June 18, 2020	July 1, 2022	Fixed interest rate 9.5%		807		807		816
Total Vertical Communications, Inc. ⁽²⁰⁾						12,807		13,744		13,603

Sub-total: Manufacturing (38.9%)*					$	89,779	$	93,088	$	92,726

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date⁽¹⁷⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Pharmaceutical ⁽²⁾
Zosano Pharma Corporation	Equipment Financing	January 16, 2020	April 1, 2022	Fixed interest rate 9.4%; EOT 12.0%	$	2,256	$	2,756	$	2,530
	Equipment Financing	January 16, 2020	July 1, 2022	Fixed interest rate 9.7%; EOT 12.0%		1,501		1,757		1,642
	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 9.9%; EOT 12.0%		1,608		1,769		1,710
	Equipment Financing	January 16, 2020	April 1, 2023	Fixed interest rate 9.9%; EOT 12.0%		1,787		1,919		1,884
	Equipment Financing	January 16, 2020	May 1, 2023	Fixed interest rate 10.5%; EOT 12.0%		1,316		1,420		1,384
Total Zosano Pharma Corporation						8,468		9,621		9,150

Sub-total: Pharmaceutical (3.8%)*					$	8,468	$	9,621	$	9,150

Professional, Scientific, and Technical Services ⁽²⁾
Augmedix, Inc.	Secured Loan	January 16, 2020	April 1, 2023	Fixed interest rate 12.0%; EOT 6.5%	$	9,422	$	9,602	$	9,629

BackBlaze, Inc.	Equipment Financing	January 16, 2020	January 1, 2023	Fixed interest rate 7.2%; EOT 11.5%	$	907	$	1,042	$	1,046
	Equipment Financing	January 16, 2020	April 1, 2023	Fixed interest rate 7.4%; EOT 11.5%		117		131		132
	Equipment Financing	January 16, 2020	June 1, 2023	Fixed interest rate 7.4%; EOT 11.5%		905		1,001		1,006
	Equipment Financing	January 16, 2020	August 1, 2023	Fixed interest rate 7.5%; EOT 11.5%		180		196		197
	Equipment Financing	January 16, 2020	September 1, 2023	Fixed interest rate 7.7%; EOT 11.5%		185		201		201
	Equipment Financing	January 16, 2020	October 1, 2023	Fixed interest rate 7.5%; EOT 11.5%		186		200		201
	Equipment Financing	January 16, 2020	November 1, 2023	Fixed interest rate 7.2%; EOT 11.5%		621		670		670
	Equipment Financing	January 16, 2020	December 1, 2023	Fixed interest rate 7.5%; EOT 11.5%		822		881		881
	Equipment Financing	January 16, 2020	January 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		717		764		763
	Equipment Financing	January 20, 2020	February 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		732		775		775
	Equipment Financing	February 1, 2020	March 1, 2024	Fixed interest rate 7.2%; EOT 11.5%		636		673		672
	Equipment Financing	March 26, 2020	April 1, 2024	Fixed interest rate 7.4%; EOT 11.5%		192		201		206
	Equipment Financing	April 17, 2020	May 1, 2024	Fixed interest rate 7.3%; EOT 11.5%		1,246		1,303		1,311
	Equipment Financing	July 27, 2020	August 1, 2024	Fixed interest rate 7.5%; EOT 11.5%		1,336		1,374		1,378
	Equipment Financing	September 4, 2020	October 1, 2024	Fixed interest rate 7.2%; EOT 11.5%		239		243		237
Total BackBlaze, Inc.						9,021		9,655		9,676

Cuebiq, Inc.	Secured Loan	March 4, 2020	April 1, 2024	Variable interest rate PRIME + 7.3% or Floor rate 12.0%; EOT 4.5% ⁽⁹⁾	$	5,000	$	5,030	$	4,963

Edeniq, Inc.	Secured Loan	January 16, 2020	September 1, 2021	Fixed interest rate 13.0%; EOT 9.5%	$	3,039	$	1,102	$	859
	Secured Loan	January 16, 2020	September 1, 2021	Fixed interest rate 13.0%; EOT 9.5%		2,282		762		648
Total Edeniq, Inc. ⁽¹¹⁾ ⁽²⁰⁾						5,321		1,864		1,507

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date⁽¹⁷⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Professional, Scientific, and Technical Services, Continued
Incontext Solutions, Inc.	Secured Loan	January 16, 2020	October 1, 2023	Fixed interest rate 11.75%; EOT 11.4%	$	7,149	$	7,401	$	6,998

Matterport, Inc.	Secured Loan	January 16, 2020	May 1, 2022	Fixed interest rate 11.5%; EOT 5.0%	$	4,870	$	5,560	$	5,599

Pendulum Therapeutics, Inc.	Equipment Financing	January 16, 2020	May 1, 2023	Fixed interest rate 7.7%; EOT 5.0%	$	347	$	338	$	338
	Equipment Financing	January 17, 2020	August 1, 2023	Fixed interest rate 7.8%; EOT 5.0%		2,084		2,147		2,164
	Equipment Financing	March 6, 2020	October 1, 2023	Fixed interest rate 7.7%; EOT 5.0%		616		620		626
	Equipment Financing	July 15, 2020	February 1, 2024	Fixed interest rate 9.8%; EOT 6.0%		894		895		881
Total Pendulum Therapeutics, Inc.						3,941		4,000		4,009

Reciprocity, Inc.	Secured Loan	September 25, 2020	October 1, 2024	Variable interest rate PRIME + 8.0% or Floor rate 11.3%; EOT 2.0% ⁽⁹⁾	$	10,000	$	9,862	$	9,805

Sun Basket, Inc.	Secured Loan	December 31, 2020	December 1, 2024	Variable interest rate PRIME + 8.5% or Floor rate 11.8%; EOT 5.0% ⁽⁹⁾		18,375		17,831		17,831

Utility Associates, Inc. ⁽¹¹⁾	Secured Loan	January 16, 2020	October 1, 2023	PIK Fixed interest rate 11.0% ⁽¹⁹⁾	$	750	$	830	$	604

Sub-total: Professional, Scientific, and Technical Services (29.6%)*					$	73,849	$	71,635	$	70,621

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽¹⁷⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Real Estate ⁽²⁾
Knockaway, Inc.	Secured Loan	January 16, 2020	December 1, 2023	Fixed interest rate 11.0%; EOT 3.0%	$	10,000	$	10,103	$	10,112
	Secured Loan	January 16, 2020	February 1 , 2024	Fixed interest rate 11.0%; EOT 3.0%		2,500		2,519		2,549
	Secured Loan	January 16, 2020	March 1, 2024	Fixed interest rate 11.0%; EOT 3.0%		2,500		2,516		2,548
Total Knockaway, Inc.						15,000		15,138		15,209

Wanderjaunt, Inc.	Equipment Financing	January 16, 2020	June 1, 2023	Fixed interest rate 10.2%; EOT 12.0%	$	387	$	388	$	380
	Equipment Financing	January 16, 2020	August 1, 2023	Fixed interest rate 10.2%; EOT 12.0%		1,230		1,313		1,296
Total Wanderjaunt, Inc.						1,617		1,701		1,676

Sub-total: Real Estate (9.6%)*					$	16,617	$	16,839	$	16,885

Rental and Leasing Services⁽²⁾
EquipmentShare, Inc.	Equipment Financing	June 24, 2020	July 1, 2023	Fixed interest rate 10.7%; EOT 5.0%	$	7,538	$	7,685	$	7,730
	Equipment Financing	July 2, 2020	August 1, 2023	Fixed interest rate 10.1%; EOT 5.0%		864		879		884
	Equipment Financing	August 7, 2020	September 1, 2023	Fixed interest rate 10.2%; EOT 5.0%		1,908		1,935		1,944
	Equipment Financing	September 18, 2020	October 1, 2023	Fixed interest rate 10.4%; EOT 5.0%		3,422		3,458		3,470
	Equipment Financing	September 29, 2020	October 1, 2024	Fixed interest rate 8.3%; EOT 10.0%		429		435		435
	Equipment Financing	October 2, 2020	November 1, 2023	Fixed interest rate 10.4%; EOT 5.0%		811		818		818
	Equipment Financing	October 9, 2020	November 1, 2023	Fixed interest rate 10.5%; EOT 5.0%		2,560		2,581		2,581
	Equipment Financing	November 4, 2020	December 1, 2023	Fixed interest rate 10.1%; EOT 5.0%		2,491		2,506		2,506
	Equipment Financing	December 4, 2020	January 1, 2024	Fixed interest rate 10.1%; EOT 5.0%		1,995		2,002		2,002
	Equipment Financing	December 21, 2020	January 1, 2024	Fixed interest rate 10.5%; EOT 5.0%		797		799		799
Total EquipmentShare, Inc.						22,815		23,098		23,169

Maxwell Financial Labs, Inc.	Secured Loan	October 7, 2020	November 1, 2024	Variable interest rate PRIME + 8.0% or Floor rate 11.25%; EOT 4.0% ⁽⁹⁾	$	3,000	$	2,964	$	2,964
	Secured Loan	December 22, 2020	January 1, 2025	Variable interest rate PRIME + 8.0% or Floor rate 11.25%; EOT 4.0% ⁽⁹⁾		3,000		2,938		2,938
Total Maxwell Financial Labs, Inc.						6,000		5,902		5,902

Sub-total: Rental and Leasing Services (12.2%)*					$	28,815	$	29,000	$	29,071

Retail Trade ⁽²⁾
Birchbox, Inc. ⁽²⁰⁾	Secured Loan	January 16, 2020	July 1, 2024	Fixed interest rate 9.0%; EOT 7.5%	$	10,000	$	10,433	$	9,924

Boosted eCommerce, Inc. ⁽¹⁴⁾	Secured Loan	December 18, 2020	January 1, 2023	Variable interest rate PRIME + 7.75% or Floor rate 11.0%; EOT 3.25% ⁽⁹⁾	$	5,000	$	4,933	$	4,933

Gobble, Inc.	Secured Loan	January 16, 2020	July 1, 2023	Fixed interest rate 11.3%; EOT 6.0%	$	3,443	$	3,544	$	3,556
	Secured Loan	January 16, 2020	July 1, 2023	Fixed interest rate 11.5%; EOT 6.0%		1,730		1,781		1,795
Total Gobble Inc.						5,173		5,325		5,351

Madison Reed, Inc.	Secured Loan	April 23, 2020	May 1, 2024	Variable interest rate PRIME + 6.0% or Floor rate 10.3%; EOT 4.0% ⁽⁹⁾	$	17,500	$	17,471	$	17,835

Portofino Labs, Inc. ⁽¹⁴⁾	Secured Loan	December 31, 2020	July 1, 2025	Variable interest rate PRIME + 8.25% or Floor rate 11.5%; EOT 4.0% ⁽⁹⁾	$	2,000	$	1,984	$	1,984

Super73, Inc. ⁽¹⁴⁾	Secured Loan	December 31, 2020	January 1, 2025	Variable interest rate PRIME + 7.3% or Floor rate 11.8%; EOT 4.0% ⁽⁹⁾	$	5,500	$	5,416	$	5,416

UnTuckIt, Inc.	Secured Loan	January 16, 2020	June 1, 2024	Fixed interest rate 12.0%; EOT 5.0%	$	20,000	$	21,098	$	19,230

Sub-total: Retail Trade (27.1%)*					$	65,173	$	66,660	$	64,673

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽¹⁷⁾	Maturity Date	Interest Rate ⁽⁴⁾	Principal Amount ⁽⁵⁾		Cost		Fair Value ⁽⁶⁾
Debt Securities, Continued

Utilities ⁽²⁾
Invenia, Inc.	Secured Loan	January 16, 2020	January 1, 2023	Fixed interest rate 11.5%; EOT 5.0%	$	6,570	$	7,042	$	6,991
	Secured Loan	January 16, 2020	May 1, 2023	Fixed interest rate 11.5%; EOT 5.0%		3,326		3,537		3,550
	Secured Loan	January 16, 2020	January 1, 2024	Fixed interest rate 11.5%; EOT 5.0%		3,000		3,058		3,165
	Secured Loan	January 17, 2020	February 1, 2024	Fixed interest rate 11.5%; EOT 5.0%		4,000		4,103		4,200
	Secured Loan	June 8, 2020	July 1, 2024	Fixed interest rate 11.5%: EOT 5.0%		4,000		4,043		4,160
	Secured Loan	October 29, 2020	November 1, 2024	Fixed interest rate 11.5%: EOT 5.0%		5,000		5,017		5,017
Total Invenia, Inc. ⁽⁸⁾						25,896		26,800		27,083

Sub-total: Utilities (11.4%)*					$	25,896	$	26,800	$	27,083

Wholesale Trade ⁽²⁾
BaubleBar, Inc.	Secured Loan	January 16, 2020	March 1, 2023	Fixed interest rate 11.5%; EOT 7.3%	$	5,752	$	6,576	$	6,148

Grandpad, Inc.	Equipment Financing	November 16, 2020	June 1, 2023	Fixed interest rate 10.6%; EOT 5.0%	$	2,899	$	2,907	$	2,907
	Equipment Financing	December 23, 2020	July 1, 2023	Fixed interest rate 10.8%; EOT 5.0%		3,672		3,667		3,667
Total Grandpad, Inc. ⁽¹⁴⁾						6,571		6,574		6,574

GrubMarket, Inc.	Secured Loan	June 15, 2020	July 1, 2024	Fixed interest rate 10.5%; EOT 3.0%	$	10,000	$	9,875	$	10,114

Sub-total: Wholesale Trade (9.6%)*					$	22,323	$	23,025	$	22,836

Total: Debt Securities (186.0%)* ⁽¹³⁾					$	448,010	$	447,510	$	443,219

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽¹⁷⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾
Warrant Investments

Agriculture, Forestry, Fishing and Hunting ⁽²⁾
Bowery Farming, Inc.	Warrant	January 16, 2020	June 10, 2029	Common Stock	68,863	$	5.08	$	410	$	403
	Warrant	December 22, 2020	December 22, 2030	Common Stock	29,925	$	6.24	$	160	$	160
Total Bowery Farming, Inc.									570		563


Robotany, Inc.	Warrant	January 16, 2020	July 19, 2029	Common Stock	262,870	$	0.26	$	128	$	92

Sub-Total: Agriculture, Forestry, Fishing and Hunting (0.3%)*								$	698	$	655

Construction ⁽²⁾
Project Frog, Inc. ⁽²⁰⁾	Warrant	January 16, 2020	July 26, 2026	Preferred Series AA	391,990	$	0.19	$	18	$	2

Sub-Total: Construction (0.0%)*								$	18	$	2

Educational Services ⁽²⁾
Qubed, Inc. dba Yellowbrick	Warrant	January 16, 2020	September 28, 2028	Common Stock	222,222	$	0.90	$	120	$	593

Sub-Total: Educational Services (0.2%)*								$	120	$	593

Finance and Insurance ⁽²⁾
DailyPay, Inc.	Warrant	September 30, 2020	September 30, 2030	Common Stock	89,264	$	3.00	$	151	$	206

Petal Card, Inc.	Warrant	January 16, 2020	November 27, 2029	Preferred Series B	250,268	$	1.32	$	147	$	350

Realty Mogul, Co	Warrant	January 16, 2020	December 18, 2027	Preferred Series B	234,421	$	3.88	$	285	$	25

Sub-Total: Finance and Insurance (0.2%)*								$	583	$	581

Health Care and Social Assistance ⁽²⁾
Lark Technologies, Inc.	Warrant	September 30, 2020	September 30, 2030	Common Stock	76,231	$	1.76	$	177	$	163

Sub-Total: Health Care and Social Assistance (0.1%)*								$	177	$	163

Information ⁽²⁾
Convercent, Inc.	Warrant	January 16, 2020	November 30, 2025	Preferred Series 1	3,139,579	$	0.16	$	924	$	610

Figg, Inc. ⁽⁷⁾	Warrant	January 16, 2020	March 31, 2028	Common Stock	935,198	$	0.07	$	—	$	—

Everalbum, Inc.	Warrant	January 16, 2020	July 29, 2026	Preferred Series A	851,063	$	0.10	$	24	$	6

Firefly Systems, Inc.	Warrant	January 31, 2020	January 29, 2030	Common Stock	133,147	$	1.14	$	282	$	132

Gtxcel, Inc.	Warrant	January 16, 2020	September 24, 2025	Preferred Series C	1,000,000	$	0.21	$	83	$	4
	Warrant	January 16, 2020	September 24, 2025	Preferred Series D	1,000,000	$	0.21		83		12
Total Gtxcel, Inc.									166		16

Hytrust, Inc.	Warrant	January 16, 2020	June 23, 2026	Preferred Series D2	424,808	$	0.82	$	172	$	—

Lucidworks, Inc.	Warrant	January 16, 2020	June 27, 2026	Preferred Series D	619,435	$	0.77	$	806	$	1,509

Oto Analytics, Inc.	Warrant	January 16, 2020	August 31, 2028	Preferred Series B	1,018,718	$	0.79	$	295	$	221

RapidMiner, Inc.	Warrant	January 16, 2020	March 25, 2029	Preferred Series C-1	11,624	$	60.22	$	528	$	357

STS Media, Inc.⁽⁷⁾	Warrant	January 16, 2020	March 15, 2028	Preferred Series C	20,210	$	24.74	$	—	$	—


Sub-Total: Information (1.2%)*								$	3,197	$	2,851

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽¹⁷⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾
Warrant Investments, Continued

Manufacturing ⁽²⁾
Atieva, Inc. ⁽¹³⁾	Warrant	January 16, 2020	March 31, 2027	Preferred Series D	390,016	$	5.13	$	3,067	$	1,053
	Warrant	January 16, 2020	September 8, 2027	Preferred Series D	195,008	$	5.13		1,533		526
Total Atieva, Inc.									4,600		1,579

AyDeeKay LLC	Warrant	January 16, 2020	March 30, 2028	Preferred Series G	6,250	$	35.42	$	31	$	32

Footprint International Holding, Inc.	Warrant	February 14, 2020	February 14, 2030	Common Stock	26,852	$	0.31	$	5	$	81
	Warrant	June 22, 2020	June 22, 2030	Common Stock	10,836	$	0.31		4		33
Total Footprint International Holding, Inc.									9		114

Happiest Baby, Inc.	Warrant	January 16, 2020	May 16, 2029	Common Stock	182,554	$	0.33	$	193	$	126

Hexatech, Inc. ⁽⁷⁾	Warrant	January 16, 2020	April 2, 2022	Preferred Series A	226	$	2.77	$	—	$	—

Lensvector, Inc.	Warrant	January 16, 2020	December 30, 2021	Preferred Series C	85,065	$	1.18	$	32	$	—

Mainspring Energy, Inc.	Warrant	January 16, 2020	July 9, 2029	Common Stock	140,186	$	1.15	$	283	$	394
	Warrant	November 20, 2020	November 20, 2030	Common Stock	81,294	$	1.15		226		229
Total Mainspring Energy, Inc.									509		623

Molekule, Inc.	Warrant	June 19, 2020	June 19, 2030	Preferred Series C-1	32,051		3.12	$	16	$	23

SBG Labs, Inc.	Warrant	January 16, 2020	June 29, 2023	Preferred Series A-1	42,857	$	0.70	$	13	$	10
	Warrant	January 16, 2020	September 18, 2024	Preferred Series A-1	25,714	$	0.70		8		6
	Warrant	January 16, 2020	January 14, 2024	Preferred Series A-1	21,492	$	0.70		7		5
	Warrant	January 16, 2020	March 24, 2025	Preferred Series A-1	12,155	$	0.70		4		3
	Warrant	January 16, 2020	October 10, 2023	Preferred Series A-1	11,150	$	0.70		4		3
	Warrant	January 16, 2020	May 6, 2024	Preferred Series A-1	11,145	$	0.70		4		3
	Warrant	January 16, 2020	June 9, 2024	Preferred Series A-1	7,085	$	0.70		2		2
	Warrant	January 16, 2020	May 20, 2024	Preferred Series A-1	342,857	$	0.70		110		80
	Warrant	January 16, 2020	March 26, 2025	Preferred Series A-1	200,000	$	0.70		65		48
Total SBG Labs, Inc.									217		160

The Fynder Group, Inc.	Warrant	October 14, 2020	October 14, 2030	Common Stock	107,190	$	0.49	$	201	$	282

Vertical Communications, Inc. ^{(7) (20)}	Warrant	January 16, 2020	July 11, 2026	Preferred Series A	828,479	$	1.00	$	—	$	—

Sub-Total: Manufacturing (1.2%)*								$	5,808	$	2,939

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽¹⁷⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾
Warrant Investments, Continued

Pharmaceutical ⁽²⁾
Ology Bioservices, Inc. ⁽²⁰⁾	Warrant	January 16, 2020	November 14, 2021	Common Stock	67,961	$	1.03	$	1,122	$	2,216

Zosano Pharma Corporation	Warrant	January 16, 2020	September 25, 2025	Common Stock	75,000	$	3.59	$	69	$	18

Sub-Total: Pharmaceutical (0.9%)*								$	1,191	$	2,234

Professional, Scientific, and Technical Services ⁽²⁾
Augmedix, Inc.	Warrant	January 16, 2020	September 3, 2029	Preferred Series B	580,383	$	2.88	$	449	$	379

Continuity, Inc.	Warrant	January 16, 2020	March 29, 2026	Preferred Series C	1,588,806	$	0.25	$	21	$	45

Crowdtap, Inc.	Warrant	January 16, 2020	December 16, 2025	Preferred Series B	442,233	$	1.09	$	42	$	140
	Warrant	January 16, 2020	November 30, 2027	Preferred Series B	100,000	$	1.09		9		32
Total Crowdtap, Inc.									51		172

Dynamics, Inc.	Warrant	January 16, 2020	March 10, 2024	Common Stock	17,000	$	10.59	$	86	$	—

E La Carte, Inc.	Warrant	January 16, 2020	July 28, 2027	Common Stock	497,183	$	0.30	$	186	$	123
	Warrant	January 16, 2020	July 28, 2027	Preferred Series A	104,284	$	7.49		15		34
	Warrant	January 16, 2020	July 28, 2027	Preferred Series AA-1	106,841	$	7.49		15		1
Total E La Carte, Inc.									216		158

Edeniq, Inc.	Warrant	January 16, 2020	December 23, 2026	Preferred Series B	2,685,501	$	0.22	$	—	$	—
	Warrant	January 16, 2020	December 23, 2026	Preferred Series B	2,184,672	$	0.01		—		—
	Warrant	January 16, 2020	March 12, 2028	Preferred Series C	5,106,972	$	0.44		—		—
	Warrant	January 16, 2020	October 15, 2028	Preferred Series C	3,850,294	$	0.01		—		—
Total Edeniq, Inc. ^(7)(20)									—		—

Fingerprint Digital, Inc.	Warrant	January 16, 2020	April 29, 2026	Preferred Series B	48,102	$	10.39	$	165	$	84

Hologram, Inc.	Warrant	January 31, 2020	January 27, 2030	Common Stock	193,054	$	0.26	$	49	$	33

Hospitalists Now, Inc.	Warrant	January 16, 2020	March 30, 2026	Preferred Series D2	135,807	$	5.89	$	71	$	272
	Warrant	January 16, 2020	December 6, 2026	Preferred Series D2	750,000	$	5.89		391		1,505
Total Hospitalists Now, Inc.									462		1,777

Incontext Solutions, Inc.	Warrant	January 16, 2020	September 28, 2028	Preferred Series AA-1	332,858	$	1.47	$	34	$	47

Matterport, Inc.	Warrant	January 16, 2020	April 20, 2028	Common Stock	143,813	$	1.43	$	434	$	603

Pendulum Therapeutics, Inc.	Warrant	January 16, 2020	October 9, 2029	Preferred Series B	55,263	$	1.90	$	44	$	65
	Warrant	June 1, 2020	July 15, 2030	Preferred Series B	36,842	$	1.90		36		43
Total Pendulum Therapeutics, Inc.									80		108

Reciprocity, Inc.	Warrant	September 25, 2020	September 25, 2030	Common Stock	114,678	$	4.17	$	99	$	145

Resilinc, Inc.	Warrant	January 16, 2020	December 15, 2025	Preferred Series A	589,275	$	0.51	$	40	$	100


Saylent Technologies, Inc.	Warrant	January 16, 2020	March 31, 2027	Preferred Series C	24,096	$	9.96	$	108	$	94

Sun Basket, Inc.	Warrant	January 16, 2020	October 5, 2027	Preferred Series C-2	249,306	$	6.02	$	111	$	343
	Warrant	December 31, 2020	December 31, 2030	Common Stock	118,678	$	0.89		545		546
									656		889

Utility Associates, Inc.	Warrant	January 16, 2020	June 30, 2025	Preferred Series A	92,511	$	4.54	$	55	$	4
	Warrant	January 16, 2020	May 1, 2026	Preferred Series A	60,000	$	4.54		36		3
	Warrant	January 16, 2020	May 22, 2027	Preferred Series A	200,000	$	4.54		120		8
Total Utility Associates, Inc.									211		15

Sub-Total: Professional, Scientific, and Technical Services (2.0%)*								$	3,161	$	4,649

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽¹⁷⁾	Expiration Date	Series	Shares	Strike Price		Cost		Fair Value ⁽⁶⁾
Warrant Investments, Continued

Real Estate ⁽²⁾
Egomotion Corporation	Warrant	January 16, 2020	December 10, 2028	Preferred Series A ⁽⁷⁾	60,786	$	1.32	$	—	$	53
	Warrant	January 16, 2020	June 29, 2028	Preferred Series A	121,571	$	1.32		219		106
Total Egomotion Corporation									219		159

Knockaway, Inc.	Warrant	January 16, 2020	May 24, 2029	Preferred Series B	87,955	$	8.53	$	209	$	272

Sub-Total: Real Estate (0.2%)*								$	428	$	431

Rental and Leasing Services ⁽²⁾

Maxwell Financial Labs, Inc.	Warrant	October 7, 2020	October 7, 2030	Common Stock	106,735	$	0.29	$	21	$	33
	Warrant	December 22, 2020	December 22, 2030	Common Stock	110,860	$	0.29		34		34
Total Maxwell Financial Labs, Inc.									55		67

Sub-Total: Rental and Leasing Services (0.0%)*								$	55	$	67

Retail Trade ⁽²⁾
Boosted eCommerce, Inc. ⁽¹⁴⁾	Warrant	December 18, 2020	December 14, 2030	Preferred Series A-1	759,263	$	0.84	$	259	$	259

Gobble, Inc.	Warrant	January 16, 2020	May 9, 2028	Common Stock	74,635	$	1.20	$	73	$	63
	Warrant	January 16, 2020	December 27, 2029	Common Stock	10,000	$	1.22		617		467
Total Gobble, Inc.									690		530

Madison Reed, Inc.	Warrant	January 16, 2020	March 23, 2027	Preferred Series C	194,553	$	2.57	$	185	$	241
	Warrant	January 16, 2020	July 18, 2028	Common Stock	43,158	$	0.99		71		78
	Warrant	January 16, 2020	May 19, 2029	Common Stock	36,585	$	1.23		56		62
Total Madison Reed, Inc.									312		381

Portofino Labs, Inc. ⁽¹⁴⁾	Warrant	December 31, 2020	December 31, 2030	Common Stock	39,659	$	1.53	$	15	$	15

Super73, Inc. ⁽¹⁴⁾	Warrant	December 31, 2020	December 31, 2030	Common Stock	177,305	$	3.16	$	105	$	105

Trendly, Inc.	Warrant	January 16, 2020	August 10, 2026	Preferred Series A	245,506	$	1.14	$	222	$	256

Sub-Total: Retail Trade (0.6%)*								$	1,603	$	1,546

Wholesale Trade ⁽²⁾
BaubleBar, Inc.	Warrant	January 16, 2020	March 29, 2027	Preferred Series C	531,806	$	1.96	$	638	$	207
	Warrant	January 16, 2020	April 20, 2028	Preferred Series C	60,000	$	1.96		72		23
Total BaubleBar, Inc.									710		230

GrubMarket, Inc.	Warrant	June 15, 2020	June 15, 2030	Common Stock	405,000	$	1.10	$	116	$	837

Sub-Total: Wholesale Trade (0.4%)*								$	826	$	1,067

Total: Warrant Investments (7.4%)*⁽¹³⁾								$	17,865	$	17,778

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)


Portfolio Company ⁽¹⁾	Type of Investment ⁽³⁾	Investment Date ⁽¹⁷⁾	Shares / Principal		Series	Cost		Fair Value ⁽⁶⁾
Equity Investments
Construction ⁽²⁾
Project Frog, Inc.	Equity	January 16, 2020		8,118,527	Preferred Series AA-1 ⁽¹⁸⁾	$	702	$	36
	Equity	January 16, 2020		6,300,134	Preferred Series BB ⁽¹⁸⁾		2,667		449
Total Project Frog, Inc. ⁽²⁰⁾							3,369		485

Sub-Total: Construction (0.2%)*						$	3,369	$	485

Health Care and Social Assistance ⁽²⁾
WorkWell Prevention & Care Inc.	Equity	January 16, 2020		7,000,000	Common Stock	$	51	$	—
	Equity	January 16, 2020		3,450	Preferred Series P ⁽¹⁸⁾		3,450		657
	Equity	January 16, 2020	$	1,470	Convertible Notes ⁽¹⁰⁾		1,519		1,542
Total WorkWell Prevention & Care Inc. ⁽²⁰⁾							5,020		2,199

Sub-Total: Health Care and Social Assistance (0.9%)*						$	5,020	$	2,199

Manufacturing ⁽²⁾
Store Intelligence, Inc. ⁽²⁰⁾	Equity	May 2, 2020		1,430,000	Preferred Series A ⁽¹⁸⁾	$	608	$	694

Vertical Communications, Inc.	Equity	January 16, 2020		3,892,485	Preferred Series 1 ^(7)(18)	$	—	$	—
	Equity	January 16, 2020	$	5,500	Convertible Notes⁽¹⁰⁾		3,966		3,350
Total Vertical Communications, Inc. ⁽²⁰⁾							3,966		3,350

Sub-Total: Manufacturing (1.7%)*						$	4,574	$	4,044

Pharmaceutical ⁽²⁾
Ology Bioservices, Inc. ⁽²⁰⁾	Equity	January 16, 2020		382,277	Common Stock ⁽¹⁶⁾	$	6,691	$	12,856

Sub-Total: Pharmaceutical (5.4%)*						$	6,691	$	12,856

Professional, Scientific, and Technical Services ⁽²⁾
Dynamics, Inc.	Equity	January 16, 2020		17,726	Preferred Series A ⁽¹⁸⁾	$	390	$	—
	Equity	January 16, 2020		15,000	Common Stock ⁽⁷⁾		—		—
Total Dynamics, Inc.							390		—

Edeniq, Inc.	Equity	January 16, 2020		7,807,499	Preferred Series B ^(7)(18)	$	—	$	—
	Equity	January 16, 2020		2,441,082	Preferred Series C ^(7)(18)		—		—
	Equity	January 16, 2020	$	1,303	Convertible Notes ^(7)(10)		—		—
Total Edeniq, Inc. ⁽²⁰⁾							—		—

Instart Logic, Inc.	Equity	January 16, 2020	$	2,600	Convertible Notes ⁽¹⁰⁾	$	2,646	$	3,625

Sub-Total: Professional, Scientific, and Technical Services (1.5%)*						$	3,036	$	3,625

Retail Trade ⁽²⁾
Birchbox, Inc. ⁽²⁰⁾	Equity	April 20, 2020		3,140,927	Preferred Series D ⁽¹⁸⁾	$	10,271	$	9,445

Sub-Total: Retail Trade (4.0%)*						$	10,271	$	9,445

Total: Equity Investments (13.7%)*⁽¹³⁾						$	32,961	$	32,654

Total Investment in Securities (207.2%)*						$	498,336	$	493,651

Cash, Cash Equivalents, and Restricted Cash
Goldman Sachs Financial Square Government Institutional Fund						$	60,284	$	60,284
Other cash accounts							817		817
Cash, Cash Equivalents, and Restricted Cash (25.6%)*							61,101		61,101

Total Portfolio Investments and Cash and Cash Equivalents (232.9% of net assets)						$	559,437	$	554,752

Table of Contents

TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2020
(In thousands, except share and per share data)

(1)

All portfolio companies are located in North America. As of December 31, 2020, the Company had two foreign domiciled portfolio companies - one in Canada (11.3% of NAV) and one in Cayman Islands (0.7% of NAV). The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale and may be deemed to be “restricted securities” under the Securities Act.

(2)	The Company uses the North American Industry Classification System (“NAICS”) code for classifying the industry grouping of its portfolio companies.

(3)

(4)

(5)	Principal is net of repayments, if any, as per the terms of the debt instrument’s contract.

(6)	All investments were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s board of directors.

(7)	Investment has zero cost basis as it was purchased at a fair market value of zero as part of the Formation Transaction.

(8)

Indicates a “non-qualifying asset” under section 55(a) by the Investment Company Act of 1940, as amended. The Company’s percentage of non-qualifying assets represents 5.1% of the Company’s total assets as of December 31, 2020. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets. Asset is not a U.S. entity. Invenia, Inc. is a Canadian corporation, and Atieva, Inc. is a Cayman Island corporation.

(9)	The interest rate on variable interest rate investments represents a benchmark rate plus spread. The benchmark interest rate is subject to an interest rate floor. The benchmark rate Prime was 3.25% as of December 30, 2020.

(10)	Convertible notes represent investments through which the Company will participate in future equity rounds at preferential rates. There are no principal or interest payments made against the note unless conversion does not take place.

(11)	Debt is on non-accrual status as of December 30, 2020 and is therefore considered non-income producing.

Table of Contents

(12)	Investment has an unfunded commitment as of December 31, 2020 (see “Note 6 – Commitments and Contingencies”). The fair value of the investment includes the impact of the fair value of any unfunded commitments.

(13)	All of the Company’s debt, warrant and equity securities are pledged as collateral supporting the amounts outstanding under the credit facility with Credit Suisse AG (see “Note 5 – Borrowings”), except as noted.

(14)	Investment is not pledged as collateral supporting amounts outstanding under the credit facility with Credit Suisse AG.

(15)	Investment is considered non-income producing.

(16)	Certain third parties have rights to 17,485 shares of Ology Bioservices common stock at a fair value of approximately $0.6 million as of December 31, 2020.

(17)	Investment date represents the date of initial investment date, either purchases or funding, not adjusted for modifications. For assets purchased from the Legacy Funds as part of the Formation Transactions, investment date is January 16, 2020, the date of the Formation Transactions.

(18)	Preferred stock represent investments through which the Company will have preference in liquidation rights and do not contain any cumulative preferred dividends.

(19)

(20)

This investment is deemed to be a “Control Investment” or an “Affiliate Investment.” The Company classifies its investment portfolio in accordance with the requirements of the 1940 Act. Control Investments are defined by the Investment Company Act of 1940, as amended, as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. Affiliate Investments are defined by the Investment Company Act of 1940, as amended, as investments in companies in which the Company owns between 5% and 25% (inclusive) of the voting securities and does not have rights to maintain greater than 50% of the board representation. As defined in the Investment Company Act, the Company is deemed to be an “Affiliated Person” of this portfolio company. Fair value as of December 31, 2020 along with transactions during the year ended December 31, 2020 in these control or affiliated investments are as follows:


									Net change in
									Unrealized
	Fair Value at		Gross		Gross		Realized		(Depreciation)/		Fair Value at		Interest
	December 31, 2019		Additions ⁽¹⁾		Reductions ⁽²⁾		Gain/(Loss)		Appreciation		December 31, 2020		Income
For the Year Ended December 31, 2020
Control Investments
Birchbox, Inc.	$	—	$	20,704	$		$	—	$	(1,335)	$	19,369	$	1,289
Edeniq, Inc.		—		3,278		(1,414)		—		(357)		1,507		—
Project Frog, Inc.		—		7,432				—		(2,916)		4,516		552
Vertical Communications, Inc.		—		17,904		(194)		—		(757)		16,953		1,425
WorkWell Prevention and Care Inc.		—		9,362				—		(2,977)		6,385		395
Total Control Investments	$	—	$	58,680	$	(1,608)	$	—	$	(8,342)	$	48,730	$	3,661

Affiliate Investments
Ology Bioservices, Inc.	$	—	$	7,813	$		$	—	$	7,259	$	15,072	$	—
Store Intelligence, Inc.		—		12,840				—		(262)		12,578		1,191
Total Affiliate Investments	$	—	$	20,653	$	—	$	—	$	6,997	$	27,650	$	1,191

Total Control and Affiliate Investments	$	—	$	79,333	$	(1,608)	$	—	$	(1,345)	$	76,380	$	4,852

(1)

Table of Contents

(2)

Table of Contents

TRINITY CAPITAL INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Note 1. Organization and Basis of Presentation

Trinity Capital Inc., (“Trinity Capital” and, together with its subsidiary, the “Company”) is a specialty lending company focused on providing debt, including loans and equipment financings, to growth stage companies, including venture-backed companies and companies with institutional equity investors. Trinity Capital was formed on August 12, 2019 as a Maryland corporation and commenced operations on January 16, 2020. Prior to January 16, 2020, Trinity Capital had no operations, except for matters relating to its formation and organization as a business development company (“BDC”).

Trinity Capital is an internally managed, closed-end, non-diversified management investment company that has elected to be regulated as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”). Trinity Capital has elected to be treated, and intends to continue to qualify annually, as a regulated investment company (a “RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”), for U.S. federal income tax purposes.

On September 27, 2019, Trinity Capital was initially capitalized with the issuance of 10 shares of its common stock for $150 to its sole stockholder. On January 16, 2020, Trinity Capital completed a series of transactions, including a private equity offering, a private debt offering, and the acquisition of Trinity Capital Investment, LLC (“TCI”), Trinity Capital Fund II, L.P. (“Fund II”), Trinity Capital Fund III, L.P. (“Fund III”), Trinity Capital Fund IV, L.P. (“Fund IV”), and Trinity Sidecar Income Fund, L.P. (“Sidecar Fund”) (collectively the “Legacy Funds”) through mergers of the Legacy Funds with and into Trinity Capital as well as Trinity Capital’s acquisition of Trinity Capital Holdings, LLC (“Trinity Capital Holdings”) (collectively, the “Formation Transactions”).

Trinity Capital’s common stock began trading on the Nasdaq Global Select Market on January 29, 2021 under the symbol “TRIN” in connection with its initial public offering of shares of its common stock (“IPO”).

Basis of Presentation

The Company’s interim consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Articles 6, 10 and 12 of Regulation S-X. Accordingly, certain disclosures accompanying annual financial statements prepared in accordance with GAAP are omitted. In the opinion of management, the unaudited financial results included herein contain all adjustments, consisting solely of normal accruals, considered necessary for the fair statement of the results for the interim period included herein. The current period’s consolidated results of operations are not necessarily indicative of results that may be achieved for the year. The interim consolidated financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission (“SEC”). As an investment company, the Company follows accounting and reporting guidance determined by the Financial Accounting Standards Board (“FASB”), in Accounting Standards Codification, as amended (“ASC”) 946 - Financial Services – Investment Companies (“ASC 946”).

Formation Transactions

The Formation Transactions were accounted for as a business combination in accordance with FASB ASC 805, Business Combinations (“ASC 805”), and as a result the assets acquired, and liabilities assumed were recorded at fair values as of January 16, 2020. Transaction costs related to the acquisition of a business are expensed as incurred and excluded from the fair value of the consideration transferred.

Table of Contents

On January 16, 2020, the Company completed a private offering of shares of its common stock (the “Private Common Stock Offering”) in reliance upon the available exemptions from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to which the Company issued and sold 7,000,000 shares of its common stock for aggregate gross proceeds of approximately $105.0 million. Keefe, Bruyette & Woods, Inc. (“KBW”) acted as the initial purchaser and placement agent in connection with the Private Common Stock Offering pursuant to a purchase/placement agreement, dated January 8, 2020, by and between the Company and KBW. KBW exercised in full its option to purchase or place additional shares and on January 29, 2020 the Company issued and sold an additional 1,333,333 shares of its common stock for gross proceeds of approximately $20.0 million. As a result, the Company issued and sold a total of 8,333,333 shares of its common stock pursuant to the Private Common Stock Offering for aggregate net proceeds of approximately $114.4 million, net of offering costs of approximately $10.6 million.

On January 16, 2020, concurrent with the initial closing of the Private Common Stock Offering, the Company completed a private debt offering (the “144A Note Offering” and together with the Private Common Stock Offering, the “Private Offerings”) of $105.0 million in aggregate principal amount of the Company’s unsecured 7.00% Notes due 2025 (the “2025 Notes”). On January 29, 2020, an over-allotment option related to the 144A Note Offering was exercised in full and on the Company issued and sold an additional $20.0 million in aggregate principal amount of the Notes. As a result, the Company issued and sold $125.0 million in aggregate principal amount of the Notes. See “Note 5 - Borrowings” and “Note 7 – Stockholder’s Equity.”

On January 16, 2020, immediately following the consummation of the Private Offerings, the Company used a portion of the proceeds of the Private Offerings to acquire, through the Formation Transactions, the Legacy Funds and Trinity Capital Holdings. Each member/limited partner of the Legacy Funds was given the option to elect to receive cash and or shares of the Company’s common stock in exchange for its limited partner interests or membership interests, as applicable. The general partners, managers or managing members of the Legacy Funds received only shares in exchange for their interests held in such capacities. As a result of the Formation Transactions, the Legacy Funds were merged with and into the Company and Trinity Capital Holdings became a wholly owned subsidiary of the Company.

As consideration for the partnership and membership interests in the Legacy Funds, the Company issued 9,183,185 shares of its common stock at $15.00 per share for a total value of approximately $137.7 million and paid approximately $108.7 million in cash to the Legacy Funds’ investors, which included the general partners/managers of the Legacy Funds (the “Legacy Investors”). The acquisition consideration of the Formation Transactions was based on valuations as of September 30, 2019, as adjusted for assets that were disposed of by the Legacy Funds, as well as earnings, capital contributions and distributions paid to the general partners, managers or managing members, and material events affecting the portfolio companies of the Legacy Funds subsequent to September 30, 2019 and through the closing date of the Formation Transactions.

A summary of the fair value of the assets acquired and liabilities assumed from the Legacy Funds as of the acquisition date is as follows (in thousands):


Investments acquired	$	417,023
Interest receivable and other assets acquired		1,191
Accounts payable and accrued liabilities assumed		(680)
Customer deposits assumed		(4,250)
Credit facility assumed		(190,000)
Financing fees related to credit facility acquired		1,900
Cash acquired		19,183
Total net assets acquired	$	244,367

The total merger consideration of the Legacy Funds of approximately $246.4 million exceeded the fair value of the net assets acquired as of the acquisition date, and as a result, the Company included a loss of approximately $2.1 million in Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds in the Consolidated Statements of Operations. During the quarter ended December 31, 2020, upon filing the final tax returns for the Legacy Funds, the Company reversed approximately $0.4 million of accrued liabilities assumed related to expected tax expense of the Legacy Funds.

Table of Contents

Additionally, as part of the Formation Transactions, the Company also used a portion of the proceeds of the Private Offerings to acquire 100% of the equity interests of Trinity Capital Holdings, the sole member of Trinity Management IV, LLC, the investment manager to Fund IV and the sub-adviser to Fund II and Fund III, the Company issued 533,332 shares of common stock at $15.00 per share for a total value of approximately $8.0 million and paid approximately $2.0 million in cash. In connection with the acquisition of Trinity Capital Holdings, the Company also assumed a $3.5 million severance related liability with respect to a former member of certain general partners of certain Legacy Funds. Prior to the completion of the Formation Transactions, Trinity Capital Holdings acquired approximately $0.2 million of certain net assets from Trinity SBIC Management, LLC, the investment manager to Fund II and Fund III.

In connection with the acquisition of Trinity Capital Holdings, approximately $13.5 million (consisting of the aggregate purchase price and severance related liability assumed) was expensed to Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds in the Consolidated Statements of Operations. Under ASC 805, such amount represents the settlement price, based on the estimated fair value of the future profits and cash flows that would otherwise have been contractually due to Trinity Capital Holdings, had the underlying management agreements with each of the Legacy Funds not been canceled in order to enter into the Formation Transactions and operate the Company as an internally managed BDC.

Principles of Consolidation

Under ASC 946, the Company is precluded from consolidating portfolio company investments, including those in which it has a controlling interest, unless the portfolio company is another investment company. An exception to this general principle occurs if the Company holds a controlling interest in an operating company that provides all or substantially all of its services directly to the Company or to its portfolio companies. None of the portfolio investments made by the Company qualify for this exception. Therefore, the Company’s investment portfolio is carried on the Consolidated Statements of Assets and Liabilities at fair value, as discussed further in “Note 3 - Investments,” with any adjustments to fair value recognized as "Net unrealized appreciation (depreciation) from investments" on the Consolidated Statements of Operations.

The Company’s consolidated operations include the activities of its wholly owned subsidiaries, Trinity Funding 1, LLC (“TF1”), and TrinCap Funding, LLC (“TCF”). TF1 was formed on August 14, 2019 as a Delaware limited liability company with Fund II as its sole equity member. On January 16, 2020, in connection with the Formation Transactions, the Company acquired TF1 through Fund II and became a party to, and assumed, a $300 million credit agreement (as amended, the “Credit Facility”) with Credit Suisse AG (“Credit Suisse”) through TF1. TCF was formed on August 5, 2021 as a Delaware limited liability company with the Company as its sole equity member. TF1 and TCF are special purpose bankruptcy-remote entities and are a separate legal entity from the Company. Any assets conveyed to TF1 or TCF are not available to creditors of the Company or any other entity other than TF1 or TCF’s lenders. TF1 and TCF are consolidated for financial reporting purposes and in accordance with GAAP, and the portfolio investments held by these subsidiaries, if any, are included in the Company’s consolidated financial statements and recorded at fair value. All intercompany balances and transactions have been eliminated. There has been no activity in TCF.

In accordance with Rule 10-01(b)(1) of Regulation S-X, as amended, the Company must determine which of its unconsolidated controlled portfolio companies, if any, are considered “significant subsidiaries.” In evaluating these unconsolidated controlled portfolio companies, there are two significance tests utilized per Rule 1-02(w) of Regulation S-X to determine if any of the Company’s Control Investments (as defined in “Note 2 - Summary of Significant Accounting Policies”) are considered significant subsidiaries: the investment test, and the income test. As of September 30, 2021 and December 31, 2020, the Company had no single investment that met either of these two tests.

Table of Contents

Note 2. Summary of Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ materially from those estimates.

Investment Transactions

Loan originations are recorded on the date of the legally binding commitment. Realized gains or losses are recorded using the specific identification method as the difference between the net proceeds received, excluding prepayment fees, if any, and the amortized cost basis of the investment without regard to unrealized gains or losses previously recognized, and include investments written off during the period, net of recoveries. The net change in unrealized gains or losses primarily reflects the change in investment fair values as of the last business day of the reporting period and also includes the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period.

Valuation of Investments

The Company’s investments are carried at fair value in accordance with the 1940 Act and ASC 946 and measured in accordance with ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that each of the portfolio investments is sold in a hypothetical transaction in the principal or, as applicable, most advantageous market using market participant assumptions as of the measurement date. Market participants are defined as buyers and sellers in the principal market that are independent, knowledgeable and willing and able to transact. The Company values its investments at fair value as determined in good faith pursuant to a consistent valuation policy by the Company’s Board of Directors (the “Board”) in accordance with the provisions of ASC 820 and the 1940 Act.

While the Board is ultimately and solely responsible for determining the fair value of the Company’s investments, the Company has engaged independent valuation firms to provide the Company with valuation assistance with respect to its investments. The Company engages independent valuation firms on a discretionary basis. Specifically, on a quarterly basis, the Company will identify portfolio investments with respect to which an independent valuation firm will assist in valuing. The Company selects these portfolio investments based on a number of factors, including, but not limited to, the potential for material fluctuations in valuation results, size, credit quality and the time lapse since the last valuation of the portfolio investment by an independent valuation firm.

Investments recorded on the Company’s Consolidated Statements of Assets and Liabilities are categorized based on the inputs to the valuation techniques as follows:

Level 1 — Investments whose values are based on unadjusted quoted prices for identical assets in an active market that the Company has the ability to access (examples include investments in active exchange-traded equity securities and investments in most U.S. government and agency securities).

Level 2 — Investments whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the investment.

Table of Contents

Level 3 — Investments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (for example, investments in illiquid securities issued by privately held companies). These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the investment.

Given the nature of lending to venture capital-backed growth stage companies, 92.2%, based on fair value, of the Company’s investments in these portfolio companies are considered Level 3 assets under ASC 820 because there is no known or accessible market or market indexes for these investment securities to be traded or exchanged. Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. The Company uses an internally developed portfolio investment rating system in connection with its investment oversight, portfolio management and analysis and investment valuation procedures. This system takes into account both quantitative and qualitative factors of the portfolio companies. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.

Debt Securities

The debt securities identified on the Consolidated Schedule of Investments are secured loans and equipment financings made to growth stage companies. For portfolio investments in debt securities for which the Company has determined that third-party quotes or other independent pricing are not available, the Company generally estimates the fair value based on the assumptions that hypothetical market participants would use to value the investment in a current hypothetical sale using an income approach.

In its application of the income approach to determine the fair value of debt securities, the Company bases its assessment of fair value on projections of the discounted future free cash flows that the security will likely generate, including analyzing the discounted cash flows of interest and principal amounts for the security, as set forth in the associated loan and equipment financing agreements, as well as market yields and the financial position and credit risk of the portfolio company (the “Hypothetical Market Yield Method”). The discount rate applied to the future cash flows of the security is based on the calibrated yield implied by the terms of the Company’s investment adjusted for changes in market yields and performance of the subject company. The Company’s estimate of the expected repayment date of its loans and equipment financings securities is either the maturity date of the instrument or the anticipated pre-payment date, depending on the facts and circumstances. The Hypothetical Market Yield Method analysis also considers changes in leverage levels, credit quality, portfolio company performance, market yield movements, and other factors. If there is deterioration in credit quality or if a security is in workout status, the Company may consider other factors in determining the fair value of the security, including, but not limited to, the value attributable to the security from the enterprise value of the portfolio company or the proceeds that would most likely be received in a liquidation analysis.

Equity-Related Securities and Warrants

Often the Company is issued warrants by issuers as yield enhancements. These warrants are recorded as assets at estimated fair value on the grant date. The Company determines the cost basis of the warrants or other equity securities received based upon their respective fair values on the date of receipt in proportion to the total fair value of the debt and warrants or other equity securities received. Depending on the facts and circumstances, the Company usually utilizes a combination of one or several forms of the market approach as well as contingent claim analyses (a form of option analysis) to estimate the fair value of the securities as of the measurement date and determines the cost basis using a relative fair value methodology. As part of its application of the market approach, the Company estimates the enterprise value of a portfolio company utilizing customary pricing multiples, based on the development stage of the underlying issuers, or other appropriate valuation methods, such as considering recent transactions in the equity securities of the portfolio company or third-party valuations that are assessed to be indicative of fair value of the respective portfolio company, and, if appropriate based on the facts and circumstances performs an allocation of the enterprise value to the equity securities utilizing a contingent claim analysis and/or other waterfall calculation by which it allocates the enterprise value across the portfolio company’s securities in order of their preference relative to one another.

Table of Contents

Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Company’s financial instruments, consisting of cash, investments, receivables, payables and other liabilities approximate the fair values of such items due to the short-term nature of these instruments. Refer to “Note 4 – Fair Value of Financial Instruments” for further discussion.

Cash, Cash Equivalents and Restricted Cash

Cash, cash equivalents and restricted cash consist of funds deposited with financial institutions and short-term (original maturity of three months or less) liquid investments in money market deposit accounts. Cash equivalents are classified as Level 1 assets and are valued using the Net Asset Value (“NAV”) per share of the money market fund. As of September 30, 2021 and December 31, 2020, cash, cash equivalents and restricted cash consisted of $40.3 million and $61.1 million, respectively, of which $39.7 million and $60.3 million, respectively, is held in the Goldman Sachs Financial Square Government Institutional Fund. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insured limit and therefore is subject to credit risk. All of the Company’s cash deposits are held at large, established, high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote. As of September 30, 2021 and December 31, 2020, restricted cash consisted of approximately $15.0 million and $15.7 million, respectively, related to the Credit Facility covenants (See “Note 5 – Borrowings”), and an additional amount of approximately $0.7 million as of December 31, 2020 was held in escrow related to the payout of a severance related liability assumed as part of the Formation Transactions with respect to a former member of certain general partners of certain Legacy Funds.

Other Assets

Other assets generally consist of fixed assets net of accumulated depreciation, right of use asset, security deposits and other assets.

Equity Offering Costs

Equity offering costs consist of fees and costs incurred in connection with the sale of the Company’s common stock, including legal, accounting and printing fees. These costs are deferred at the time of incurrence and are subsequently charged as a reduction to capital when the offering takes place or as shares are issued. Deferred costs are periodically reviewed and expensed if the related registration is no longer active.

Debt Financing Costs

The Company records costs related to the issuance of debt obligations as deferred debt financing costs. These costs are deferred and amortized using the straight-line method over the stated maturity life of the obligations.

Security Deposits

Security deposits are collected upon funding equipment financings and are applied in lieu of regular payments at the end of the term.

Income Recognition

Interest Income

Table of Contents

based on the effective yield method. As of September 30, 2021 and December 31, 2020, the EOT payment receivable of approximately $38.2 million and $37.9 million, respectively, is included as a component of the cost basis of the Company’s current debt securities. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, then the acceleration of the unaccreted OID and EOT is recognized as interest income.

The Company had a limited number of debt investments in its portfolio that contain a payment-in-kind (“PIK”) provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. The Company will generally cease accruing PIK interest if there is insufficient value to support the accrual or management does not expect the portfolio company to be able to pay all principal and interest due. No PIK interest income was recorded during the three and nine months ended September 30, 2021. The Company recorded no PIK income during the three months ended September 30, 2020, and $0.2 million in PIK interest income during the nine months ended September 30, 2020.

Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, are amortized into interest income over the contractual life of the loan. The Company recognizes nonrecurring fees and additional OID and EOT received in consideration for contract modifications commencing in the quarter relating to the specific modification.

Fee Income

The Company recognizes one-time fee income, including, but not limited to, structuring fees, prepayment penalties, and exit fees related to a change in ownership of the portfolio company, as other income when earned. These fees are generally earned when the portfolio company enters into an equipment financing arrangement or pays off their outstanding indebtedness prior to the scheduled maturity.

Non-Accrual Policy

When a debt security becomes 90 days or more past due, or if management otherwise does not expect that principal, interest, and other obligations due will be collected in full, the Company will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or the Company believes the borrower has demonstrated the ability to repay its current and future contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable is determined to be doubtful. However, the Company may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection.

As of September 30, 2021, loans to two portfolio companies were on non-accrual status with a total cost of approximately $13.0 million, and a total fair market value of approximately $7.6 million, or 1.1%, of the fair value of the Company’s investment portfolio. As of December 31, 2020, loans to three portfolio companies were on non-accrual status with a total cost of approximately $3.4 million, and a total fair value of approximately $2.2 million, or 0.5%, of the total fair value of the Company’s investment portfolio.

Net Realized Gains / (Losses)

Realized gains / (losses) are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written-off during the period net of recoveries and realized gains or losses from in-kind redemptions. Net proceeds excludes any prepayment penalties, exit fees, and OID and EOT acceleration. Prepayment penalties and exit fees received at the time of sale or redemption are included in fee income on the Consolidated Statements of Operations. OID and EOT acceleration is included in interest income on the Consolidated Statement of Operations.

Table of Contents

Net Unrealized Appreciation / (Depreciation)

Net change in unrealized appreciation / (depreciation) reflects the net change in the fair value of the investment portfolio and financial instruments and the reclassification of any prior period unrealized appreciation or depreciation on exited investments and financial instruments to realized gains or losses.

Stock Based Compensation

The Company has issued and may, from time to time, issue restricted stock to its officers and employees under the 2019 Trinity Capital Inc. Long Term Incentive Plan and to its non-employee directors under the Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan. The Company accounts for its share-based compensation plan using the fair value method, as prescribed by ASC 718, Compensation – Stock Compensation. Accordingly, for restricted stock awards, the Company measures the grant date fair value based upon the market price of its common stock on the date of the grant and amortizes the fair value of the awards as share-based compensation expense over the requisite service period, which is generally the vesting term.

The Company has also adopted Accounting Standards Update (“ASU”) 2016-09, Compensation—Stock Compensation: Improvements to Employee Share-Based Payment Accounting, which requires that all excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards) be recognized as income tax expense or benefit in the income statement and not delay recognition of a tax benefit until the tax benefit is realized through a reduction to taxes payable. Accordingly, the tax effects of exercised or vested awards are treated as discrete items in the reporting period in which they occur. Additionally, the Company has elected to account for forfeitures as they occur.

Earnings Per Share

The Company's earnings per share ("EPS") amounts have been computed based on the weighted-average number of shares of common stock outstanding for the period. Basic earnings per share is computed by dividing net increase (decrease) in net assets resulting from operations by the weighted-average number of common shares outstanding for the period. In accordance with ASC 260, Earnings Per Share, the unvested shares of restricted stock awarded pursuant to Trinity Capital’s equity compensation plans are participating securities and, therefore, are included in the basic earnings per share calculation. Diluted EPS is computed by dividing net increase (decrease) in net assets resulting from operations by the weighted average number of shares of common stock assuming all potential shares had been issued and the additional shares of common stock were dilutive. Diluted EPS reflects the potential dilution from the assumed conversion of the Company’s 6.00% Convertible Notes due 2025 (the “Convertible Notes”).

Income Taxes

The Company has elected to be treated, and intends to continue to qualify annually, as a RIC under Subchapter M of the Code for U.S. federal tax purposes. In order to maintain its treatment as a RIC, the Company is generally required to distribute at least annually to its stockholders at least 90% of the sum of its investment company taxable income (which generally includes its net ordinary taxable income and realized net short-term capital gains in excess of realized net long-term capital losses) and its net tax-exempt income (if any). The Company generally will not pay corporate-level income tax on these distributed amounts, but will pay corporate-level income tax on any retained amounts.

The Company evaluates tax positions taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority in accordance with ASC 740, Income Taxes (“ASC 740”), as modified by ASC 946. Tax benefits of positions not deemed to meet the more-likely-than-not threshold, or uncertain tax positions, would be recorded as tax expense in the current year. It is the Company’s policy to recognize accrued interest and penalties related to uncertain tax benefits in income tax expense. The Company has no material uncertain tax positions as of September 30, 2021 and December 31, 2020. All the Company’s tax returns remain subject to examination by U.S. federal and state tax authorities.

Table of Contents

Based on federal excise distribution requirements applicable to RICs, the Company will be subject to a 4% nondeductible federal excise tax on undistributed taxable income and gains unless the Company distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October 31 in that calendar year and (3) any income or gain realized, but not distributed, in the preceding years. For this purpose, however, any ordinary income or capital gain net income retained by the Company and on which the Company paid corporate income tax is considered to have been distributed. The Company, at its discretion, may determine to carry forward taxable income or gain and pay a 4% excise tax on the amount by which it falls short of this calendar-year distribution requirement. If the Company chooses to do so, this generally would increase expenses and reduce the amount available to be distributed to stockholders. The Company will accrue excise tax on estimated undistributed taxable income and gain as required on an annual basis.

Distributions

Distributions to common stockholders are recorded on the record date. The amount of taxable income to be paid out as a distribution is determined by the Board each quarter and is generally based upon the earnings estimated by management of the Company. Capital gains, if any, are distributed at least annually, although the Company may decide to retain all or some of those capital gains for investment and pay corporate-level income taxes on those retained amounts. If the Company chooses to do so, this generally would increase expenses and reduce the amount available to be distributed to stockholders.

Reclassification

Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. Included in net change in unrealized appreciation/(depreciation) for the nine months ended September 30, 2020 is the third-party participation of approximately $0.2 million, which was reclassified from interest expense and other debt financing costs. This reclassification had no effect on the previously reported net increase (decrease) in net assets.

Note 3. Investments

The Company provides debt, including loans and equipment financings, to growth stage companies, including venture capital-backed companies and companies with institutional equity investors, primarily in the United States. The Company’s investment strategy includes making investments consisting primarily of term loans and equipment financings, and, to a lesser extent, working capital loans, equity and equity-related investments. In addition, the Company may obtain warrants or contingent exit fees at funding from many of the portfolio companies.

Debt Securities

The Company’s debt securities primarily consist of direct investments in interest-bearing secured loans and equipment financings to privately held companies based in the United States. Secured loans are generally secured by a blanket first lien or a blanket second lien on the assets of the portfolio company. Equipment financings typically include a specific asset lien on mission critical assets as well as a second lien on the assets of the portfolio company. These debt securities typically have a term of between three and five years from the original investment date. Certain of the debt securities are “covenant-lite” loans, which generally are loans that do not have a complete set of financial maintenance covenants and have covenants that are incurrence-based, meaning they are only tested and can only be breached following an affirmative action of the borrower rather than by a deterioration in the borrower’s financial condition. The equipment financings in the investment portfolio generally have fixed interest rates. The loans in the investment portfolio generally have fixed interest rates or floating interest rates subject to interest rate floors. Both equipment financings and loans generally include an EOT payment.

The specific terms of each debt security vary depending on the creditworthiness of the portfolio company and the projected value of the financed assets. Companies with stronger creditworthiness may receive an initial period of lower financing factor, which is analogous to an interest-only period on a traditional term loan. Equipment financings may

Table of Contents

include upfront interim payments and security deposits. Equipment financing arrangements have various structural protections, including customary default penalties, information and reporting rights, material adverse change or investor abandonment provisions, consent rights for any additions or changes to senior debt, and, as needed, intercreditor agreements with cross-default provisions to protect the Company’s second lien positions.

Warrant Investments

In connection with the Company’s debt investments, the Company may receive warrants in the portfolio company. Warrants received in connection with a debt investment typically include a potentially discounted contract price to exercise, and thus, as a portfolio company appreciates in value, the Company may achieve additional investment return from this equity interest. The warrants typically contain provisions that protect the Company as a minority-interest holder, as well as secured or unsecured put rights, or rights to sell such securities back to the portfolio company, upon the occurrence of specified events. In certain cases, the Company may also obtain follow-up rights in connection with these equity interests, which allow the Company to participate in future financing rounds.

Equity Investments

In specific circumstances, the Company may seek to make direct equity investments in situations where it is appropriate to align the interests of the Company with key management and stockholders of the portfolio company, and to allow for participation in the appreciation in the equity values of the portfolio company. These equity investments are generally made in connection with debt investments. The Company seeks to maintain fully diluted equity positions in the portfolio companies of 5% to 50% and may have controlling equity interests in some instances.

Table of Contents

Portfolio Industry Classification

The Company’s portfolio investments are in companies conducting business in a variety of industries. The following table summarizes the composition of the Company’s portfolio investments by industry at cost and fair value and as a percentage of the total portfolio as of September 30, 2021 and December 31, 2020 (dollars in thousands):


	September 30, 2021						December 31, 2020
	Cost			Fair Value			Cost			Fair Value
Industry	Amount		%	Amount		%	Amount		%	Amount		%
Manufacturing	$	155,092	24.3%		179,415	26.5%	$	103,471	20.8%	$	99,709	20.2%
Professional, Scientific, and Technical Services		109,869	17.2%		124,438	18.4%		77,831	15.6%		78,893	16.0%
Information		60,378	9.5%		62,264	9.2%		31,843	6.4%		30,709	6.2%
Finance and Insurance		52,453	8.2%		54,141	8.0%		35,320	7.0%		35,699	7.2%
Health Care and Social Assistance		49,722	7.8%		44,822	6.6%		14,348	2.9%		11,422	2.3%
Retail Trade		33,946	5.3%		33,558	5.0%		78,534	15.7%		75,664	15.4%
Real Estate		32,036	5.0%		32,011	4.7%		17,267	3.5%		17,316	3.5%
Space Research and Technology		30,404	4.8%		30,626	4.5%		—	0.0%		—	0.0%
Rental and Leasing Services		26,561	4.2%		27,174	4.0%		29,055	5.8%		29,138	5.9%
Utilities		22,420	3.5%		22,636	3.3%		26,800	5.4%		27,083	5.5%
Educational Services		18,156	2.8%		18,741	2.8%		9,359	1.9%		9,816	2.0%
Agriculture, Forestry, Fishing and Hunting		12,057	1.9%		14,166	2.1%		20,981	4.2%		20,837	4.2%
Wholesale Trade		10,612	1.7%		10,955	1.6%		23,850	4.8%		23,903	4.8%
Administrative and Support and Waste Management and Remediation Services		6,708	1.1%		7,890	1.2%		2,370	0.5%		2,328	0.5%
Construction		11,806	1.8%		8,178	1.2%		9,804	2.0%		6,894	1.4%
Pharmaceutical		6,494	0.9%		6,231	0.9%		17,503	3.5%		24,240	4.9%
Total	$	638,714	100.0%	$	677,246	100.0%	$	498,336	100.0%	$	493,651	100.0%

Table of Contents

The geographic composition is determined by the location of the corporate headquarters of the portfolio company. The following table summarizes the composition of the Company’s portfolio investments by geographic region of the United States and other countries at cost and fair value and as a percentage of the total portfolio as of September 30, 2021 and December 31, 2020 (dollars in thousands):


	September 30, 2021						December 31, 2020
	Cost			Fair Value			Cost			Fair Value
Geographic Region	Amount		%	Amount		%	Amount		%	Amount		%
United States:
West	$	289,855	45.4%	$	327,929	48.4%	$	247,204	49.6%	$	241,096	48.8%
Northeast		173,880	27.2%		177,266	26.2%		131,692	26.4%		127,801	25.9%
South		59,581	9.3%		59,912	8.8%		463	0.1%		1,777	0.4%
Mountain		51,066	8.0%		52,600	7.8%		33,842	6.8%		33,969	6.9%
Midwest		30,862	4.8%		26,191	3.9%		47,324	9.5%		44,092	8.9%
Southeast		1,125	0.2%		781	0.1%		11,011	2.2%		17,834	3.6%
Canada		32,345	5.1%		32,567	4.8%		26,800	5.4%		27,082	5.5%
Total	$	638,714	100.0%	$	677,246	100.0%	$	498,336	100.0%	$	493,651	100.0%

The following table summarizes the composition of the Company’s portfolio investments by investment type at cost and fair value and as a percentage of the total portfolio as of September 30, 2021 and December 31, 2020 (dollars in thousands):


	September 30, 2021						December 31, 2020
	Cost			Fair Value			Cost			Fair Value
Investment	Amount		%	Amount		%	Amount		%	Amount		%
Secured Loan	$	474,412	74.3%	$	468,869	69.2%	$	324,544	65.1%	$	320,718	65.0%
Equipment Financing		108,812	17.0%		108,794	16.1%		122,966	24.7%		122,501	24.8%
Equity		40,677	6.4%		72,066	10.6%		32,961	6.6%		32,654	6.6%
Warrants		14,813	2.3%		27,517	4.1%		17,865	3.6%		17,778	3.6%
Total	$	638,714	100.0%	$	677,246	100.0%	$	498,336	100.0%	$	493,651	100.0%

Table of Contents

Certain Risk Factors

In the ordinary course of business, the Company manages a variety of risks including market risk, credit risk and liquidity risk. The Company identifies, measures and monitors risk through various control mechanisms, including trading limits and diversifying exposures and activities across a variety of instruments, markets and counterparties.

Market risk is the risk of potential adverse changes to the value of financial instruments because of changes in market conditions, including as a result of changes in the credit quality of a particular issuer, credit spreads, interest rates, and other movements and volatility in security prices or commodities. In particular, the Company may invest in issuers that are experiencing or have experienced financial or business difficulties (including difficulties resulting from the initiation or prospect of significant litigation or bankruptcy proceedings), which involves significant risks. The Company manages its exposure to market risk through the use of risk management strategies and various analytical monitoring techniques.

The Company’s investments may, at any time, include securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately.

The Company’s investments consist of growth stage companies, many of which have relatively limited operating histories and also may experience variation in operating results. Many of these companies conduct business in regulated industries and could be affected by the changes in government regulations. Most of the Company’s borrowers will need additional capital to satisfy their continuing working capital needs and other requirements, and in many instances, to service the interest and principal payments on the debt.

Table of Contents

Note 4. Fair Value of Financial Instruments

ASC 820 defines fair value, establishes a framework for measuring fair value, and establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. The Company accounts for its investments at fair value. As of September 30, 2021 and December 31, 2020, the Company’s portfolio investments consisted primarily of investments in secured loans and equipment financings. The fair value amounts have been measured as of the reporting date and have not been reevaluated or updated for purposes of these financial statements subsequent to that date. As such, the fair values of these financial instruments subsequent to the reporting date may be different than amounts reported.

In accordance with ASC 820, the Company has categorized its investments based on the priority of the inputs to the valuation technique into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical investments (Level 1) and the lowest priority to unobservable inputs (Level 3). See “Note 2 - Summary of Significant Accounting Policies.”

As required by ASC 820, when the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). Therefore, unrealized appreciation and depreciation related to such investments categorized within the Level 3 tables below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).

The fair value determination of each portfolio investment categorized as Level 3 required one or more of the following unobservable inputs:

●

Financial information obtained from each portfolio company, including unaudited statements of operations and balance sheets for the most recent period available as compared to budgeted numbers;

●

Current and projected financial condition of the portfolio company;

●

Current and projected ability of the portfolio company to service its debt obligations;

●

Type and amount of collateral, if any, underlying the investment;

●

Current financial ratios (e.g., fixed charge coverage ratio, interest coverage ratio and net debt/EBITDA ratio) applicable to the investment;

●

Current liquidity of the investment and related financial ratios (e.g., current ratio and quick ratio);

●

Pending debt or capital restructuring of the portfolio company;

●

Projected operating results of the portfolio company;

●

Current information regarding any offers to purchase the investment;

●

Current ability of the portfolio company to raise any additional financing as needed;

●

Changes in the economic environment, which may have a material impact on the operating results of the portfolio company;

●

Internal occurrences that may have an impact (both positive and negative) on the operating performance of the portfolio company;

●

Qualitative assessment of key management;

Table of Contents

●

Contractual rights, obligations or restrictions associated with the investment; and

●

Time to exit.

The use of significant unobservable inputs creates uncertainty in the measurement of fair value as of the reporting date. The significant unobservable inputs used in the fair value measurement of the Company’s investments, are (i) earnings before interest, tax, depreciation, and amortization (“EBITDA”) and revenue multiples (both projected and historic), and (ii) volatility assumptions. Significant increases (decreases) in EBITDA and revenue multiple inputs in isolation would result in a significantly higher (lower) fair value measurement. Similarly, significant increases (decreases) in volatility inputs in isolation would result in a significantly higher (lower) fair value assessment. On the contrary, significant increases (decreases) in weighted average cost of capital inputs in isolation would result in a significantly lower (higher) fair value measurement. However, due to the nature of certain investments, fair value measurements may be based on other criteria, such as third-party appraisals of collateral and fair values as determined by independent third parties, which are not presented in the tables below.

The Company’s assets measured at fair value by investment type on a recurring basis as of September 30, 2021 were as follows:


		Fair Value Measurements at Reporting Date Using
	Quoted Prices		Significant
	in Active		Other		Significant
	Markets for		Observable		Unobservable
	Identical Assets		Inputs		Inputs
Assets	(Level 1)		(Level 2)		(Level 3)		Total
Secured Loans	$	—	$	—	$	468,869	$	468,869
Equipment Financings		—		—		108,794		108,794
Equity		—		51,811		20,255		72,066
Warrants		—		968		26,549		27,517
Total Investments at fair value		—		52,779		624,467		677,246
Cash, cash equivalents and restricted cash		40,313		—		—		40,313
Total	$	40,313	$	52,779	$	624,467	$	717,559

The Company’s assets measured at fair value by investment type on a recurring basis as of December 31, 2020 were as follows:


		Fair Value Measurements at Reporting Date Using
	Quoted Prices		Significant
	in Active		Other		Significant
	Markets for		Observable		Unobservable
	Identical Assets		Inputs		Inputs
Assets	(Level 1)		(Level 2)		(Level 3)		Total
Secured Loans	$	—	$	—	$	320,718	$	320,718
Equipment Financings		—		—		122,501		122,501
Equity		—		—		32,654		32,654
Warrants		—		—		17,778		17,778
Total Investments at fair value		—		—		493,651		493,651
Cash, cash equivalents and restricted cash		61,101		—		—		61,101
Total	$	61,101	$	—	$	493,651	$	554,752

Table of Contents

Debt investments include both secured loans and equipment financing securities. The following table provides a summary of the significant unobservable inputs used to fair value the Level 3 portfolio investments as of September 30, 2021 (dollars in thousands):


	Fair Value as of
	September 30,		Valuation Techniques/	Unobservable		Weighted
Investment Type	2021		Methodologies	Inputs ⁽¹⁾	Range	Average ⁽²⁾

Debt investments	$	446,961	Discounted Cash Flows	Hypothetical Market Yield	10.8% - 31.1%	14.4	%

		115,809	Originated within the past three months	Origination Market Yield	11.1% - 15.8%	12.4	%

		5,275	Transactions Precedent⁽⁶⁾	Transaction Price	n/a	n/a

		9,618	Liquidation Scenario	Probability Weighting of Alternative Outcomes	40.0% - 60.0%	n/a

Equity investments		15,986	Market Approach	Revenue Multiple Only ⁽³⁾	0.7x - 1.8x	1.5	x

		1,769	Market Approach	Revenue Multiple ⁽³⁾	0.7x - 31.7x	9.6	x
				Volatility ⁽⁵⁾	62.0% - 75.5%	65.8	%
				Risk-Free Interest Rate	0.1% - 0.5%	0.1	%
				Estimated Time to Exit (in years)	0.5 - 3.0	1.2
				Discount for Lack of Marketability ⁽⁸⁾	14.1% - 29.4%	18.5	%

		2,500	Transactions Precedent⁽⁶⁾	Transaction Price	n/a	n/a

Warrants		22,542	Market Approach	Revenue Multiple ⁽³⁾	0.3x - 31.7x	3.6	x
				Company Specific Adjustment ⁽⁴⁾	10.9% - 33.0%	13.0	%
				Volatility ⁽⁵⁾	36.6% - 115.6%	65.6	%
				Risk-Free Interest Rate	0.0% - 0.8%	0.3	%
				Estimated Time to Exit (in years)	0.3 - 4.2	2.1

		900	Transactions Precedent⁽⁶⁾	Transaction Price	n/a	n/a

		3,107	Other⁽⁷⁾	Probability Weighting of Alternative Outcomes	40.0% - 60.0%	n/a

Total Level 3 Investments	$	624,467

(1)

The significant unobservable inputs used in the fair value measurement of the Company’s debt securities are hypothetical market yields and premiums/(discounts). The hypothetical market yield is defined as the exit price of an investment in a hypothetical market to hypothetical market participants where buyers and sellers are willing participants. The significant unobservable inputs used in the fair value measurement of the Company’s equity and warrant securities are revenue multiples and portfolio company specific adjustment factors. Additional inputs used in the option pricing model (“OPM”) include industry volatility, risk free interest rate and estimated time to exit. Significant increases (decreases) in the inputs in isolation would result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. For some investments, additional consideration may be given to data from the last round of financing or merger/acquisition events near the measurement date.

(2)	Weighted averages are calculated based on the fair market value of each investment.

(3)	Represents amounts used when the Company has determined that market participants would use such multiples when pricing the investments.

(4)	Represents amounts used when the Company has determined market participants would take into account these discounts when pricing the investments.

(5)	Represents the range of industry volatility used by market participants when pricing the investment.

(6)	Represents investments where there is an observable transaction or pending event for the investment.

(7)	The fair market value of these investments is derived based on recent private market and merger and acquisition transaction prices.

Table of Contents

(8)	Represents amounts used when the Company has determined market participants would take into account these discounts when pricing the investments.

The following table provides a summary of the significant unobservable inputs used to fair value the Level 3 portfolio investments as of December 31, 2020 (dollars in thousands):


	Fair Value as of
	December 31,		Valuation Techniques/	Unobservable		Weighted
Investment Type	2020		Methodologies	Inputs ⁽¹⁾	Range	Average ⁽²⁾

Debt investments	$	330,184	Discounted Cash Flows	Hypothetical Market Yield	9.5% - 31.2%	15.1	%

		99,053	Originated within the past three months	Origination Market Yield	12.9% - 15.2%	14.2	%

		11,771	Transactions Precedent⁽⁶⁾	Transaction Price	n/a	n/a

		2,211	Liquidation Scenario	Probability Weighting of Alternative Outcomes	60.0% - 90.0%	n/a

Equity investments		3,623	Liquidation Scenario	Probability Weighting of Alternative Outcomes	30.0% - 70.0%	n/a

		5,550	Market Approach	Revenue Multiple Only ⁽³⁾	0.5x - 0.9x	0.7	x

		23,481	Market Approach	Revenue Multiple ⁽³⁾	0.36x - 3.0x	1.8	x
				Company Specific Adjustment ⁽⁴⁾	(17.5)% - 150.0%	74.9	%
				Volatility ⁽⁵⁾	45.0% - 80.0%	59.8	%
				Risk-Free Interest Rate	0.1% - 0.2%	0.1	%
				Estimated Time to Exit (in years)	0.5 - 2.0	1.1

Warrants		15,133	Market Approach	Revenue Multiple ⁽³⁾	0.3x - 20.75x	3.2	x
				EBITDA Multiple	n/a	10.9	x
				Company Specific Adjustment ⁽⁴⁾	(50.0)% - 10.0%	(13.1)	%
				Volatility ⁽⁵⁾	20.0% - 104.7%	53.4	%
				Risk-Free Interest Rate	0.1% - 3.0%	0.9	%
				Estimated Time to Exit (in years)	0.2 - 10.0	3.3

		2,645	Black Scholes Option Pricing Model	Volatility ⁽⁵⁾	46.8% - 132.3%	52.0	%
				Risk-Free Interest Rate	0.1% - 0.7%	0.1	%
				Estimated Time to Exit (in years)	0.5 - 7.3	0.8

Total Level 3 Investments	$	493,651

(1)

(2)	Weighted averages are calculated based on the fair market value of each investment.

(3)	Represents amounts used when the Company has determined that market participants would use such multiples when pricing the investments.

(4)	Represents amounts used when the Company has determined market participants would take into account these discounts when pricing the investments.

(5)	Represents the range of industry volatility used by market participants when pricing the investment.

(6)	Represents investments where there is an observable transaction or pending event for the investment.

Table of Contents

The following table provides a summary of changes in the debt, including loans and equipment financings (collectively “Debt”), equity, and warrants fair value of the Company’s Level 3 portfolio investments for the nine months ended September 30, 2021 (in thousands):


	Type of Investment
	Debt		Equity		Warrants		Total
Fair Value as of December 31, 2020	$	443,219	$	32,654	$	17,778	$	493,651
Purchases, net of deferred fees		339,099		10,753		4,638		354,490
Transfers out of Level 3 ⁽¹⁾		—		—		(2,611)		(2,611)
Proceeds from sales and paydowns		(222,693)		(13,535)		(3,904)		(240,132)
Accretion of OID and EOT payments		16,807		—		—		16,807
Net realized gain/(loss)		2,501		1,475		1,280		5,256
Third party participation ⁽²⁾		—		(283)		—		(283)
Change in unrealized appreciation/(depreciation)		(1,270)		(10,809)		9,368		(2,711)
Fair Value as of September 30, 2021	$	577,663	$	20,255	$	26,549	$	624,467

Net change in unrealized appreciation/depreciation on Level 3 investments still held as of September 30, 2021	$	(1,641)	$	(4,773)	$	9,882	$	3,467

(1)

Transfers out of Level 3 during the nine months ended September 30, 2021 primarily relates to the exercise of warrants held in three portfolio companies, to equity investments during the period and the corresponding company’s public offering transaction. During the nine months ended September 30, 2021, there were no transfers into Level 3.

(2)

Certain third parties had rights to 17,485 shares of Ology Bioservices common stock at a fair value of approximately $0.6 million as of December 31, 2020. In March 2021, these shares were reissued by Ology Bioservices directly to the third parties and the corresponding liability was removed from the Consolidated Statement of Assets and Liabilities. The activity related to these shares and the related liability is recorded against unrealized appreciation/(depreciation).


	Type of Investment
	Debt		Equity		Warrants		Total
Fair Value as of January 1, 2020	$	—	$	—	$	—	$	—
Formation Transactions acquisitions		375,858		24,066		17,099		417,023
Purchases, net of deferred fees		234,418		2,170		1,976		238,564
Non-cash conversion⁽¹⁾		(10,148)		10,879		532		1,263
Proceeds from sales and paydowns		(157,046)		(3,855)		—		(160,901)
Accretion of OID and EOT payments		11,788		—		—		11,788
Net realized gain/(loss)		(7,361)		(300)		(1,742)		(9,403)
Third party participation ⁽²⁾		—		283		—		283
Change in unrealized appreciation/(depreciation)		(4,290)		(589)		(87)		(4,966)
Fair Value as of December 31, 2020 ⁽³⁾	$	443,219	$	32,654	$	17,778	$	493,651

Net change in unrealized appreciation/depreciation on Level 3 investments still held as of December 31, 2020	$	(4,290)	$	(589)	$	(87)	$	(4,966)

(1)	The non-cash conversion includes non-cash restructuring transactions of two portfolio companies in which our outstanding loan investments were converted to equity instruments during the period.

(2)	Certain third parties had rights to 17,485 shares of Ology Bioservices common stock at a fair value of approximately $0.6 million as of December 31, 2020. The activity related to these shares and the related liability is recorded against unrealized appreciation/(depreciation).

Table of Contents

(3)	During the year ended December 31, 2020, there were no transfers into or out of Level 3.

Fair Value of Financial Instruments Carried at Cost

As of September 30, 2021 and December 31, 2020, the carrying value of the Credit Facility is approximately $9.5 million and $132.9 million, net of unamortized deferred financing costs of $0.5 million and $2.1 million, respectively. The carrying value of the Company’s Credit Facility as of September 30, 2021 and December 31, 2020 approximates the fair value, which was estimated using a market yield approach with Level 3 inputs.

As of September 30, 2021 and December 31, 2020, the carrying value of the 2025 Notes is approximately $121.1 million and $120.3 million, respectively, net of unamortized deferred financing costs of $3.9 million and $4.7 million, respectively. The 2025 Notes have a fixed interest rate as discussed in “Note 5 – Borrowings.” The fair value of the 2025 Notes as of September 30, 2021 and December 31, 2020 was approximately $147.2 million and $131.4 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.

As of September 30, 2021 and December 31, 2020, the carrying value of the Convertible Notes is approximately $47.4 million and $46.6 million, respectively, net of unamortized deferred financing costs and discount of $2.7 million and $3.4 million, respectively. The Convertible Notes have a fixed interest rate as discussed in “Note 5 – Borrowings.” The fair value of the Company’s Convertible Notes as of September 30, 2021 and December 31, 2020 was approximately $53.1 million and $46.6 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.

As of September 30, 2021, the carrying value of the Company’s 4.375% Notes due 2026 (the “2026 Notes”) is approximately $122.4 million, respectively, net of unamortized deferred financing costs and discount of $2.6 million respectively. The 2026 Notes have a fixed interest rate as discussed in “Note 5 – Borrowings.” The cost of the 2026 Notes as of September 30, 2021 approximates the fair value, based on the recent funding.

Table of Contents

Note 5. Borrowings

Credit Suisse Credit Facility

On January 9, 2020, TF1 and its affiliates borrowed $190.0 million under the Credit Facility. On January 16, 2020, in connection with the Formation Transactions, through its wholly owned subsidiary, TF1, the Company became a party to, and assumed, the Credit Facility with Credit Suisse. The Credit Facility matures on January 8, 2022, unless extended. Borrowings under the Credit Facility bear interest at a rate of the three-month London Interbank Offered Rate (“LIBOR”) plus 3.25%. The Credit Facility is collateralized by all investments held by TF1 and permits an advance rate of up to 65% of eligible investments. The Credit Facility contains covenants that, among other things, require the Company to maintain minimum tangible net worth and leverage ratios, minimum cash balance of $15.0 million, and a cash reserve of 60 days for interest. The Company has the ability to borrow up to an aggregate of $300.0 million, and the Credit Facility borrowing base contains certain criteria for eligible investments and includes concentration limits as defined in the Credit Facility. As of September 30, 2021 and December 31, 2020, the Company had $10.0 million and $135.0 million, respectively, in borrowings outstanding under the Credit Facility and a borrowing availability of approximately $181.5 million and $42.0 million, respectively.

During the three months ended September 30, 2021, the Company borrowed an additional $46.0 million on the Credit Facility and made repayments of $106.0 million. During the nine months ended September 30, 2021, the Company borrowed an additional $71.0 million and made repayments of $196.0 million. During the year ended December 31, 2020, the Company borrowed an additional $30.0 million and made repayments of $85.0 million and incurred approximately $4.0 million of financing costs in connection with the Credit Facility that are capitalized and deferred using the straight-line method over the life of the facility. As of September 30, 2021 and December 31, 2020, unamortized deferred financing costs related to the Credit Facility were $0.5 million and $2.1 million, respectively and presented as a direct deduction from the carrying amount of the debt liability on the Consolidated Statements of Assets and Liabilities.

The summary information regarding the Credit Facility is as follows (dollars in thousands):


	Three Months Ended						Nine Months Ended
	September 30, 2021			September 30, 2020			September 30, 2021			September 30, 2020
Stated interest expense	$	525		$	948		$	1,684		$	3,948
Amortization of deferred financing costs		526			487			1,581			1,394
Total interest and amortization of deferred financing costs	$	1,051		$	1,435		$	3,265		$	5,342

Weighted average effective interest rate		6.9	%		5.5	%		6.7	%		8.4	%
Weighted average outstanding balance	$	61,043		$	105,110		$	64,875		$	127,094

2025 Notes

Concurrent with the completion of a private common stock offering, on January 16, 2020, the Company completed the 144A Note Offering of $105.0 million in aggregate principal amount of the unsecured 2025 Notes in reliance upon the available exemptions from the registration requirements of the Securities Act. KBW, as the initial purchaser, exercised in full its option to purchase or place additional Notes and on January 29, 2020 the Company issued and sold an additional $20.0 million in aggregate principal amount of the 2025 Notes. As a result, the Company issued and sold a total of $125.0 million in aggregate principal amount of the 2025 Notes pursuant to the 144A Note Offering.

The 2025 Notes were issued pursuant to an Indenture dated as of January 16, 2020 (the “Base Indenture”), between the Company and U.S. Bank National Association, as trustee (the “Trustee”), and a First Supplemental Indenture, dated as of January 16, 2020 (the “First Supplemental Indenture” and together with the Base Indenture, the “2025 Notes Indenture”), between the Company and the Trustee. The 2025 Notes mature on January 16, 2025 (the “Maturity Date”), unless repurchased or redeemed in accordance with their terms prior to such date. The 2025 Notes are redeemable, in whole or in part, at any time, or from time to time, at the Company’s option, on or after January 16, 2023 at a redemption

Table of Contents

price equal to 100% of the outstanding principal amount thereof, plus accrued and unpaid interest to, but excluding, the date of redemption. The holders of the 2025 Notes do not have the option to have the notes repaid or repurchased by the Company prior to the Maturity Date.

The 2025 Notes bear interest at a fixed rate of 7.00% per year payable quarterly on March 15, June 15, September 15, and December 15 of each year, commencing on March 15, 2020. The 2025 Notes are direct, general unsecured obligations of the Company and rank pari passu, or equal in right of payment with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated.

Concurrent with the closing of the 144A Note Offering, on January 16, 2020, the Company entered into a registration rights agreement for the benefit of the purchasers of the 2025 Notes in the 144A Note Offering. Pursuant to the terms of this registration rights agreement, the Company filed with the SEC a registration statement, which was initially declared effective on October 20, 2020, registering the public resale of the 2025 Notes by the holders thereof that elected to include their 2025 Notes in such registration statement.

Aggregate offering costs in connection with the 2025 Notes issuance, including the underwriter’s discount and commissions, were approximately $5.8 million, which were capitalized and deferred. As of September 30, 2021 and December 31, 2020, unamortized deferred financing costs related to the 2025 Notes were $3.9 million and $4.7 million, respectively.

The components of interest expense and related fees for the 2025 Notes are as follows (in thousands):


	Three Months Ended						Nine Months Ended
	September 30, 2021			September 30, 2020			September 30, 2021			September 30, 2020
Stated interest expense	$	2,188		$	2,139		$	6,563		$	6,198
Amortization of deferred financing costs		297			278			879			788
Total interest and amortization of deferred financing costs	$	2,485		$	2,417		$	7,442		$	6,986

Weighted average effective interest rate		8.0	%		7.7	%		7.9	%		11.2	%

2026 Notes

On August 24, 2021, the Company issued and sold $125 million in aggregate principal amount of its unsecured 2026 Notes under its shelf Registration Statement on Form N-2 (File No. 333-257818) previously filed with the SEC, as supplemented by a preliminary prospectus supplement dated August 19, 2021, a final prospectus supplement dated August 19, 2021, and a pricing term sheet dated August 19, 2021.

The 2026 Notes were issued pursuant to the Base Indenture and a Third Supplemental Indenture, dated as of August 24, 2021 (the “Third Supplemental Indenture” and together with the Base Indenture, the “2026 Notes Indenture”), between the Company and the Trustee. The 2026 Notes mature on August 24, 2026, unless repurchased or redeemed in accordance with their terms prior to such date. The 2026 Notes are redeemable, in whole or in part, at any time, or from time to time, at the Company’s option, at a redemption price equal to the greater of (1) 100% of the principal amount of the 2026 Notes to be redeemed or (2) the sum of the present values of the remaining scheduled payments of principal and interest (exclusive of accrued and unpaid interest to the date of redemption) on the 2026 Notes to be redeemed, discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using the applicable treasury rate plus 50 basis points, plus, in each case, accrued and unpaid interest to the redemption date; provided, however, that if the Company redeems any 2026 Notes on or after July 24, 2026, the redemption price for the 2026 Notes will be equal to 100% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption. In addition, if a change of control repurchase event (as defined in the 2026 Notes Indenture) occurs prior to the maturity date of the 2026 Notes or the Company’s redemption of all outstanding 2026 Notes, the Company will be required, subject to certain conditions, to make an offer to the

Table of Contents

holders thereof to repurchase for cash some or all of the 2026 Notes at a repurchase price equal to 100% of the principal amount of the 2026 Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the date of repurchase.

The 2026 Notes bear interest at a fixed rate of 4.375% per year payable semiannually on February 15 and August 15 of each year, commencing on February 15, 2022. The 2026 Notes are direct, general unsecured obligations of the Company and rank pari passu, or equal in right of payment, with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated.

Aggregate offering costs in connection with the 2026 Notes issuance, including the underwriter’s discount and commissions, were approximately $2.6 million, which were capitalized and deferred. As of September 30, 2021, unamortized deferred financing costs related to the 2026 Notes were $2.6 million.

The components of interest expense and related fees for the 2026 Notes are as follows (in thousands):


	Three Months Ended						Nine Months Ended
	September 30, 2021			September 30, 2020			September 30, 2021			September 30, 2020
Stated interest expense	$	577		$	—		$	577		$	—
Amortization of deferred financing costs		55			—			55			—
Total interest and amortization of deferred financing costs	$	632		$	—		$	632		$	—

Weighted average effective interest rate		5.0	%		—	%		5.0	%		—	%

Convertible Notes

On December 11, 2020, the Company completed a private offering (the “Private Convertible Note Offering”) of $50 million in aggregate principal amount of its unsecured 6.00% Convertible Notes due 2025 (the “Convertible Notes”) in reliance upon the available exemptions from the registration requirements of the Securities Act. KBW acted as the initial purchaser and placement agent in connection with the Private Convertible Note Offering pursuant to a purchase/placement agreement dated December 4, 2020 by and between the Company and KBW.

The Convertible Notes were issued pursuant to the Base Indenture and a Second Supplemental Indenture, dated as of December 11, 2020 (the “Second Supplemental Indenture” and together with the Base Indenture, the “Convertible Notes Indenture”), between the Company and the Trustee. Concurrent with the closing of the Convertible Note Offering, on December 11, 2020, the Company entered into a registration rights agreement for the benefit of the holders of the Convertible Notes and the shares of common stock issuable upon conversion thereof. The effective interest rate of the Convertible Notes was approximately 7.2% annualized.

The Convertible Notes bear interest at a fixed rate of 6.00% per year, subject to additional interest upon certain events, payable semiannually in arrears on May 1 and November 1 of each year, beginning on May 1, 2021. If an investment grade rating is not maintained with respect to the Convertible Notes, additional interest of 0.75% per annum will accrue on the Convertible Notes until such time as the Convertible Notes have received an investment grade rating of “BBB-” (or its equivalent) or better. The rating remained at investment grade as of September 30, 2021. The Convertible Notes mature on December 11, 2025 (the “Convertible Notes Maturity Date”), unless earlier converted or repurchased in accordance with their terms.

Holders may convert their Convertible Notes, at their option, at any time on or prior to the close of business on the business day immediately preceding the Convertible Notes Maturity Date. The conversion rate was initially 66.6667 shares of the Company’s common stock, per $1,000 principal amount of the Convertible Notes (equivalent to an initial conversion price of approximately $15.00 per share of common stock). Effective immediately after the close of business on September 30, 2021, the conversion rate changed to 66.7960 shares of the Company’s common stock, per $1,000 principal amount of the Convertible Notes (equivalent to a conversion price of approximately $14.97 per share of

Table of Contents

common stock) as a result of a certain cash dividend of the Company. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events, further described in the Convertible Note Indenture, that occur prior to the Convertible Notes Maturity Date, the Company will increase the conversion rate for a holder who elects to convert its Convertible Notes in connection with such a corporate event in certain circumstances. Upon conversion of the Convertible Notes, the Company will pay or deliver, as the case may be, cash, shares of common stock, or a combination of cash and shares of common stock, at the Company’s election, per $1,000 principal amount of the Convertible Notes, equal to the then existing conversion rate.

At the Company’s option, it may cause holders to convert all or a portion of the then outstanding principal amount of the Convertible Notes plus accrued but unpaid interest, at any time on or prior to the close of business on the business day immediately preceding the Convertible Notes Maturity Date, if the closing sale price of the Company’s common stock for any 30 consecutive trading days exceeds 120% of the conversion price, as may be adjusted. Upon such conversion, the Company will pay or deliver, as the case may be, cash, shares of common stock, or a combination of cash and shares of common stock, at the Company’s election, per $1,000 principal amount of the Convertible Notes, equal to the then existing conversion rate, and a forced conversion make-whole payment (as defined in the Second Supplemental Indenture), if any, in cash.

The Company may not redeem the Convertible Notes at its option prior to maturity. In addition, if the Company undergoes a fundamental change (as defined in the Second Supplemental Indenture), holders may require the Company to repurchase for cash all or part of such holders’ Convertible Notes at a repurchase price equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.

The Convertible Notes are direct unsecured obligations of the Company and rank pari passu, or equal, in right of payment with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated, including, without limitation, the 2025 Notes, and senior in right of payment to all of the Company’s future indebtedness or other obligations that are expressly subordinated, or junior, in right of payment to the Convertible Notes.

Aggregate offering costs in connection with the Convertible Note Offering, including the initial purchaser and placement agent discount and commissions, were approximately $1.8 million which were capitalized and deferred. As of September 30, 2021 and December 31, 2020, unamortized deferred financing costs related to the Convertible Notes were $1.1 million and $1.7 million, respectively.

The Convertible Notes are accounted for in accordance with ASC 470-20 Debt Instruments with Conversion and Other Options. In accounting for the Convertible Notes, the Company estimated at the time of issuance that the values of the debt and the embedded conversion feature of the Convertible Notes were approximately 99.1% and 0.9%, respectively. The original issue discount of 0.9%, or approximately $0.5 million, attributable to the conversion feature of the Convertible Notes was recorded in “capital in excess of par value” in the Consolidated Statements of Assets and Liabilities as of December 31, 2020.

In January 2021, the Company early adopted Accounting Standard Update (“ASU”) No. 2020-06, Debt – Debt with Conversion and Other Options (“ASU 2020-06”), under which the accounting for convertible instruments was simplified by removing the separate accounting for embedded conversion features. As such, approximately $0.5 million was reversed out of net assets and reduced the original issue discount for the Convertible Notes.

Table of Contents

The components of the carrying value of the Convertible Notes were as follows (in thousands):


	September 30, 2021		December 31, 2020
Principal amount of debt	$	50,000	$	50,000
Unamortized debt issuance cost		(1,101)		(1,672)
Original issue discount related to equity component, net of accretion		—		(468)
Original issue discount, net of accretion		(1,549)		(1,308)
Carrying value of Convertible Notes	$	47,350	$	46,552

The components of interest expense and related fees for the Convertible Notes were as follows (in thousands):


	Three Months Ended					Nine Months Ended
	September 30, 2021			September 30, 2020		September 30, 2021			September 30, 2020
Stated interest expense	$	750		$	—	$	2,242		$	—
Amortization of deferred financing costs and original issue discount		158			—		469			—
Total interest and amortization of deferred financing costs and original issue discount	$	908		$	—	$	2,711		$	—

Weighted average effective interest rate		7.3	%		—		7.3	%		—

As of September 30, 2021 and December 31, 2020, the Company was in compliance with the terms of the Credit Facility, the 2025 Notes Indenture, the 2026 Notes Indenture and the Convertible Notes Indenture.

Note 6. Commitments and Contingencies

Unfunded Commitments

The Company’s commitments and contingencies consist primarily of unused commitments to extend credit in the form of loans or equipment financings to the Company’s portfolio companies. A portion of these unfunded contractual commitments as of September 30, 2021 and December 31, 2020 are generally dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Company’s credit agreements contain customary lending provisions that allow the Company relief from funding obligations for previously made commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the Company. Since a portion of these commitments may expire without being withdrawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Company’s disclosure of unfunded contractual commitments as of September 30, 2021 and December 31, 2020 includes only those commitments which are available at the request of the portfolio company and are unencumbered by milestones or additional lending provisions.

As of September 30, 2021 the Company had an aggregate of approximately $0.4 million of unfunded commitments to one portfolio company, Dandelion, Inc. These unfunded commitments are available at the request of such portfolio companies and unencumbered by milestones. The fair value of these unfunded commitments is considered to approximate the cost of such commitments as the yields determined at the time of underwriting are expected to be materially consistent with the yields upon funding. The Company will fund its unfunded commitments from the same sources it uses to fund its investment commitments that are funded at the time they are made (which are typically through existing cash and cash equivalents and borrowings under the Credit Facility) and maintains adequate liquidity to fund its unfunded commitments through these sources.

Table of Contents

claims that may be made against the Company; however, based on the Company’s experience, the risk of loss is remote and no such claims are expected to occur. As such, the Company has not accrued any liability in connection with such indemnifications.

Leases

FASB ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”) requires that a lessee evaluate its leases to determine whether they should be classified as operating or financing leases. The Company identified two significant operating leases for its office space in Chandler, AZ and its new headquarters in Phoenix, AZ. The lease for the Chandler office commenced February 21, 2017 and expires July 31, 2022. The Chandler lease contains a five-year extension option for a final expiration date of July 31, 2027, which the company will not exercise. The Company has also entered into a lease for new office space in downtown Phoenix, Arizona (“PHX”), which commenced on June 4, 2021 and expires on December 31, 2028. The PHX lease contains two five-year extension options for a final expiration date of December 31, 2038.

The total lease expense incurred for the three months ended September 30, 2021 and 2020 was approximately $0.1 million for each period. The total lease expense for the nine months ended September 30, 2021 and 2020 was approximately $0.3 and $0.1 million, respectively. As of September 30, 2021 and December 31, 2020, the right of use asset related to the office operating leases was $2.5 million and $0.4 million, respectively, and the lease liability was $2.7 million and $0.4 million, respectively. As of September 30, 2021, the remaining lease term for the Chandler office was 0.8 years and the discount rate was 3.25%. As of September 30, 2021, the remaining lease term for the Phoenix office was 10 years and the discount rate was 3.75%.

The following table shows future minimum payments under the Company’s operating leases as of September 30, 2021 (in thousands):


For the Years Ended December 31,		Total
2021	$	56
2022		484
2023		361
2023		371
2024		380
Thereafter		1,619
Total	$	3,271

Legal Proceedings

The Company may, from time to time, be involved in litigation arising out of its operations in the normal course of business or otherwise. Furthermore, third parties may try to seek to impose liability on the Company in connection with the activities of its portfolio companies. As of September 30, 2021, there are no material legal matters or material litigation pending of which the Company is aware.

Note 7. Stockholder’s Equity

The Company authorized 200,000,000 shares of its common stock with a par value of $0.001 per share. On September 27, 2019, the Company was initially capitalized with the issuance of 10 shares of its common stock for an aggregate purchase price of $150 to its sole shareholder.

Private Common Stock Offerings

On January 16, 2020, the Company completed the Private Common Stock Offering. As a result, the Company issued and sold a total of 8,333,333 shares of its common stock for aggregate net proceeds of approximately $114.4 million, net of offering costs of approximately $10.6 million. Refer to “Note 1 – Organization and Basis of Presentation” for further details.

Table of Contents

Concurrent with the closing of the Private Common Stock Offering, on January 16, 2020, the Company entered into a registration rights agreement for the benefit of the purchasers of shares of its common stock in such offering and the Legacy Investors that received shares of its common stock in connection with the Formation Transactions that were not the Company’s directors, officers and affiliates. Pursuant to the terms of this registration rights agreement, the Company no longer has any registration obligations with respect to such shares because (i) such shares may be sold by any such stockholder in a single transaction without registration pursuant to Rule 144 under the Securities Act, (ii) the Company has been subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, for a period of at least 90 days and is current in the filing of all such required reports and (iii) such shares have been listed for trading on the Nasdaq Global Select Market.

Formation Transactions

On January 16, 2020, immediately following the initial closings of the Private Offerings, the Company used the proceeds from the Private Offerings to complete the Formation Transactions, pursuant to which the Company acquired the Legacy Funds and Trinity Capital Holdings. In consideration for the Legacy Funds, the Company issued 9,183,185 shares of common stock at $15.00 per share for a total value of approximately $137.7 million and paid approximately $108.7 million in cash to the Legacy Investors. As consideration for all of the equity interests in Trinity Capital Holdings, the Company issued 533,332 shares of its common stock at $15.00 per share for a total value of approximately $8.0 million and paid approximately $2.0 million in cash. Refer to “Note 1 – Organization and Basis of Presentation” for further details regarding the Formation Transactions.

Initial Public Offering

The Company’s common stock began trading on the Nasdaq Global Select Market on January 29, 2021 under the symbol “TRIN.” On February 2, 2021, the Company completed its initial public offering of 8,006,291 shares of common stock at a price of $14.00 per share, inclusive of the underwriters’ option to purchase additional shares, which was exercised in full. Proceeds from this offering were primarily used to pay down a portion of our existing indebtedness outstanding under the Credit Facility.

Distribution Reinvestment Plan

The Company’s amended and restated distribution reinvestment plan (“DRIP”) provides for the reinvestment of distributions in the form of common stock on behalf of its stockholders, unless a stockholder has elected to receive distributions in cash. As a result, if the Company declares a cash distribution, its stockholders who have not “opted out” of the DRIP by the opt out date will have their cash distribution automatically reinvested into additional shares of the Company’s common stock. The share requirements of the DRIP may be satisfied through the issuance of common shares or through open market purchases of common shares by the DRIP plan administrator. Newly issued shares will be valued based upon the final closing price of the Company’s common stock on the valuation date determined for each distribution by the Board.

The Company’s DRIP is administered by its transfer agent on behalf of the Company’s record holders and participating brokerage firms. Brokerage firms and other financial intermediaries may decide not to participate in the Company’s DRIP but may provide a similar distribution reinvestment plan for their clients. During the three months ended September 30, 2021, the Company issued 63,390 shares of common stock for a total of approximately $0.9 million under the DRIP. During the nine months ended September 30, 2021, the Company issued 227,099 shares of common stock for a total of approximately $3.2 million under the DRIP. During the year ended December 31, 2020, the Company issued 271,414 shares of common stock for a total of approximately $3.4 million under the DRIP.

Table of Contents

Distributions

The following table summarizes distributions declared and/or paid by the Company since inception:


Declaration Date	Record Date	Payment Date	Per Share Amount
May 7, 2020	May 29, 2020	June 5, 2020	$	0.22
August 10, 2020	August 21, 2020	September 4, 2020		0.27
November 9, 2020	November 20, 2020	December 4, 2020		0.27
December 22, 2020	December 30, 2020	January 15, 2021		0.27
March 23, 2021	March 31, 2021	April 16, 2021		0.28
June 15, 2021	June 30, 2021	July 15, 2021		0.29
September 13, 2021	September 30, 2021	October 15, 2021		0.33
		Total	$	1.93

Note 8. Equity Incentive Plans

2019 Long Term Incentive Plan

The Company’s Board adopted and approved the 2019 Trinity Capital Inc. Long Term Incentive Plan (the “2019 Long Term Incentive Plan”) on October 17, 2019 and the Company’s stockholders approved the 2019 Long Term Incentive Plan on June 17, 2021 at the Company’s 2021 Annual Meeting of Stockholders, with the 2019 Long Term Incentive Plan becoming effective on June 17, 2021. Under the 2019 Long Term Incentive Plan, awards of restricted stock, incentive stock options and non-statutory stock options (together with incentive stock options, “Options”) may be granted to certain of the Company’s executive officers, employee directors and other employees (collectively, the “Employee Participants”) in accordance with the SEC exemptive order the Company received on May 27, 2021 (the “SEC Exemptive Order”). While the 2019 Long Term Incentive Plan contemplates grants of restricted stock, restricted stock units, Options, dividend equivalent rights, performance awards and other stock-based awards to the Employee Participants, the Company only sought and received exemptive relief from the SEC pursuant to the SEC Exemptive Order to grant awards of restricted stock and Options. As a result, the Company will only grant awards of such securities under the 2019 Long Term Incentive Plan. The Employee Participants will have the right to receive dividends on such awarded restricted stock, unless and until the restricted stock is forfeited.

Subject to certain adjustments under the 2019 Long Term Incentive Plan, the maximum aggregate number of shares of the Company’s common stock authorized for issuance under the 2019 Long Term Incentive Plan is 3,600,000 shares. The 2019 Long Term Incentive Plan is to be administered by the Compensation Committee of the Board (the “Compensation Committee”) in accordance with the terms of the 2019 Long Term Incentive Plan. The 2019 Long Term Incentive Plan will terminate on the day prior to the tenth anniversary of the date it was initially adopted by the Board, unless terminated sooner by action of the Board or the Compensation Committee, as applicable.

For additional information regarding the 2019 Long Term Incentive Plan, please refer to the Company’s Current Report on Form 8-K filed with the SEC on June 23, 2021, and the Company’s definitive proxy statement filed with the SEC on April 28, 2021.

During the three and nine months ended September 30, 2021, the Company granted 581,300 shares of restricted stock under the 2019 Long Term Incentive Plan. The Company determined that the fair value of such restricted stock granted under the 2019 Long Term Incentive Plan during the three and nine months ended September 30, 2021 was approximately $9.6 million for each period and recognized total share-based compensation expense of $0.1 million for each period. As of September 30, 2020, no restricted stock had been issued under the 2019 Long Term Incentive Plan. As of September 30, 2021 there was approximately $9.5 million of total unrecognized compensation costs related to non-vested restricted stock awards. These costs are expected to be recognized over a weighted average period of 3.1 years. As of September 30, 2020, there were no unrecognized compensation costs.

Table of Contents

2019 Restricted Stock Plan

The Company’s Board adopted and approved the Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan (the “2019 Restricted Stock Plan”) on October 17, 2019 and the Company’s stockholders approved the 2019 Restricted Stock Plan on June 17, 2021 at the Company’s 2021 Annual Meeting of Stockholders. The 2019 Restricted Stock Plan became effective on June 17, 2021 and provides for grants of restricted stock awards (“Non-Employee Director Awards”) to the Company’s non-employee directors (the “Non-Employee Director Participants”), which are directors who are not “interested persons” of the Company (as such term is defined in Section 2(a)(19) of the 1940 Act) in accordance with the SEC Exemptive Order. The Non-Employee Director Participants will have the right to receive dividends on such awarded restricted stock, unless and until the restricted stock is forfeited.

Subject to certain adjustments under the 2019 Restricted Stock Plan, the total number of shares of the Company’s common stock that may be subject to Non-Employee Director Awards is 60,000 shares. The 2019 Restricted Stock Plan is to be administered by the Compensation Committee, subject to the discretion of the Board. The 2019 Restricted Stock Plan will terminate on the day prior to the tenth anniversary of the date it was approved by the Company’s stockholders, unless terminated sooner by action of the Board.

For additional information regarding the 2019 Restricted Stock Plan, please refer to the Company’s Current Report on Form 8-K, filed with the SEC on June 23, 2021, and the Company’s definitive proxy statement filed with the SEC on April 28, 2021.

During the three and nine months ended September 30, 2021, the Company granted 12,132 shares of restricted stock under the 2019 Restricted Stock Plan. The Company determined that the fair value of such restricted stock granted under the 2019 Restricted Stock Plan during the three and nine months ended September 30, 2021 was approximately $0.2 million for each period and recognized total share-based compensation expense of approximately $12,000 for each period. As of September 30, 2020, no restricted stock had been issued under the 2019 Restricted Stock Plan. As of September 30, 2021 there was approximately $0.2 million of total unrecognized compensation costs related to non-vested restricted stock awards. These costs are expected to be recognized over a nine month period. As of September 30, 2020, there were no unrecognized compensation costs.

Table of Contents

Note 9. Earnings Per Share

The following table sets forth the computation of the basic and diluted earnings per common share for the three and nine months ended September 30, 2021 and 2020 (in thousands except shares and per share information):



	Three Months Ended				Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Earnings per common share - basic
Numerator for basic earnings per share	$	27,181	$	12,334	$	77,210	$	(15,835)
Denominator for basic weighted average shares		26,641,084		18,166,491		25,569,565		18,033,173
Earnings per common share - basic	$	1.02	$	0.68	$	3.02	$	(0.88)
Earnings per common share - diluted
Numerator for increase in net assets per share	$	27,181	$	12,334	$	77,210	$	(15,835)
Adjustment for interest expense and deferred financing costs on Convertible Notes		908		—		2,715		—
Numerator for diluted earnings per share		28,089		12,334		79,925		(15,835)
Denominator for basic weighted average shares		26,641,084		18,166,491		25,569,565		18,033,173
Adjustment for dilutive effect of Convertible Notes		3,333,335		—		3,333,335		—
Denominator for diluted weighted average shares		29,974,419		18,166,491		28,902,900		18,033,173
Earnings per common share - diluted	$	0.94	$	0.68	$	2.77	$	(0.88)

In certain circumstances, the Convertible Notes will be convertible into cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s election which can be dilutive to common stockholders. Diluted earnings (loss) available to each share of common stock outstanding during the reporting period included any additional shares of common stock that would be issued if all potentially dilutive securities were exercised. In accordance with ASU 2020-06, the Company is required to disclose diluted EPS using the if-converted method that assumes conversion of convertible securities at the beginning of the reporting period and is intended to show the maximum dilution effect to common stockholders regardless of how the conversion can occur.

Since there were no Convertible Notes outstanding for the three and nine months ended September 30, 2020, there was no impact on diluted earnings per common share.

Note 10. Income Taxes

The Company has elected to be treated, and to intends to continue to qualify annually, as a RIC under Subchapter M of the Code for U.S. federal tax purposes. In order to maintain its treatment as a RIC, the Company is generally required to distribute at least annually to its stockholders at least 90% of the sum of its investment company taxable income (which generally includes its net ordinary taxable income and realized net short-term capital gains in excess of realized net long-term capital losses) and its net tax-exempt income (if any). The Company generally will not pay corporate-level income tax on these distributed amounts, but will pay corporate-level income tax on any retained amounts.

The amount of taxable income to be paid out as a distribution is determined by the Board each quarter and is generally based upon the annual earnings estimated by management of the Company. Net capital gains, if any, are distributed at least annually, although the Company may decide to retain all or some of those capital gains for investment and pay corporate-level income taxes on those retained amounts. If the Company chooses to do so, this generally would increase expenses and reduce the amount available to be distributed to stockholders. In the event the Company’s taxable income (including any net capital gains) for a fiscal year fall below the amount of distributions declared and paid with

Table of Contents

respect to that year, however, a portion of the total amount of those distributions may be deemed a return of capital for tax purposes to the Company’s stockholders.

Because federal income tax regulations differ from accounting principles generally accepted in the United States, distributions in accordance with tax regulations may differ from net investment income and realized gains recognized for financial reporting purposes. Differences may be permanent or temporary in nature. Permanent differences are reclassified among capital accounts in the financial statements to reflect their appropriate tax character. Temporary differences arise when certain items of income, expense, gain or loss are recognized at some time in the future.

The following table sets forth the tax cost basis and the estimated aggregate gross unrealized appreciation and depreciation from investments for federal income tax purposes as of and for the period ended September 30, 2021 and December 31, 2020 (in thousands):


	September 30, 2021		December 31, 2020
Tax Cost of Investments ⁽¹⁾	$	679,027	$	559,437

	September 30, 2021		December 31, 2020
Unrealized appreciation	$	73,951	$	14,879
Unrealized depreciation		(30,735)		(19,845)
Net unrealized appreciation/(depreciation) from investments	$	43,216	$	(4,966)

(1)	Includes cost of short-term investments, including cash and cash equivalents.

Table of Contents

Note 11. Financial Highlights

The following presents financial highlights (in thousands except share and per share information):




	Nine Months Ended
	September 30, 2021			September 30, 2020
Per Share Data: ⁽¹⁾
Net asset value, beginning of period	$	13.03		$	14.97	⁽²⁾

Net investment income		1.11			1.00	⁽³⁾
Net realized and unrealized gains/(losses) on investments ⁽⁴⁾		1.91			(1.01)
Costs related to acquisition of Trinity Capital Holdings and Legacy Funds		—			(0.86)
Net increase/(decrease) in net assets resulting from operations		3.02			(0.87)

Offering costs		(0.29)			(0.59)
Effect of shares issued ⁽⁵⁾		(0.14)			(0.01)
Equity component of convertible notes		(0.02)			—
Distributions ⁽⁶⁾		(0.90)			(0.49)
Total increase/(decrease) in net assets		1.67			(1.96)

Net asset value, end of period	$	14.70		$	13.01

Shares outstanding, end of period		27,148,096			18,236,043
Weighted average shares outstanding		25,569,565			18,033,173	⁽³⁾
Total return based on net asset value ⁽⁷⁾ ⁽⁸⁾		19.7	%		(9.8)	% ⁽⁹⁾
Total return based on market value ⁽¹⁰⁾		19.4	%		na

Ratio/Supplemental Data:
Per share market value at end of period	$	16.09			n/a
Net assets, end of period*	$	399,006		$	237,325
Ratio of total expenses to average net assets ⁽¹¹⁾		11.4	%		13.4	%
Ratio of net investment income to average net assets ⁽¹¹⁾		10.8	%		11.2	%
Ratio of interest and credit facility expenses to average net assets ⁽¹¹⁾		5.3	%		7.7	%
Portfolio turnover rate ^{(8) (12)}		43.0	%		27.4	%
Asset coverage ratio ⁽¹³⁾		228.7	%		198.6	%

* Rounded to the nearest thousand.

(1)	Based on actual number of shares outstanding at the end of the corresponding period or the weighted average shares outstanding for the period, unless otherwise noted, as appropriate.

(2)	The net asset value as of January 16, 2020 (commencement of operations) is calculated based on the initial common stock purchase price of $15.00 per share less the accumulated loss of $0.03 per share from August 12, 2019 (the date of inception) through December 31, 2019.

(3)	Calculated based upon weighted average shares outstanding for the period from January 16, 2020 (commencement of operations) through September 30, 2020.

(4)	Net realized and unrealized gains/(losses) on investments include rounding adjustments to reconcile the change in net asset value per share.

Table of Contents

(5)

Includes the impact of the different share amounts as a result of calculating certain per share data based on the weighted-average basic shares outstanding during the period and certain per share data based on the shares outstanding as of a period end or transaction date. Also includes the impact of the issuance of shares related to the equity incentive plans. Refer to “Note 8 – Equity Incentive Plans” for further details.

(6)	The per share data reflects the actual amount of distributions declared per share for the applicable period.

(7)	Total return based on net asset value is calculated as the change in net asset value per share during the period plus declared distributions per share during the period, divided by the beginning net asset value per share.

(8)	Not annualized.

(9)	Total return excluding costs related to acquisition of Trinity Capital Holdings and the Legacy Funds would have been (4.1)%.

(10)

Total return based on market value is calculated as the change in market value per share during the period, taking into account dividends. The beginning market value per share is based on the market price of $14.00 per share on January 29, 2021, the date of the Company’s listing on Nasdaq, and not annualized.

(11)	Annualized.

(12)	Portfolio turnover rate is calculated using the lesser of year-to-date cash sales/repayments or year-to-date cash purchases over the average of the total investments at fair value.

(13)	Based on outstanding debt of $310.0 million and $240.0 million as of September 30, 2021 and 2020, respectively.

Table of Contents

Senior Securities

Information about the Company’s senior securities (including debt securities and other indebtedness) is shown in the following table as of September 30, 2021 and December 31, 2020. No senior securities were outstanding as of December 31, 2019.


Class and Period	Total Amount Outstanding Exclusive of Treasury Securities ⁽¹⁾		Asset Coverage per Unit ⁽²⁾		Involuntary Liquidating Preference per Unit ⁽³⁾	Average Market Value per Unit ⁽⁴⁾
Credit Suisse Credit Facility
September 30, 2021	$	10,000		2,287	-	-
December 31, 2020		135,000		1,770	-	-
December 31, 2019		-		-	-	-

2025 Notes
September 30, 2021	$	125,000		2,287	-	-
December 31, 2020		125,000		1,770	-	-
December 31, 2019		-		-	-	-

Convertible Notes
September 30, 2021	$	50,000		2,287	-	-
December 31, 2020		50,000		1,770	-	-
December 31, 2019		-		-	-	-

2026 Notes
September 30, 2021	$	125,000		2,287	-	-
December 31, 2020 ⁽⁵⁾		-		-	-	-
December 31, 2019		-		-	-	-

Total
September 30, 2021	$	310,000		2,287	-	-
December 31, 2020		310,000		1,770	-	-
December 31, 2019		-		-	-	-

(1)	Total amount of each class of senior securities outstanding at the end of the period presented.

(2)

Asset coverage per unit is the ratio of the carrying value of total assets, less all liabilities excluding indebtedness represented by senior securities in this table to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness and is calculated on a consolidated basis.

(3)	The amount to which such class of senior security would be entitled upon the Company’s involuntary liquidation in preference to any security junior to it. The “–” in this column indicates information that the SEC expressly does not require to be disclosed for certain types of senior securities.

(4)	Not applicable because the senior securities are not registered for public trading.

(5)	The 2026 Notes were issued on August 24, 2021.

Table of Contents

Note 12. Related Party Transactions

Through the Formation Transactions, the Company acquired 100% of the equity interests of Trinity Capital Holdings and the Legacy Funds were merged with and into the Company. Members of the Company’s management, including Steven L. Brown, Kyle Brown, Gerald Harder and Ron Kundich, owned 100% of the equity interests in Trinity Capital Holdings and controlling interests in the general partners/managers of the Legacy Funds.

As a result of the Formation Transactions, Messrs. S. Brown, K. Brown, Harder and Kundich collectively received (i) 533,332 shares of the Company’s common stock valued at approximately $8.0 million and approximately $2.0 million in cash in exchange for their equity interests in Trinity Capital Holdings, and (ii) 377,441 shares of the Company’s common stock valued at approximately $5.7 million for their limited partner and general partner interests in the Legacy Funds.

During the three and nine months ended September 30, 2021 and the year ended December 31, 2020, certain related parties received distributions from the Company relating to their shares held. Refer to “Note 7 – Stockholder’s Equity” for further details on the Company’s Distribution Reinvestment Plan and the distributions declared. Additionally, during the Company’s IPO certain related parties purchased additional shares of the Company’s common stock. These acquisitions were made at the IPO price of $14.00 per share. During the three and nine months ended September 30, 2021 Company’s directors and executive officers and certain employees received restricted stock awards under the 2019 Long Term Incentive Plan and the 2019 Restricted Stock Plan. No restricted stock awards were granted or outstanding under such plans during the year ended December 31, 2020. Refer to “Note 8 – Equity Incentive Plans” for further details on the Company’s share-based compensation plans.

The Company has entered into indemnification agreements with its directors and executive officers. The indemnification agreements are intended to provide the Company’s directors and executive officers the maximum indemnification permitted under Maryland law and the 1940 Act. Each indemnification agreement provides that the Company shall indemnify the director or executive officer who is a party to the agreement, or an “Indemnitee,” including the advancement of legal expenses, if, by reason of his or her corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed proceeding, to the maximum extent permitted by Maryland law and the 1940 Act.

Note 13. Recent Accounting Pronouncements

In March 2020, the FASB issued ASU 2020-04, “Reference rate reform (Topic 848) - Facilitation of the effects of reference rate reform on financial reporting” and in January 2021, the FASB issued ASU 2021-01, “Reference rate reform (Topic 848).” The amendments in these updates provide optional expedients and exceptions for applying U.S. GAAP to certain contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform and became effective upon issuance for all entities. ASU 2020-04 and ASU 2021-01 are elective and are effective on March 12, 2020 through December 31, 2022. The Company does not plan on adopting, as it expects that the adoption of the guidance will not have a material impact on its consolidated financial statements.

In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (“ASU 2020-06”) under which the accounting for convertible instruments will be simplified by removing major separation models required under current GAAP. Accordingly, more convertible instruments will be reported as a single liability or equity with no separate accounting for embedded conversion features. Certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception will be removed and, as a result, more equity contracts will qualify for the scope exception. ASU 2020-06 will also simplify the diluted earnings-per-share calculation in certain areas. ASU 2020-06 will be effective for years beginning after December 31, 2021, including interim periods within those fiscal years. Early adoption will be permitted for fiscal periods beginning after December 15, 2020 (including interim periods within the same fiscal year). The Company early adopted ASU 2020-06 on January 1, 2021, with no material impact to the consolidated financial statements other than no longer separately accounting for the embedded conversion feature.

Table of Contents

Rule 2a-5 under the 1940 Act was recently adopted by the SEC and establishes requirements for determining fair value in good faith for purposes of the 1940 Act. The Company is evaluating the impact of adopting Rule 2a-5 and intends to comply with the new rule’s requirements on or before the compliance date in September 2022.

Note 14. Subsequent Events

The Company’s management evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. Except as noted below, there have been no subsequent events that occurred during such period that would require recognition or disclosure.

KeyBank Credit Facility

On October 27, 2021, TrinCapFunding, LLC (“TCF”), a wholly owned subsidiary of the Company, as borrower, and the Company, as servicer, entered into a credit agreement (the “KeyBank Credit Agreement”) with the lenders from time to time party thereto, KeyBank, National Association (“KeyBank”), as administrative agent and syndication agent, and Wells Fargo, National Association, as collateral custodian and paying agent (such credit facility, the “KeyBank Credit Facility”).

The KeyBank Credit Facility includes an initial commitment of $75 million from KeyBank and allows the company, through TCF, to borrow up to $300 million. Borrowings under the KeyBank Credit Facility will initially bear interest at a rate equal to the one-month LIBOR plus 3.25%, which interest rate may decrease to one-month LIBOR plus 2.85% upon the achievement of certain benchmarks, including criteria related to the number and composition of assets in the KeyBank Credit Facility’s collateral pool. The KeyBank Credit Facility provides for a variable advance rate of up to 60% on eligible term loans and up to 64% on eligible equipment finance loans.

The KeyBank Credit Facility includes a three-year revolving period and a two-year amortization period, and it matures on October 27, 2026, unless extended, and is collateralized by all investment assets held by TCF. The KeyBank Credit Agreement contains representations and warranties and affirmative and negative covenants customary for secured financings of this type, including certain financial covenants such as a consolidated tangible net worth requirement and a required asset coverage ratio.

The KeyBank Credit Agreement also contains customary events of defaults (subject to certain grace periods, as applicable), including but not limited to the nonpayment of principal, interest or fees; breach of covenants; inaccuracy of representations or warranties in any material respect; voluntary or involuntary bankruptcy proceedings; and change of control of the borrower without the prior written consent of KeyBank.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Except where the context suggests otherwise, the terms “we,” “us,” “our,” and “the Company” refer to Trinity Capital Inc. and its consolidated subsidiaries. The information contained in this section should be read in conjunction with our consolidated financial statements and related notes thereto appearing elsewhere in this Quarterly Report on Form 10-Q.

Forward-Looking Statements

This quarterly report contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and undue reliance should not be placed thereon. Any statements about our expectations, beliefs, plans, predictions, forecasts, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but not always, made through the use of words or phrases such as “anticipate,” “believes,” “can,” “could,” “may,” “predicts,” “potential,” “should,” “will,” “estimate,” “plans,” “projects,” “continuing,” “ongoing,” “expects,” “intends” and similar words or phrases. Accordingly, these statements are only predictions and involve estimates, known and unknown risks, assumptions and uncertainties that could cause actual results to differ materially from those expressed in them. Our actual results could differ materially from those anticipated in such forward-looking statements as a result of several factors discussed under Item 1A. “Risk Factors” of Part II of this quarterly report and Item 1A. “Risk Factors” of Part I of our Annual Report on Form 10-K, filed with the SEC on March 4, 2021, including the following factors, among others:

●

our limited operating history as a business development company (“BDC”);

●

our future operating results, including the impact of the SARS-CoV-2 (“COVID-19”) pandemic;

●

our dependence upon our management team and key investment professionals;

●

our ability to manage our business and future growth;

●

risks related to investments in growth stage companies, other venture capital-backed companies and generally U.S. companies;

●

the ability of our portfolio companies to achieve their objectives, including as a result of the COVID-19 pandemic;

●

the use of leverage;

●

risks related to the uncertainty of the value of our portfolio investments;

●

changes in political, economic or industry conditions, the interest rate and inflation rate environments or conditions affecting the financial and capital markets, including as a result of the COVID-19 pandemic;

●

uncertainty surrounding the financial and/or political stability of the United States, the United Kingdom, the European Union and China, including as a result of the COVID-19 pandemic;

●

the dependence of our future success on the general economy and its impact on the industries in which we invest;

●

risks related to changes in interest rates and inflation rates, our expenses, and other general economic conditions and the effect on our net investment income;

●

the effect of changes in tax laws and regulations and interpretations thereof;

Table of Contents

●

the impact on our business of new or amended legislation or regulations, including the Coronavirus Aid, Relief and Economic Security Act, the stimulus package passed by Congress and signed into law in December 2020 and the American Rescue Plan Act of 2021 signed into law in March 2021;

●

risks related to market volatility, including general price and volume fluctuations in stock markets;

●

our ability to make distributions, including as a result of the COVID-19 pandemic; and

●

our ability to maintain our status as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”), and qualify annually for tax treatment as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Additionally, there may be other risks that are otherwise described from time to time in the reports that we file with the Securities and Exchange Commission. Any forward-looking statements in this report should be considered in light of various important factors, including the risks and uncertainties listed above, as well as others. All forward-looking statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ materially from expectations, and, therefore, you are cautioned not to place undue reliance on such statements. Any forward-looking statements are qualified in their entirety by reference to the risk factors discussed throughout this quarterly report. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. Because we are an investment company, the forward-looking statements and projections contained in this quarterly report are excluded from the safe harbor protections provided by Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (the “safe harbor” provision of the Private Securities Litigation Reform Act of 1995).

Overview

We are a specialty lending company providing debt, including loans and equipment financings, to growth stage companies, including venture-backed companies and companies with institutional equity investors. We are an internally managed, closed-end, non-diversified management investment company that has elected to be regulated as BDC under the 1940 Act. We have elected to be treated, and intend to continue to qualify annually, as a RIC under Subchapter M of the Code for U.S. federal income tax purposes. As a BDC and a RIC, we are required to comply with certain regulatory requirements.

Our investment objective is to generate current income and, to a lesser extent, capital appreciation through our investments. We seek to achieve our investment objective by making investments consisting primarily of term loans and equipment financings and, to a lesser extent, working capital loans, equity and equity-related investments. In addition, we may obtain warrants or contingent exit fees at funding from many of our portfolio companies, providing an additional potential source of investment returns. We generally are required to invest at least 70% of our total assets in qualifying assets in accordance with the 1940 Act but may invest up to 30% of our total assets in non-qualifying assets, as permitted by the 1940 Act.

We target investments in growth stage companies, which are typically private companies, including venture-backed companies and companies with institutional equity investors. We define “growth stage companies” as companies that have significant ownership and active participation by sponsors, such as institutional investors or private equity firms, and expected annual revenues of up to $100.0 million. Subject to the requirements of the 1940 Act, we are not limited to investing in any particular industry or geographic area and seek to invest in under-financed segments of the private credit markets.

Our loans and equipment financings may have initial interest-only periods of up to 24 months and generally fully amortize over a total term of up to 60 months. These investments are typically secured by a blanket first position lien, a specific asset lien on mission critical assets and/or a blanket second position lien. We may also make a limited number of direct equity and equity-related investments in conjunction with our debt investments. We target growth stage companies that have recently issued equity to raise cash to offset potential cash flow needs related to projected growth, have

Table of Contents

achieved positive cash flow to cover debt service, or have institutional investors committed to providing additional funding. A loan or equipment financing may be structured to tie the amortization of the loan or equipment financing to the portfolio company’s projected cash balances while cash is still available for operations. As such, the loan or equipment financing may have a reduced risk of default. We believe that the amortizing nature of our investments will mitigate risk and significantly reduce the risk of our investments over a relatively short period. We focus on protecting and recovering principal in each investment and structure our investments to provide downside protection.

Our History

Trinity Capital Inc. was incorporated under the general corporation laws of the State of Maryland on August 12, 2019 and commenced operations on January 16, 2020. Prior to January 16, 2020, we had no operations, except for matters relating to our formation and organization as a BDC.

On January 16, 2020, through a series of transactions (the “Formation Transactions”), we acquired Trinity Capital Investment, LLC ( “TCI, LLC”), Trinity Capital Fund II, L.P. (“Fund II”), Trinity Capital Fund III, L.P. (“Fund III”), Trinity Capital Fund IV, L.P. (“Fund IV”) and Trinity Sidecar Income Fund, L.P. (“Sidecar Fund,” and collectively, the “Legacy Funds”) and all of their respective assets (the “Legacy Assets”), including their respective investment portfolios (the “Legacy Portfolio”), as well as Trinity Capital Holdings, LLC (“Trinity Capital Holdings”), a holding company whose subsidiaries managed and/or had the right to receive fees from certain of the Legacy Funds. In order to complete these transactions we used a portion of the proceeds from our private equity offering and private debt offering that occurred on January 16, 2020 (refer to "Item 8. Consolidated Financial Statements and Supplementary Data - Note 1. Organization and Basis of Presentation" for further discussion of these transactions).

The Legacy Funds were merged with and into the Company, and we issued 9,183,185 shares of our common stock for an aggregate amount of approximately $137.7 million and paid approximately $108.7 million in cash to the Legacy Funds’ investors, which included the general partners, managers or managing members of the Legacy Funds (the “Legacy Investors”), to acquire the Legacy Funds and all of their respective assets, including the Legacy Portfolio. Our senior management team, led by Steven L. Brown, comprises the majority of the senior management team that managed the Legacy Funds and sourced the Legacy Portfolio.

As part of the Formation Transactions, we also acquired 100% of the equity interests of Trinity Capital Holdings for an aggregate purchase price of $10.0 million, which was comprised of 533,332 shares of our common stock, totaling approximately $8.0 million, and approximately $2.0 million in cash. In connection with the acquisition of such equity interests, the Company also assumed a $3.5 million severance related liability with respect to a former member of certain general partners of certain Legacy Funds. In connection with the acquisition of Trinity Capital Holdings, approximately $13.5 million (consisting of the aggregate purchase price and severance related liability assumed) was expensed to Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds in the Consolidated Statements of Operations. As a result of the Formation Transactions, Trinity Capital Holdings became a wholly owned subsidiary of the Company.

On February 2, 2021, we completed our initial public offering of 8,006,291 shares of our common stock at a price of $14.00 per share, inclusive of the underwriters’ option to purchase additional shares, which was exercised in full. Our common stock began trading on the Nasdaq Global Select Market on January 29, 2021 under the symbol “TRIN.” Proceeds from this offering were primarily used to pay down a portion of our existing indebtedness outstanding under the Credit Facility.

Critical Accounting Policies

The Company’s financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and pursuant to Regulation S-X under the Securities Act of 1933, as amended (the “Securities Act”). The Company follows accounting and reporting guidance as determined by the Financial Accounting Standards Board (“FASB”), in FASB Accounting Standards Codification (“ASC”) 946, Financial Services — Investment Companies.

Table of Contents

The preparation of our financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets and any other parameters used in determining such estimates could cause actual results to differ materially. Valuation of investments, income recognition, realized / unrealized gains or losses and U.S. federal income taxes are considered to be our critical accounting policies and estimates. –For additional information, please refer to “Note 2 - Summary of Significant Accounting Policies” in the notes to the consolidated financial statements included with this Quarterly Report on Form 10-Q.

Reclassification

Valuation of Investments

The most significant estimate inherent in the preparation of the Company’s consolidated financial statements is the valuation of investments and the related amounts of unrealized appreciation and depreciation of investments recorded. The Company’s investments are carried at fair value in accordance with the 1940 Act and ASC 946 and measured in accordance with ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that each of the portfolio investments is sold in a hypothetical transaction in the principal or, as applicable, most advantageous market using market participant assumptions as of the measurement date. Market participants are defined as buyers and sellers in the principal market that are independent, knowledgeable and willing and able to transact. The Company values its investments at fair value as determined in good faith by the Company’s Board of Directors (the “Board”) in accordance with the provisions of ASC 820 and the 1940 Act.

While the Board is ultimately and solely responsible for determining the fair value of the Company’s investments, the Company has engaged independent valuation firms to provide the Company with valuation assistance with respect to its investments. The Company engages independent valuation firms on a discretionary basis. Specifically, on a quarterly basis, the Company will identify portfolio investments with respect to which an independent valuation firm will assist in valuing certain investments. The Company selects these portfolio investments based on a number of factors, including, but not limited to, the potential for material fluctuations in valuation results, size, credit quality and the time lapse since the last valuation of the portfolio investment by an independent valuation firm.

Investments recorded on our Consolidated Statements of Assets and Liabilities are categorized based on the inputs to the valuation techniques as follows:

Table of Contents

Given the nature of lending to venture capital-backed growth stage companies, substantially all of the Company’s investments in these portfolio companies are considered Level 3 assets under ASC 820 because there is no known or accessible market or market indexes for these investment securities to be traded or exchanged. The Company uses an internally developed portfolio investment rating system in connection with its investment oversight, portfolio management and analysis and investment valuation procedures. This system takes into account both quantitative and qualitative factors of the portfolio companies. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.

Income Recognition

Interest Income

The Company recognizes interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount (“OID”) initially includes the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities, and is accreted into interest income over the term of the loan as a yield enhancement based on the effective yield method. In addition, the Company may also be entitled to an end-of-term (“EOT”) fee. EOT fees related to debt investments to be paid at the termination of the financing arrangements are accreted into interest income over the contractual life of the debt based on the effective yield method. As of September 30, 2021 and December 31, 2020, the Company had an EOT payment receivable of approximately $38.2 million and $37.9 million, respectively, which is included as a component of the cost basis of the Company’s current debt securities. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, then the acceleration of the unaccreted OID and EOT is recognized as interest income.

Fee Income

Portfolio Composition and Investment Activity

Portfolio Composition

Through the Formation Transactions, we acquired the Legacy Assets, including the Legacy Portfolio, from the Legacy Funds, as well as Trinity Capital Holdings. The Legacy Portfolio became our investment portfolio. As of September 30, 2021, our investment portfolio had an aggregate fair value of approximately $677.2 million and was comprised of approximately $468.9 million in secured loans, $108.8 million in equipment financings, and $99.6 million in equity and warrants, across 89 portfolio companies. As of December 31, 2020, our investment portfolio had an

Table of Contents

aggregate fair value of approximately $493.7 million and was comprised of approximately $320.7 million in secured loans, $122.5 million in equipment financings, and $50.5 million in equity and equity-related investments, including warrants, across 80 portfolio companies.

A summary of the composition of our investment portfolio at cost and fair value as a percentage of total investments are shown in following table as of September 30, 2021 and December 31, 2020:


	September 30, 2021		December 31, 2020

		Fair		Fair
Type	Cost	Value	Cost	Value
Secured Loans	74.3%	69.2%	65.1%	65.0%
Equipment Financings	17.0%	16.1%	24.7%	24.8%
Equity	6.4%	10.6%	6.6%	6.6%
Warrants	2.3%	4.1%	3.6%	3.6%
Total	100.0%	100.0%	100.0%	100.0%

The following table shows the composition of our investment portfolio by geographic region at cost and fair value as a percentage of total investments as of September 30, 2021 and December 31, 2020. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.


	September 30, 2021		December 31, 2020
		Fair		Fair
Geographic Region	Cost	Value	Cost	Value
United States
West	45.4%	48.4%	49.6%	48.8%
Northeast	27.2%	26.2%	26.4%	25.9%
South	9.3%	8.8%	0.1%	0.4%
Mountain	8.0%	7.8%	6.8%	6.9%
Midwest	4.8%	3.9%	9.5%	8.9%
Southeast	0.2%	0.1%	2.2%	3.6%
Canada	5.1%	4.8%	5.4%	5.5%
Total	100.0%	100.0%	100.0%	100.0%

Table of Contents

Set forth below is a table showing the industry composition of our investment portfolio at cost and fair value as a percentage of total investments as of September 30, 2021 and December 31, 2020:


	September 30, 2021		December 31, 2020
		Fair		Fair
Industry	Cost	Value	Cost	Value
Manufacturing	24.3%	26.5%	20.8%	20.2%
Professional, Scientific, and Technical Services	17.2%	18.4%	15.6%	16.0%
Information	9.5%	9.2%	6.4%	6.2%
Finance and Insurance	8.2%	8.0%	7.0%	7.2%
Health Care and Social Assistance	7.8%	6.6%	2.9%	2.3%
Retail Trade	5.3%	5.0%	15.7%	15.4%
Real Estate	5.0%	4.7%	3.5%	3.5%
Space Research and Technology	4.8%	4.5%	0.0%	0.0%
Rental and Leasing Services	4.2%	4.0%	5.8%	5.9%
Utilities	3.5%	3.3%	5.4%	5.5%
Educational Services	2.8%	2.8%	1.9%	2.0%
Agriculture, Forestry, Fishing and Hunting	1.9%	2.1%	4.2%	4.2%
Wholesale Trade	1.7%	1.6%	4.8%	4.8%
Administrative and Support and Waste Management and Remediation Services	1.1%	1.2%	0.5%	0.5%
Construction	1.8%	1.2%	2.0%	1.4%
Pharmaceutical	0.9%	0.9%	3.5%	4.9%
Total	100.0%	100.0%	100.0%	100.0%

As of September 30, 2021 and December 31, 2020, the debt, including loans and equipment financings, in our portfolio had a weighted average time to maturity of approximately 3.4 years. Additional information regarding our portfolio is set forth in the schedule of investments and the related notes thereto included with this Quarterly Report on Form 10-Q.

Concentrations of Credit Risk

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount. Industry and sector concentrations will vary from period to period based on portfolio activity.

As of September 30, 2021 and December 31, 2020, the Company’s ten largest portfolio companies represented approximately 37.8% and 42.5%, respectively, of the total fair value of the Company’s investments in portfolio companies. As of September 30, 2021 and December 31, 2020, the Company had nine and 14 portfolio companies that represented 5% or more of the Company’s net assets, respectively.

Investment Activity

During the nine months ended September 30, 2021, we made an aggregate of approximately $235.8 million of investments in 22 new portfolio companies and approximately $124.9 million of investments in 20 existing portfolio companies, excluding fees. During the nine months ended September 30, 2021, we received an aggregate of $240.1 million in proceeds from repayments and sales of our investments, including proceeds of approximately $165.5 million from early repayments on our debt investments.

During the year ended December 31, 2020, in addition to $417.0 million in investments we acquired in connection with the Formation Transactions, we made an aggregate of approximately $144.3 million of investments in 18 new portfolio companies and approximately $95.7 million of investments in 18 existing portfolio companies. During the year ended December 31, 2020, we received an aggregate of $160.9 million in proceeds from repayments and sales of our investments including proceeds of approximately $108.8 million from early repayments.

Table of Contents

The following table provides a summary of the changes in the investment portfolio for the nine months ended September 30, 2021 and the year ended December 31, 2020 (in thousands):



	Nine Months Ended		Year Ended
	September 30, 2021		December 31, 2020
Beginning Portfolio	$	493,651	$	—
Formation Transactions acquisitions		—		417,023
Purchases, net of deferred fees		358,450		238,564
Non-cash conversion		—		1,263
Proceeds from Paydowns and Sales		(57,142)		(52,111)
Proceeds from early debt repayments		(182,990)		(108,790)
Accretion of OID and EOT payments		16,806		11,788
Net realized gain/(loss)		5,256		(9,403)
Third party participation ⁽¹⁾		(283)		283
Change in unrealized appreciation/(depreciation)		43,498		(4,966)
Ending Portfolio	$	677,246	$	493,651

(1)

Certain third parties had rights to 17,485 shares of Ology Bioservices common stock at a fair value of approximately $0.6 million as of December 31, 2020. During March 2021, these shares were reissued by Ology Bioservices directly to the third parties and the corresponding liability was removed from the Consolidated Statement of Assets and Liabilities. The activity related to these shares and the related liability is recorded against unrealized appreciation/(depreciation).

The level of our investment activity can vary substantially from period to period depending on many factors, including the amount of debt, including loans and equipment financings, and equity capital required by growth stage companies, the general economic environment and market conditions and the competitive environment for the types of investments we make.

Portfolio Asset Quality

Our portfolio management team uses an ongoing investment risk rating system to characterize and monitor our outstanding loans and equipment financings. Our portfolio management team monitors and, when appropriate, recommends changes to the investment risk ratings. Our Investment Committee reviews the recommendations and/or changes to the investment risk ratings, which are submitted on a quarterly basis to the Board and its Audit Committee.

Table of Contents

For our investment risk rating system, we review seven different criteria and, based on our review of such criteria, we assign a risk rating on a scale of 1 to 5, as set forth in the following illustration.

The following table shows the distribution of our loan and equipment financing investments on the 1 to 5 investment risk rating scale range at fair value as of September 30, 2021 and December 31, 2020 (dollars in thousands):


		September 30, 2021			December 31, 2020
Investment Risk Rating		Investments at		Percentage of	Investments at		Percentage of
Scale Range	Designation	Fair Value		Total Portfolio	Fair Value		Total Portfolio
4.0 - 5.0	Very Strong Performance	$	62,872	10.9%	$	92,519	20.9%
3.0 - 3.9	Strong Performance		224,287	38.8%		212,969	48.0%
2.0 - 2.9	Performing		267,391	46.3%		116,895	26.4%
1.6 - 1.9	Watch		16,194	2.8%		19,230	4.3%
1.0 - 1.5	Default/Workout		6,919	1.2%		1,606	0.4%
Total		$	577,663	100.0%	$	443,219	100.0%

At September 30, 2021 and December 31, 2020, our loan and equipment financing investments had a weighted average risk rating score of 3.1.

Debt Investments on Non-Accrual Status

When a debt security becomes 90 days or more past due, or if our management otherwise does not expect that principal, interest, and other obligations due will be collected in full, we will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or we believe the borrower has demonstrated the ability to repay its current and future contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable is determined to be doubtful. However, we may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection.

As of September 30, 2021, loans to two portfolio companies were on non-accrual status with a total cost of approximately $13.0 million, and a total fair market value of approximately $7.6 million, or 1.1%, of the fair value of the Company’s investment portfolio. As of December 30, 2020, loans to three portfolio companies were on non-accrual status with a total cost of approximately $3.4 million, and a total fair value of approximately $2.2 million, or 0.5%, of the total fair value of the Company’s investment portfolio.

Table of Contents

Results of Operations

The following discussion and analysis of our results of operations encompasses our consolidated results for the three and nine months ended September 30, 2021 and 2020. We were formed on August 12, 2019 and commenced operations on January 16, 2020. Prior to January 16, 2020, we had no operations, except for immaterial matters relating to our formation and organization as a BDC.

Investment Income

The following table sets forth the components of investment income (in thousands):


	Three Months Ended				Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Stated interest income	$	14,025	$	9,514	$	38,205	$	27,715
Amortization of original issue discount		4,042		2,740		11,198		7,430
Acceleration of amortization of original issue discount		2,592		307		5,715		1,670
Prepayment penalty and related fees		294		657		2,239		1,714
Other fee income		837		308		1,229		1,094
Total investment income	$	21,790	$	13,526	$	58,586	$	39,623

We generate revenues primarily in the form of investment income from the investments we hold, generally in the form of interest income from our debt securities. Investment income represents interest income recognized as earned in accordance with the contractual terms of the loan agreement. Interest income from original issue discount (“OID”) represents the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities, including loans and equipment financings and is accreted into interest income over the term of the loan as a yield enhancement. Interest income from payment-in-kind (“PIK”) represents contractually deferred interest added to the loan balance recorded on an accrual basis to the extent such amounts are expected to be collected.

Loan and commitment fees in excess of related expenses are amortized into interest income over the contractual life of the loan. The Company also recognizes certain fees as one-time fee income, including, but not limited to, prepayment penalties, fees related to select covenant default, late-payment fees, structuring fees and exit fees related to a change in ownership of the portfolio company.

For the three months ended September 30, 2021, total investment income was approximately $21.8 million, which represents an approximate effective yield of 15.8% on the average investments during such period. For the three months ended September 30, 2020, total investment income was approximately $13.5 million, which represents an approximate yield of 14.1% on the investments during the period. The increase in investment income for the nine months ended September 30, 2021 is due to higher stated interest income and amortization of OID and EOT based on an increased principal value of income producing debt investments and increased non-recurring fee income, which fluctuates based on investment activity and early repayment activity.

For the nine months ended September 30, 2021, total investment income was approximately $58.6 million, which represents an approximate effective yield of 15.8% on the average investments during such period. For the nine months ended September 30, 2020, total investment income was approximately $39.6 million, which represents an approximate effective yield of 14.6% on the investments during the period. The increase in investment income for the three months ended September 30, 2021 is due to higher stated interest income and amortization of OID and EOT based on an increased principal value of income producing debt investments and increased non-recurring fee income, which can fluctuate based on investment activity and early repayment activity.

Operating Expenses

Our operating expenses are comprised of interest and fees on our borrowings, employee compensation, professional fees and general and administrative expenses. Our operating expenses totaled approximately $10.7 million and $7.9

Table of Contents

million for the three months ended September 30, 2021 and 2020, respectively, and $30.1 million and $21.5 million for the nine months ended September 30, 2021 and 2020, respectively.

Interest Expense and Other Debt Financing Costs

Interest expense and other debt financing costs on our borrowings totaled approximately $5.1 million and $3.9 million for the three months ended September 30, 2021 and 2020, respectively, and approximately $14.2 million and $12.4 million for the nine months ended September 30, 2021 and 2020, respectively. These costs are primarily comprised of interest and fees related to the Credit Facility, the 2025 Notes, the 2026 Notes and the Convertible Notes. Our weighted effective interest rate, comprised of interest and amortization of fees and discount was approximately 7.1% and 6.1% for the three months ended September 30, 2021 and 2020, respectively, and 7.3% and 6.6% for the nine months then ended, respectively. The increase in interest expense for the three months ended September 30, 2021 was primarily due to the issuance of the Convertible Notes in December 2020 and the issuance of the 2026 Notes in August 2021 and the nine month increase partially offset by paydowns in the Credit Facility.

Employee Compensation and Benefits

Employee compensation and benefits totaled approximately $3.7 million and $2.9 million for the three months ended September 30, 2021 and 2020, respectively. Employee compensation and benefits totaled approximately $11.0 million and $6.0 million for the nine months ended September 30, 2021 and 2020, respectively. The increase in employee compensation related expenses relates primarily to the accrual of bonuses expected to be paid at the discretion of management or upon approval of the Board, as applicable, as well as an increased headcount. As of September 30, 2021 and 2020, the Company had 39 and 34 employees, respectively.

The Board and the Company’s stockholders have adopted and approved the (i) 2019 Trinity Capital Inc., Long-Term Incentive Plan; and (ii) Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan, with each plan becoming effective on June 17, 2021. See “Note 8 – Equity Incentive Plans” in the Notes to Consolidated Financial Statements.

Professional Fees Expenses

Professional fees expenses, consisting of legal fees, accounting fees, third-party valuation fees, and talent acquisition fees were approximately $0.8 million and $0.7 million for the three months ended September 30, 2021 and 2020, respectively. Professional fees expenses were approximately $2.0 million and $1.9 million for the nine months ended September 30, 2021 and 2020, respectively.

General and Administrative Expenses

General and administrative expenses include insurance premiums, rent, taxes and various other expenses related to our ongoing operations. Our general and administrative expenses totaled approximately $1.1 million and $0.4 million for the three months ended September 30, 2021 and 2020, respectively. General and administrative expenses totaled approximately $2.9 million and $1.2 million for the nine months ended September 30, 2021 and 2020, respectively. The increase in general and administrative expenses for the three and nine months ended September 30, 2021 is primarily due to higher D&O insurance premiums.

Net Investment Income

As a result of approximately $21.8 million in total investment income as compared to approximately $10.7 million in total expenses, net investment income for the three months ended September 30, 2021 was approximately $11.1 million. As a result of approximately $13.5 million in total investment income as compared to approximately $7.9 million in total expenses, net investment income for the three months ended September 30, 2020 was approximately $5.6 million.

Table of Contents

As a result of approximately $58.6 million in total investment income as compared to approximately $30.1 million in total expenses, net investment income for the nine months ended September 30, 2021 was approximately $28.5 million. As a result of approximately $39.6 million in total investment income as compared to approximately $21.5 million in total expenses, net investment income for the nine months ended September 30, 2020 was approximately $18.1 million.

Net Realized Gains and Losses

Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written-off during the period.

The net realized gains (losses) from the sales, repayments, or exits of investments were comprised of the following (in thousands):


	Three Months Ended				Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Net realized gain (loss) on investments:
Gross realized gains	$	3,531	$	37	$	9,000	$	872
Gross realized losses		(2,865)		(1,527)		(3,744)		(5,246)
Total net realized gains/(losses) on investments	$	666	$	(1,490)	$	5,256	$	(4,374)

Net Change in Unrealized Appreciation / (Depreciation) from Investments

Net change in unrealized appreciation/(depreciation) from investments primarily reflects the net change in the fair value of the investment portfolio and financial instruments and the reclassification of any prior period unrealized appreciation or depreciation on exited investments and financial instruments to realized gains or losses.

Net unrealized appreciation and depreciation on investments for the three and nine months ended September 30, 2021 and 2020 is comprised of the following (in thousands):


	Three Months Ended				Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Gross unrealized appreciation	$	58,347	$	11,576	$	67,654	$	9,509
Gross unrealized depreciation		(16,715)		(3,297)		(21,092)		(23,345)
Third party participation ⁽¹⁾		—		(70)		283		(124)
Net unrealized appreciation/depreciation reclassified related to net realized gains or losses ⁽²⁾		(26,240)		—		(3,347)		—
Total net unrealized gains (losses) on investments	$	15,392	$	8,209	$	43,498	$	(13,960)

(1)	Certain third parties had rights to 17,485 shares of Ology Bioservices common stock at a fair value of approximately $0.6 million as of December 31, 2020. During March 2021, these shares were reissued by Ology Bioservices directly to the

Table of Contents

third parties and the corresponding liability was removed from the Consolidated Statement of Assets and Liabilities. The activity related to these shares and the related liability is recorded against unrealized appreciation/(depreciation).

(2)	Investments were recorded at their fair values in the Formation Transactions on January 16, 2020, therefore no reclassification of unrealized appreciation (depreciation) was recorded during the three or nine months ended September 30, 2020.

The significant changes in net unrealized appreciation (depreciation) from investments during the three months ended September 30, 2021 consisted of the following (in thousands):


	Net Unrealized
	Appreciation
Portfolio Company	(Depreciation)
Birchbox, Inc.	$	10,458
Edeniq, Inc.		3,818
Matterport, Inc.		2,832
Rigetti & Co, Inc.		1,764
Gabi Personal Insurance Agency, Inc.		1,193
Project Frog, Inc.		(903)
Bowery Farming, Inc.		(965)
Vertical Communications, Inc.		(984)
Circle Media Labs, Inc.		(2,309)
Store Intelligence, Inc.		(4,636)
Other, net		5,124
Total	$	15,392

The significant changes in net unrealized appreciation (depreciation) from investments during the three months ended September 30, 2020 consisted of the following (in thousands):


	Net Unrealized
	Appreciation
Portfolio Company	(Depreciation)
Nanotherapeutics, Inc.	$	2,202
GrubMarket, Inc.		903
Instart Logic, Inc.		894
Hospitalists Now, Inc.		730
Edeniq, Inc.		629
Oto Analytics, Inc.		(133)
Footprint International Holding, Inc.		(218)
Atieva, Inc.		(219)
Project Frog, Inc.		(289)
Birchbox, Inc.		(392)
Other, net		4,102
Total	$	8,209

Table of Contents

The significant changes in net unrealized appreciation (depreciation) from investments during the nine months ended September 30, 2021 consisted of the following (in thousands):


	Net Unrealized
	Appreciation
Portfolio Company	(Depreciation)
Lucid Motors, Inc.	$	34,422
Matterport, Inc		8,927
Edeniq, Inc.		4,174
indie Semiconductor, Inc.		2,249
Bowery Farming, Inc.		2,011
WorkWell Prevention & Care		(1,701)
Vertical Communications, Inc.		(2,019)
Circle Media Labs, Inc.		(2,306)
Store Intelligence, Inc.		(5,582)
Ology Bioservices, Inc.		(7,259)
Other, net		10,582
Total	$	43,498

The significant changes in net unrealized appreciation (depreciation) from investments during the nine months ended September 30, 2020 consisted of the following (in thousands):


	Net Unrealized
	Appreciation
Portfolio Company	(Depreciation)
Nanotherapeutics, Inc.	$	3,560
Instart Logic, Inc.		978
GrubMarket, Inc.		898
Store Intelligence, Inc.		818
Hospitalists Now, Inc.		638
Workwell Prevention & Care		(1,710)
Vertical Communications, Inc.		(2,384)
Project Frog, Inc.		(2,398)
Atieva, Inc.		(3,174)
Vidsys, Inc.		(3,907)
Other, net		(7,279)
Total	$	(13,960)

During the three and nine months ended September 30, 2021, we recorded net unrealized appreciation of $15.4 million and $43.5 million, respectively, which was primarily from net unrealized appreciation of approximately $18.6 million and $34.8 million, respectively, from our equity investments including warrants exercised during the period and net unrealized depreciation of ($0.2) million and net unrealized appreciation of $9.9 million, respectively, from our warrant investments, excluding those exercised during the period, partially offset by net unrealized depreciation from our debt investments.

During the three and nine months ended September 30, 2020, we recorded net unrealized appreciation of $8.2 million and net unrealized depreciation of ($14.0) million, respectively. The unrealized appreciation for the three months ended September 30, 2020, was primarily from unrealized appreciation of $2.6 million from our debt investments, $3.7 million from equity investments and $1.9 million from our warrant investments. The ($14.0) million of unrealized depreciation was a result of ($8.8) million of unrealized depreciation from our debt investments, ($3.4) million of unrealized depreciation from our warrant investments, and ($1.8) million of unrealized depreciation from our equity investments.

Table of Contents

Net Increase (Decrease) in Net Assets Resulting from Operations

Net increase in net assets resulting from operations during the three months ended September 30, 2021, was approximately $27.2 million. Net increase in net assets resulting from operations before formation costs during the three months ended September 30, 2020, was approximately $12.3 million. Net increase in net assets resulting from operations during the nine months ended September 30, 2021, was approximately $77.2 million. Net decrease in net assets resulting from operations before formation costs during the nine months ended September 30, 2020, was approximately $15.8 million.

Net Increase (Decrease) in Net Assets Resulting from Operations and Earnings Per Share

For the three months ended September 30, 2021 and 2020, basic net increase in net assets per common share were $1.02 and $0.68, respectively. The increase in 2021 is result of overall increased net operating results. For the nine months ended September 30, 2021, basic net increase in net assets per common share were $3.02 . For the nine months ended September 30, 2020, basic net decrease in net assets per common share were $0.88. Costs related to the acquisition of Trinity Capital Holdings was approximately $13.5 million, and the cost related to the acquisition of the Legacy Funds was approximately $2.1 million. The total cost of $15.6 million, when added to the net decrease in net assets resulting from operations before formation costs, resulted in a net decrease in net assets resulting from operations during the nine months ended September 30, 2020, of approximately $(15.8) million.

Financial Condition, Liquidity and Capital Resources

Our liquidity and capital resources are generated primarily from the net proceeds of offerings of our securities, including our initial public offering, the Private Offerings, the Convertible Notes offering and the 2026 Notes offering, borrowings under the Credit Facility and cash flows from our operations, including investment sales and repayments, as well as income earned on investments and cash equivalents. Our primary use of our funds includes investments in portfolio companies, payments of interest on our outstanding debt, and payments of fees and other operating expenses we incur. We also expect to use our funds to pay distributions to our stockholders. We have used, and expect to continue to use, our borrowings, including under the Credit Facility or any future credit facility, and proceeds from the turnover of our portfolio to finance our investment objectives and activities.

We may, from time to time, enter into additional credit facilities, increase the size of our existing Credit Facility, or issue additional securities in private or public offerings. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions, and other factors.

For the nine months ended September 30, 2021, we experienced a net decrease in cash and cash equivalents in the amount of $20.8 million, which is the net result of $104.3 million of cash used in operating activities and $1.2 million of cash used in investing activities partially offset by $84.7 million of cash provided by financing activities. During the nine months ended September 30, 2020, we experienced a net increase in cash and cash equivalents in the amount of $52.7 million, which is the net result of $148.2 million of cash provided by financing activities partially offset by $91.8 million of cash used in investing activities and $3.9 million of cash from operating activities.

As of September 30, 2021 and December 31, 2020, we had cash, cash equivalents and restricted cash of $40.3 million and $61.1 million, respectively, of which $39.7 and $60.3 million, respectively, is held in the Goldman Sachs Financial Square Government Institutional Fund. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insured limit and therefore is subject to credit risk. All of the Company’s cash deposits are held at large established high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote. As of September 30, 2021 and December 31, 2020, restricted cash consisted of approximately $15.0 million and $15.7 million, respectively, related to the Credit Facility covenants (See “Note 5 – Borrowings”), and an additional amount of approximately $0.7 million at December 31, 2020 was held in escrow related to the payout of a severance related liability assumed as part of the Formation Transactions with respect to a former member of certain general partners of certain Legacy Funds. As of September 30, 2021 and December 31, 2020, we had approximately $181.5 million and $42.0 million, respectively, of available borrowings under the Credit Facility, subject to its terms and regulatory requirements. Cash, cash equivalents and restricted cash,

Table of Contents

taken together with available borrowings under the Credit Facility, as of September 30, 2021, are expected to be sufficient for our investing activities and to conduct our operations in the near term.

On January 16, 2020, in connection with the Formation Transactions, we became a party to, and assumed, the Credit Facility through our wholly owned subsidiary, Trinity Funding 1, LLC. The Credit Facility matures on January 8, 2022, unless extended, and we have the ability to borrow up to an aggregate of $300.0 million. In addition, borrowings under the Credit Facility are subject to floating interest rates based on LIBOR, generally bearing interest at a rate of the three-month LIBOR plus 3.25%. We may utilize the leverage available under the Credit Facility to finance future investments. We used a portion of the proceeds from the Private Offerings to repay a portion of the aggregate amount outstanding under the Credit Facility in amount of approximately $60 million. As of September 30, 2021 and December 31, 2020, approximately $10.0 million and $135.0 million, respectively, was outstanding under the Credit Facility. During the three months ended September 30, 2021 we borrowed $46.0 million under the Credit Facility and made repayments of $106.0 million. During the nine months ended September 30, 2021, the Company borrowed an additional $71.0 million and made repayments of $196.0 million to Credit Suisse under the Credit Facility. During the three months ended September 30, 2020, we borrowed $10.0 million with no repayments. During the nine months ended September 30, 2020, we made repayments of approximately $85.0 million to Credit Suisse under the Credit Facility and borrowed an additional $10.0 million.

In January 2020, we completed the Private Common Stock Offering in reliance upon the available exemptions from the registration requirements of the Securities Act, pursuant to which we issued and sold 8,333,333 shares of our common stock for aggregate gross proceeds of approximately $125.0 million. A portion of the proceeds of the Private Common Stock Offering were used to complete the Formation Transactions and repay a portion of the outstanding borrowings under the Credit Facility.

In January 2020, concurrent with the completion of the Private Common Stock Offering, we completed the 144A Note Offering in reliance upon the available exemptions from the registration requirements of the Securities Act, pursuant to which we issued and sold $125.0 million in aggregate principal amount of the unsecured 2025 Notes that mature on January 16, 2025, unless repurchased or redeemed in accordance with their terms prior to such date and bear interest at a fixed rate of 7.00% per year, payable quarterly on March 15, June 15, September 15 and December 15 of each year. A portion of the proceeds of the 144A Note Offering were used to complete the Formation Transactions and repay a portion of the outstanding borrowings under the Credit Facility. Aggregate estimated offering expenses in connection with the transaction, including the fees and commissions, were approximately $4.8 million. As of September 30, 2021 and December 31, 2020, we had $125.0 million in aggregate principal amount of 2025 Notes outstanding.

In December 2020, we issued $50.0 million in aggregate principal amount of the Convertible Notes. The sale generated net proceeds of $47.0 million, including $1.7 million of debt issuance costs and $1.3 million of original issue discount. The Convertible Notes bear interest at a rate of 6.00% per year, payable semiannually in arrears on May 1 and November 1, of each year. The Convertible Notes mature on December 11, 2025, unless earlier converted by noteholders or purchased by the Company at the noteholders option upon the occurrence of a fundamental change, as defined in the indenture governing the Convertible Notes. As of September 30, 2021 and December 31, 2020, we had $50.0 million in aggregate principal amount of Convertible Notes outstanding.

In August 2021, we issued $125.0 million in aggregate principal amount of the 2026 Notes. The sale generated net proceeds of $122.4 million, including $2.6 million of debt issuance costs. The 2026 Notes mature on August 24, 2026, unless repurchased or redeemed in accordance with their terms prior to such date, and bear interest at a fixed rate of 4.375% per year, payable semiannually in arrears on February 15 and August 15 of each year. As of September 30, 2021, we had $125.0 million in aggregate principal amount of 2026 Notes outstanding.

On January 29, 2021, our common stock began trading on the Nasdaq Global Select Market under the symbol “TRIN.” On February 2, 2021, we completed our initial public offering of 8,006,291 shares of common stock at a price of $14.00 per share, inclusive of the underwriters’ option to purchase additional shares, which was exercised in full. Proceeds from this offering were primarily used to pay down a portion of our existing indebtedness outstanding under the Credit Facility.

Table of Contents

Refer to “Item 1. Consolidated Financial Statements – Note 5 – Borrowings” included in the notes to our consolidated financial statements appearing elsewhere in this report for a discussion of our borrowings.

Reduced Asset Coverage Requirements

In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. On September 27, 2019, the Board, including a “required majority” (as such term is defined in Section 57(o) of the 1940 Act) and our initial stockholder approved the application to us of the 150% minimum asset coverage ratio set forth in Section 61(a)(2) of the 1940 Act. As a result, effective September 28, 2019, the asset coverage ratio under the 1940 Act applicable to us decreased from 200% to 150%, permitting us to potentially borrow $2 for investment purposes of every $1 of investor equity. As of September 30, 2021, our asset coverage ratio was approximately 228.7% and our asset coverage ratio per unit was approximately $2,287. As of December 31, 2020, our asset coverage ratio was approximately 177.0% and our asset coverage ratio per unit was approximately $1,770. We target a leverage range of between 1.15x and 1.35x.

Commitments and Off-Balance Sheet Arrangements

Other than contractual commitments with respect to our portfolio companies and other legal contingencies incurred in the normal course of our business, we do not have any off-balance sheet financings or liabilities as of September 30, 2021 or December 31, 2020.

The Company’s commitments and contingencies consist primarily of unfunded commitments to extend credit in the form of loans to the Company’s portfolio companies. A portion of these unfunded contractual commitments as of September 30, 2021 and December 31, 2020 are dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Company’s credit agreements with its portfolio companies generally contain customary lending provisions that allow the Company relief from funding obligations for previously made commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the company. Since a portion of these commitments may expire without being withdrawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Company’s disclosure of unfunded contractual commitments includes only those which are available at the request of the portfolio company and unencumbered by milestones. As of September 30, 2021, the Company had outstanding unfunded commitments of approximately $0.4 million to one portfolio company, Dandelion, Inc. The Company will fund its future unfunded commitments from the same sources it uses to fund its investment commitments that are funded at the time they are made (which are typically through existing cash and cash equivalents and borrowings under the Credit Facility).

In the normal course of business, the Company enters into contracts that provide a variety of representations and warranties, and general indemnifications. Such contracts include those with certain service providers, brokers and trading counterparties. Any exposure to the Company under these arrangements is unknown as it would involve future claims that may be made against the Company; however, based on the Company’s experience, the risk of loss is remote and no such claims are expected to occur. As such, the Company has not accrued any liability in connection with such indemnifications.

Table of Contents

Contractual Obligations

A summary of our contractual payment obligations as of September 30, 2021, is as follows:


	Payments Due by Period
	Less than 1
	year		1 - 3 years		4 - 5 years		After 5 years		Total
Credit Facility	$	10,000	$	—	$	—	$	—	$	10,000
2025 Notes		—		—		125,000		—		125,000
Convertible Notes		—		—		50,000		—		50,000
2026 Notes		—		—		125,000		—		125,000
Operating Leases ⁽¹⁾		56		845		751		1,619		3,271
Total Contractual Obligations	$	10,056	$	845	$	300,751	$	1,619	$	313,271

(1)	Relates to lease for the Chandler office, which expires on July 31, 2022 and is subject to a five-year extension option that will not be exercised. Also includes the lease for our new headquarters in downtown Phoenix, Arizona which commenced on June 4, 2021.

Distributions

We intend to pay quarterly distributions to our stockholders out of assets legally available for distribution. All distributions will be paid at the discretion of the Board and will depend on our earnings, financial condition, maintenance of our tax treatment as a RIC, compliance with applicable BDC regulations and such other factors as the Board may deem relevant from time to time.

The following table summarizes distributions declared and/or paid by the Company since inception:


Declaration Date	Record Date	Payment Date	Per Share Amount
May 7, 2020	May 29, 2020	June 5, 2020	$	0.22
August 10, 2020	August 21, 2020	September 4, 2020		0.27
November 9, 2020	November 20, 2020	December 4, 2020		0.27
December 22, 2020	December 30, 2020	January 15, 2021		0.27
March 23, 2021	March 31, 2021	April 16, 2021		0.28
June 15, 2021	June 30, 2021	July 15, 2021		0.29
September 13, 2021	September 30, 2021	October 15, 2021		0.33
		Total	$	1.93

Table of Contents

Price Range of Common Stock

Our common stock began trading on the Nasdaq Global Select Market (“Nasdaq”) on January 29, 2021 under the symbol “TRIN” in connection with our initial public offering, which closed on February 2, 2021 (“IPO”). Prior to our IPO, the shares of our common stock were offered and sold in transactions exempt from registration under the Securities Act. As such, there was no public market for shares of our common stock during our fiscal quarters and years preceding December 31, 2020. Since our IPO, our common stock has traded at prices both above and below our net asset value per share. It is not possible to predict whether our common stock will trade at a price per share at, above or below net asset value per share.

The following table sets forth the net asset value per share of our common stock, the range of high and low closing sales prices of our common stock reported on Nasdaq, the closing sales price as a premium (discount) to net asset value and the dividends declared by us in each fiscal quarter since we began trading on Nasdaq. On November 3, 2021, the last reported closing sales price of our common stock on Nasdaq was $16.34 per share, which represented a premium of approximately 11.2% to our net asset value per share of $14.70 as of September 30, 2021, the last date prior to the date of this prospectus supplement for which we reported net asset value. As of November 3, 2021, we had approximately 145 stockholders of record, which does not include stockholders for whom shares are held in nominee or “street” name.


				Price Range
Class and Period	Net Asset Value⁽¹⁾		High		Low		High Sales Price Premium (Discount) to Net Asset Value⁽²⁾		Low Sales Price Premium (Discount) to Net Asset Value⁽²⁾		Cash Dividend Per Share⁽³⁾
Year Ending December 31, 2021
Fourth Quarter (through November 3, 2021)		*	$	16.40	$	15.79	*		*			*
Third Quarter	$	14.70	$	16.73	$	14.14	13.8	%	(3.8)	%	$	0.33
Second Quarter	$	14.33	$	15.00	$	14.10	4.7	%	(1.6)	%	$	0.29
First Quarter⁽⁴⁾	$	13.69	$	15.65	$	13.75	14.3	%	0.4	%	$	0.28

(1)	Net asset value per share is determined as of the last day in the relevant quarter and therefore may not reflect the net asset value per share on the date of the high and low closing sales prices. The net asset values shown are based on outstanding shares at the end of the relevant quarter.

(2)	Calculated as the respective high or low closing sales price less net asset value, divided by net asset value (in each case, as of the applicable quarter).

(3)	Represents the dividend or distribution declared in the relevant quarter.

(4)	Shares of our common stock began trading on Nasdaq on January 29, 2021 under the trading symbol “TRIN”.

* Not determined at time of filing.

Related Party Transactions

As discussed herein, the Legacy Funds were merged with and into the Company and we issued 9,183,185 shares of our common stock at $15.00 per share for a total value of approximately $137.7 million and paid approximately $108.7 million in cash to the Legacy Investors, which include the general partners/managers of the Legacy Funds. In addition,

Table of Contents

as part of the Formation Transactions, we acquired 100% of the equity interests of Trinity Capital Holdings for shares of our common stock and cash. Members of our management, including Steven L. Brown, Kyle Brown, Gerald Harder and Ron Kundich, owned 100% of the equity interests in Trinity Capital Holdings and controlling interests in the general partners/managers of the Legacy Funds.

We have entered into indemnification agreements with our directors and executive officers. The indemnification agreements are intended to provide our directors and executive officers with the maximum indemnification permitted under Maryland law and the 1940 Act. Each indemnification agreement provides that we shall indemnify the director or executive officer who is a party to the agreement, or an “Indemnitee,” including the advancement of legal expenses, if, by reason of his or her corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed proceeding, to the maximum extent permitted by Maryland law and the 1940 Act.

Refer to “Item 1. Consolidated Financial Statements – Note 12 – Related Party Transactions” included in the notes to our consolidated financial statements appearing elsewhere in this report for additional information.

Recent Developments

KeyBank Credit Facility

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are subject to financial market risks, including valuation risk and interest rate risk. Uncertainty with respect to the economic effects of the COVID-19 pandemic has introduced significant volatility in the financial markets, and the effect of the volatility could materially impact our market risks, including those listed below.

Table of Contents

Valuation Risk

Our investments may not have a readily available market price, and we value these investments at fair value as determined in good faith by the Board of Directors in accordance with our valuation policy. There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of our investments may fluctuate from period to period, including as a result of the impact of the COVID-19 pandemic on the economy and financial and capital markets. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been used had a ready market for the investments existed, and it is possible that the difference could be material.

Interest Rate Risk

Interest rate sensitivity and risk refer to the change in earnings that may result from changes in the level of interest rates. To the extent that we borrow money to make investments, including under the Credit Facility or any future financing arrangement, our net investment income will be affected by the difference between the rate at which we borrow funds and the rate at which we invest these funds. In periods of rising interest rates, our cost of borrowing funds would increase, which may reduce our net investment income. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income.

As of September 30, 2021, approximately 60.0% of our debt investments based on outstanding principal balance represented floating-rate investments based on Prime or LIBOR, and approximately 40.0% of our debt investments based on outstanding principal balance represented fixed rate investments. In addition, borrowings under the Credit Facility are subject to floating interest rates based on LIBOR, generally bearing interest at a rate of the three-month LIBOR plus 3.25%.

Based on our Consolidated Statements of Operations as of September 30, 2021, the following table shows the annualized impact on net income of hypothetical base rate changes in the Prime rate on our debt investments (considering interest rate floors for floating rate instruments) and the hypothetical base rate changes in the three-month LIBOR on our Credit Facility and there are no changes in our investment and borrowing structure (in thousands):


	Interest		Interest		Net
	Income		Expense		Income/(Loss)
Up 300 basis points	$	9,182	$	300	$	8,882
Up 200 basis points	$	5,786	$	200	$	5,586
Up 100 basis points	$	2,628	$	100	$	2,528
Down 100 basis points	$	—	$	(12)	$	12
Down 200 basis points	$	—	$	(12)	$	12
Down 300 basis points	$	—	$	(12)	$	12

Currency Risk

In addition, any investments we make that are denominated in a foreign currency will be subject to risks associated with changes in currency exchange rates. These risks include the possibility of significant fluctuations in the foreign currency markets, the imposition or modification of foreign exchange controls and potential illiquidity in the secondary market. These risks will vary depending upon the currency or currencies involved. As of September 30, 2021, we had two foreign domiciled portfolio companies. Our exposure to currency risk related to the debt investments is minimal as payments from such portfolio companies are received in U.S. dollars. No other investments at September 30, 2021 were subject to currency risk.

Table of Contents

Hedging

We do not currently engage in any hedging activities. However, we may, in the future, hedge against interest rate and currency exchange rate fluctuations by using standard hedging instruments such as futures, options and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in benefits of lower interest rates with respect to our portfolio of investments with fixed interest rates. We may also borrow funds in local currency as a way to hedge our non-U.S. denominated investments.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

In accordance with Rules 13a-15(b) and 15d-15(b) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q and determined that our disclosure controls and procedures are effective as of the end of the period covered by this Quarterly Report on Form 10-Q.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period ended September 30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II: OTHER INFORMATION

Item 1. Legal Proceedings

We are not currently subject to any material legal proceedings, nor, to our knowledge, are any material legal proceedings threatened against us. From time to time, we may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Furthermore, third parties may seek to impose liability on us in connection with the activities of our portfolio companies. Our business is also subject to extensive regulation, which may result in regulatory proceedings against us. While the outcome of these legal or regulatory proceedings cannot be predicted with certainty, we do not expect that these proceedings will have a material effect upon our financial condition or results of operations.

Item 1A. Risk Factors

Investing in our securities involves a number of significant risks. In addition to the other information set forth in this quarterly report on Form 10-Q, including the risk factors set forth below, you should carefully consider the risk factors discussed in “Item 1A. Risk Factors” of Annual Report on Form 10 K filed with the SEC on March 4, 2021, all of which could materially affect our business, financial condition and/or results of operations. Although the risks described below and in our other SEC filings referenced above represent the principal risks associated with an investment in us, they are not the only risks we face. Additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial, might materially and adversely affect our business, financial condition and/or results of operations.

Other than as described below, during the nine months ended September 30, 2021, there have been no material changes to the risk factors discussed in our SEC filings referenced above.

Existing stockholders may incur dilution if, in the future, we sell shares of our common stock in one or more offerings at prices below the then current net asset value per share of our common stock.

The 1940 Act prohibits us from selling shares of our common stock at a price below the current net asset value per share of such stock, with certain exceptions. One such exception is prior stockholder approval of issuances below net asset value provided that our Board of Directors makes certain determinations. At our 2021 Annual Meeting of Stockholders held on June 17, 2021, our stockholders voted to allow us to issue common stock at a price below net asset value per share for the period ending on the earlier of the one-year anniversary of the date of our 2021 Annual Meeting of Stockholders and the date of our 2022 Annual Meeting of Stockholders, which is expected to be held in May or June 2022. The proposal approved by our stockholders at our 2021 Annual Meeting of Stockholders did not specify a maximum discount below net asset value at which we are able to issue our common stock, although the number of shares sold in one or more offerings may not exceed 25% of our outstanding common stock as of the date of stockholder approval of this proposal.

If we were to issue or sell shares of our common stock at a price below our net asset value per share, such sales would result in an immediate dilution to our net asset value per share and pose a risk of dilution to our stockholders. In particular, stockholders who do not purchase additional shares at or below such discounted price in proportion to their current ownership will experience an immediate decrease in net asset value per share (as well as in the aggregate net asset value of their shares if they do not participate at all). These stockholders will also experience a disproportionately greater decrease in their participation in our earnings and assets and their voting power than the increase we experience in our assets, potential earning power and voting interests from such issuance or sale. In addition, such issuances or sales may adversely affect the price at which our common stock trades.

Because the number of shares of common stock that could be so issued and the timing of any issuance is not currently known, the actual dilutive effect cannot be predicted.

Table of Contents

We are exposed to risks associated with changes in interest rates.

Because we may borrow money to make investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds and the rate at which we invest those funds. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. A reduction in the interest rates on new investments relative to interest rates on current investments could have an adverse impact on our net investment income. However, an increase in interest rates could decrease the value of any investments we hold which earn fixed interest rates and also could increase our interest expense, thereby decreasing our net income. Also, an increase in interest rates available to investors could make an investment in our common stock less attractive if we are not able to increase our distribution rate, which could reduce the value of our common stock. Further, rising interest rates could also adversely affect our performance if such increases cause our borrowing costs to rise at a rate in excess of the rate that our investments yield.

In periods of rising interest rates, to the extent we borrow money subject to a floating interest rate, our cost of funds would increase, which could reduce our net investment income. Further, rising interest rates could also adversely affect our performance if we hold investments with floating interest rates, subject to specified minimum interest rates (such as a LIBOR floor), while at the same time engaging in borrowings subject to floating interest rates not subject to such minimums. In such a scenario, rising interest rates may increase our interest expense, even though our interest income from investments is not increasing in a corresponding manner as a result of such minimum interest rates.

If general interest rates rise, there is a risk that the portfolio companies in which we hold floating rate securities will be unable to pay escalating interest amounts, which could result in a default under their loan documents with us. Rising interest rates could also cause portfolio companies to shift cash from other productive uses to the payment of interest, which may have a material adverse effect on their business and operations and could, over time, lead to increased defaults. In addition, rising interest rates may increase pressure on us to provide fixed rate loans to our portfolio companies, which could adversely affect our net investment income, as increases in our cost of borrowed funds would not be accompanied by increased interest income from such fixed-rate investments.

On July 27, 2017, the United Kingdom’s Financial Conduct Authority (the “FCA”), which regulates LIBOR, announced that it intends to phase out LIBOR by the end of 2021. On November 30, 2020, ICE Benchmark Administration (“IBA”), the administrator of LIBOR, with the support of the United States Federal Reserve and the FCA, announced plans to consult on ceasing publication of USD LIBOR on December 31, 2021 for only the one week and two month USD LIBOR tenors, and on June 30, 2023 for all other USD LIBOR tenors, which the FCA subsequently confirmed on March 5, 2021. The United States Federal Reserve concurrently issued a statement advising banks to stop new USD LIBOR issuances by the end of 2021. Such announcements indicate that the continuation of LIBOR on the current basis cannot and will not be guaranteed after 2021. It appears highly likely that LIBOR will be discontinued or modified by 2021.

The U.S. Federal Reserve, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions (the “ARRC”), is considering replacing U.S. dollar LIBOR with a new index calculated by short term repurchase agreements, backed by Treasury securities called the Secured Overnight Financing Rate (“SOFR”). The first publication of SOFR was released in April 2018. On July 29, 2021, the ARRC formally recommended SOFR as its preferred alternative replacement rate for LIBOR. Whether or not SOFR attains market traction as a LIBOR replacement remains a question and the future of LIBOR at this time is uncertain. Although SOFR appears to be the preferred replacement rate for U.S. dollar LIBOR, at this time, it is not possible to predict the effect of any such changes, any establishment of alternative reference rates or any other reforms to LIBOR that may be enacted. The elimination of LIBOR or any other changes or reforms to the determination or supervision of LIBOR could have an adverse impact on the market for or value of any LIBOR-linked securities, loans, and other financial obligations or extensions of credit held by or due to us or on our overall financial condition or results of operations. In addition, if LIBOR ceases to exist, we may need to renegotiate credit agreements extending beyond 2021 with our portfolio companies that utilize LIBOR as a factor in determining the interest rate, in order to replace LIBOR with the new standard that is established, which may have an adverse effect on our overall financial condition or results of operations. Following the replacement of LIBOR, some or all of these credit agreements may bear interest a lower interest rate, which could have an adverse impact on our results of operations. Furthermore, under the Credit Facility with Credit

Table of Contents

Suisse, borrowings generally will bear interest at a rate of the three-month LIBOR plus 3.25%. If LIBOR ceases to exist, we will need to renegotiate certain terms of the Credit Facility. If we are unable to do so, amounts drawn under the Credit Facility may bear interest at a higher rate, which would increase the cost of our borrowings and, in turn, affect our results of operations.

We cannot predict how new tax legislation will affect us, our investments, or our stockholders, and any such legislation could adversely affect our business.

Legislative or other actions relating to taxes could have a negative effect on us. The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. The Biden Administration has proposed significant changes to the existing U.S. tax rules, and there are a number of proposals in Congress that would similarly modify the existing U.S. tax rules. The likelihood of any such legislation being enacted is uncertain, but new legislation and any U.S. Treasury regulations, administrative interpretations or court decisions interpreting such legislation could significantly and negatively affect our ability to qualify for tax treatment as a RIC or the U.S. federal income tax consequences to us and our investors of such qualification or could have other adverse consequences. Investors are urged to consult with their tax advisor regarding tax legislative, regulatory, or administrative developments and proposals and their potential effect on an investment in our common stock.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On July 15, 2021, pursuant to its amended and restated distribution reinvestment plan, the Company issued 63,390 shares of its common stock, at a price of $14.48 per share, to stockholders of record as of June 30, 2021 that did not opt out of the Company’s amended and restated distribution reinvestment plan in order to satisfy the reinvestment portion of the Company’s distribution. This issuance was not subject to the registration requirements of the Securities Act.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information

None.

Table of Contents

Item 6. Exhibits

The following exhibits are filed as part of this Quarterly Report on Form 10-Q or hereby incorporated by reference to exhibits previously filed with the SEC:


Exhibit Number		Description of Exhibits
3.1		Articles of Amendment and Restatement (incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form 10 filed on January 16, 2020).
3.2		Bylaws (incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form 10 filed on January 16, 2020).
4.1		Registration Rights Agreement, dated January 16, 2020 (Notes) (incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form 10 filed on January 16, 2020).
4.2		Registration Rights Agreement, dated December 11, 2020 (Convertible Notes) (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on December 14, 2020).
4.3		Indenture, dated as of January 16, 2020, by and between Trinity Capital Inc. and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form 10 filed on January 16, 2020).
4.4		First Supplemental Indenture, dated as of January 16, 2020, relating to the 7.00% Notes due 2025, by and between Trinity Capital Inc. and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.4 to the Company’s Registration Statement on Form 10 filed on January 16, 2020).
4.5		Form of 7.00% Note due 2025 (included as part of and incorporated by reference to Exhibit 4.5 hereto).
4.6		Second Supplemental Indenture, dated December 11, 2020, relating to the 6.00% Convertible Notes due 2025, between Trinity Capital Inc. and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed on December 14, 2020).
4.7		Form of 6.00% Convertible Notes due 2025 (included as part of and incorporated by reference to Exhibit 4.7 hereto).
4.8		Third Supplemental Indenture, dated August 24, 2021, relating to the 4.375% Note due 2026, by and between Trinity Capital Inc. and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K, filed on August 24, 2021).
4.9		Form of 4.375% Notes due 2026 (included as part of and incorporated by reference to Exhibit 4.9 hereto).
10.1		2019 Trinity Capital Inc. Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on June 23, 2021).
10.2		Form of Restricted Stock Agreement (2019 Trinity Capital Inc. Long Term Incentive Plan) (incorporated by reference to Exhibit 4.4 to the Company’s Registration Statement on Form S-8 filed on September 14, 2021).
10.3		Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on June 23, 2021).
10.4		Form of Restricted Stock Agreement (Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan) (incorporated by reference to Exhibit 4.6 to the Company’s Registration Statement on Form S-8 filed on September 14, 2021).
10.5		Form of Credit Agreement, dated October 27, 2021, relating to the Key Bank Credit Facility, by and among Trinity Capital, Inc., TrinCap Funding, LLC, KeyBank National Association, as administrative agent and syndication agent, Wells Fargo, National Association, as collateral custodian and paying agent, and the lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on November 1, 2021).
10.6		Sale and Contribution Agreement, dated October 27, 2021, between the Company and TrinCap Funding, LLC (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on November 1, 2021).
31.1*		Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

100

Table of Contents

31.2*		Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

* Filed herewith

101

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	TRINITY CAPITAL INC.

Dated: November 4, 2021	By:	/s/ Steven L. Brown
		Steven L. Brown
		Chairman and Chief Executive Officer
		(Principal Executive Officer)



Dated: November 4, 2021	By:	/s/ David Lund
		David Lund
		Chief Financial Officer and Treasurer
		(Principal Financial and Accounting Officer)

102